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Colorectal	 cancer	 (CRC)	 is	 the	 fourth	 most	 common	 cause	 of	 cancer	 death	
worldwide,	estimated	to	be	responsible	for	694,000	deaths	in	20121.	The	number	of	
CRC	 patients	 is	 concomitantly	 increasing	 in	 the	 Netherlands	 due	 to	 a	 higher	
incidence,	 population	 growth,	 aging	 of	 the	 population	 and	 due	 to	 the	 recently	
established	nationwide	screening2.		
Surgery	 is	 the	 predominant	 curative	 treatment	 type	 for	 CRC,	 but	 has	 a	major	
impact	 on	 the	 patient’s	 wellbeing	 by	 demanding	 large	 amounts	 of	 metabolic	
reserves.	 Subsequently,	 surgery	 may	 lead	 to	 the	 development	 of	 frequently	
observed	and	severe	postoperative	complications.	Anastomotic	leakage	(AL)	is	the	
most	 important	 complication	 after	 colorectal	 surgery	 and	 has	 an	 incidence	 of	 8‐
15%	 in	 the	Netherlands3.	AL	 is	 associated	with	 a	 high	 short‐term	mortality,	with	
death	rates	of	up	to	40%4,5.	Although	many	attempts	have	been	made	to	prevent	AL,	
thus	 far	none	of	 the	proposed	 interventions	have	been	successful.	Despite	proper	
patient	 selection,	 reduction	 of	 known	 preoperative	 risk	 factors	 and	 improved	
surgical	techniques	as	well	as	introduction	of	‘fast	track’	protocols,	incidence	of	AL	
has	not	decreased	over	the	past	decade(s).		
Furthermore,	 AL	 is	 associated	 with	 a	 decreased	 disease‐specific	 survival	 in	
patients	 with	 CRC	 and	 an	 increased	 recurrence	 rate	 of	 CRC	 disease4,6‐8.	 The	
necessity	 to	 answer	 the	 question	 why	 some	 patients	 develop	 AL	 still	 remains,	
especially	with	the	current	incidence	of	CRC.		Previous	work	on	this	topic	together	
with	 findings	 from	 this	 thesis	 have	 led	 to	 a	 large	 observational	 study	 in	 patients	
(REVEAL)	which	aims	to	establish	and	validate	a	diagnostic	algorithm	for	the	pre‐
operative	 prediction	 of	 the	 development	 of	 AL	 using	 a	 combination	 of	
inflammatory,	immune‐related	and	genetic	parameters.	
Research	on	anastomotic	leakage	
Research	 on	 anastomotic	 leakage	 can	 be	 divided	 into	 clinical	 research	 and	 basic	
(translational)	 research,	 often	 performed	 in	 animal	 models.	 Basic	 (and	
translational)	 studies	 on	 AL	 have,	 for	 the	 largest	 part,	 been	 focusing	 on	
interventions	reducing	AL,	either	by	using	preventive	measures	that	mechanically	
supported	 the	 anastomosis	 or	 by	 accelerating	 the	 healing	 process	 of	 the	
anastomosis.	These	interventions	have	shown	to	reduce	the	effects	of	AL	in	animal	
models,	but	no	interventions	have	proven	their	value	in	the	clinical	setting.	Clinical	
research	 has	 predominantly	 focused	 on	 identifying	 risk	 factors	 of	 AL	 and	

























clinical	 model,	 the	 patient.	 In	 practice	 however,	 this	 is	 rather	 difficult	 except	 by	
retrospective	analysis.	Therefore	considerable	information	comes	from	knowledge	
obtained	from	animal	models,	despite	the	known	limitations	of	these	models.	


















highly	 valuable	 since	 numerous	 study	 results	 can	 be	 translated	 to	 the	 human	
setting.	 Clinical	 observations	 can	 be	 investigated	 in	 depth	 and	 standardized	 in	
animal	models	and	solutions	can	be	designed	to	aid	patients	in	the	future.	However,	
the	 quality	 of	 animal	 studies	 can	 be	 significantly	 improved	 when	 researchers	
become	more	 transparent	 about	 their	 methods,	 provide	 detailed	 information	 on	
their	models	and	share	their	negative	results.		
If	researchers	could	come	to	consensus	on	what	is	acceptable	in	animal	research	




studies,	 since	 methods	 become	 clear	 down	 to	 the	 last	 detail.	 Unfortunately,	
publication	bias	still	exists	resulting	in	a	discrepancy	between	the	amount	of	animal	
experiments	 performed	 and	 the	 amount	 actually	 reported.	 This	 results	 in	 re‐
performing	 studies	 by	different	 research	 groups	 and	unnecessary	use	 of	 animals.	





Considerable	 attempts	 have	 been	 made	 to	 prevent	 AL	 after	 colorectal	 surgery,	
either	 by	 enhancing	 the	 healing	 process	 through	 different	 pharmaceutical	
approaches,	 mechanically	 strengthen	 the	 anastomosis	 or	 by	 preventing	 the	
sequelae	of	 leakage	with	 specific	 intraluminal	devices.	Especially	 the	 last	 two	are	
currently	under	extensive	investigation.	
In	2011,	Morks	and	colleagues	provided	an	overview	on	strategies	that	prevent	
or	 reduce	 the	 	 anastomotic	 leakage	 rate	by	means	of	a	device.	Morks	divided	 the	
devices	 found	 in	 the	 literature	 into	 transanal	 decompression,	 intraluminal,	 and	
biodegradable	 protective	 devices11.	 Generally	 these	 devices	 showed	 promising	
results	 in	animals	 studies,	but	 failed	 to	do	so	 in	 the	clinical	 setting.	Some	devices	
such	as	the	Coloshield	seemed	to	have	great	potential,	but	have	never	been	widely	
accepted11.		







have	 to	 be	 removed	again	 at	 some	point.	 Recently,	 a	promising	degradable	 drain	
was	tested	in	a	clinical	trial	(C‐Seal)	but	this	study	was	stopped	preliminary	after	an	
interim	 analysis	 because	 there	 were	 no	 significant	 differences	 between	 the	
intervention	group	and	the	control	group15.		
Besides	 reducing	 the	 clinical	 burden	 of	 AL,	 research	 has	 also	 focused	 on	
mechanically	supporting	anastomoses.	One	of	the	most	promising	tools	to	enhance	
colorectal	 anastomoses	 seems	 to	 be	 tissue	 adhesives.	 Several	 sorts	 of	 tissue	
adhesives	have	been	tested	(see	also	Chapter	7)	and	this	has	led	to	the	conclusion	
that	 fibrin‐based	 glues	 do	 not	 have	 a	 positive	 influence	 on	 the	 healing	 of	










There	are	 several	 risks	 related	to	 the	use	of	 tissue	adhesives.	 It	 is	known	that	
tissue	 adhesives	 can	worsen	morbidity	 and	mortality	 caused	 by	 a	 severe	 foreign	
body	 reaction	 and	 increased	 fibrosis	 at	 the	 anastomotic	 site21.	 This	 reaction	 can	
interfere	 with	 the	 balance	 between	 collagen	 synthesis	 and	 lysis,	 the	 so‐called	
collagenous	equilibrium	that	is	critical	to	anastomotic	repair22.	A	simplified	model	
of	 this	 balance	 between	 collagen	 synthesis	 and	 lysis	 is	 depicted	 in	 Figure	 1.2.	 In	
addition,	 tissue	 adhesives	 can	 cause	 adhesions	 to	 the	 anastomotic	 site	 from	
surrounding	 fat	 tissue	 or	 intestines,	 which	 in	 turn	 can	 lead	 to	 mechanical	
obstruction	and	subsequent	ileus.	Complications	related	to	postoperative	adhesion	
formation	 are	 frequent,	 have	 a	 large	 negative	 effect	 on	 patients'	 health,	 and	
increase	workload	 in	 clinical	 practice23.	Therefore,	 several	prophylactic	measures	
have	been	developed	 to	prevent	 adhesion	 formation24.	 Again,	 these	 anti‐adhesive	




While	 there	 is	 an	 on‐going	 increase	 in	 experimental	 studies	 being	 published	
regarding	AL,	the	majority	of	these	articles	lack	in	providing	details	on	anastomotic	
healing.	 Moreover,	 the	 study	 endpoints	 mainly	 provide	 information	 on	 1)	 a	
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reduction	 in	 AL	 rate	 or	 2)	 an	 increase	 in	 bursting	 pressure.	 Although	 these	
endpoints	 are	 generally	 accepted	 in	 the	 literature,	 we	 wonder	 if	 these	 outcome	
measures	 truly	 are	 surrogate	 markers	 for	 anastomotic	 healing.	 Furthermore,	
numerous	 researchers	 draw	 direct	 parallels	 between	 anastomotic	 healing	 and	
cutaneous	 wound	 healing,	 but	 are	 these	 processes	 indeed	 comparable	 or	 should	
they	be	considered	as	two	separate	physiological	processes?		
Additionally,	 it	 is	 difficult	 to	 come	 up	 with	 new	 treatment	 strategies	 or	
preventive	 measures	 in	 order	 to	 decrease	 AL	 when	 the	 pathophysiology	 of	
anastomotic	 healing	 is	 largely	 unknown.	 The	 focus	 of	 research	 on	 bowel	
anastomoses	should	therefore	be	redirected	from	prophylactic	interventions	tested	
on	 animals	 towards	 studies	 that	 unravel	 the	 processes	 of	 normal	 anastomotic	
healing.	 This	 should	 include	 identification	 of	 essential	 factors	 and	 possible	
deficiencies	 in	 these	 factors	 that	 cause	 disruption	 of	 the	 anastomotic	 healing	
process,	and	consequently	AL.			
To	date,	no	consensus	has	been	reached	among	researchers	on	1)	which	layer	of	
the	 bowel	 wall	 is	 most	 important	 in	 anastomotic	 healing,	 2)	 if	 gastrointestinal	
healing	 can	 be	 compared	 to	 cutaneous	 healing,	 3)	 if	 bacteria	 play	 a	 role	 in	 the	




several	 animal	 models.	 In	 our	 view	 this	 is	 not	 appropriate	 since	 an	 insightful	
understanding	 of	 the	 molecular	 and	 biochemical	 pathways	 of	 intestinal	






























in	 colorectal	 anastomosis	 surgery	 is	 lacking,	 regardless	 of	 the	 level	 of	
anastomosis28.	Besides	suture	methods,	the	configuration	of	the	suture	bite	may	be	
of	interest.	Both	full‐thickness	and	sero‐submucosal	sutures	seem	to	be	sufficient	to	
anatomically	 apposition	 both	 sides	 of	 the	 bowel,	 thereby	 promoting	 wound	
healing29.	 However,	 studies	 reporting	 on	 suture	 bites	 are	 rare	 and	 could	 be	 of	




after	 gastrointestinal	 surgery	 and	 start	 to	 deposit	 collagen.	 In	 an	 experimental	




as	a	scaffold	 for	 infiltrating	cells32.	However,	 the	role	of	 the	mucosa	 is	completely	
neglected	 in	 anastomotic	 healing	 when	 the	 submucosa	 is	 considered	 the	 most	
important	layer.		
In	 the	early	90s,	 it	has	been	demonstrated	 that	 an	anastomosis	 causes	a	deep	
and	long	lasting	reduction	in	energy	metabolism,	especially	in	the	mucosa	and	the	
muscle	 layers33.	 The	 function	 of	 the	 mucosa	 in	 anastomotic	 healing	 and	 leakage	
should	not	be	disregarded	and	may	even	play	a	more	important	role	than	currently	
recognized.	 Partly	 because	 bacteria	 house	 in	 the	 mucus	 of	 the	 colon	 and	 these	
bacteria	 are	 proposed	 as	 one	 of	 the	 causal	 factors	 in	 AL,	which	 occurs	when	 the	
healing	process	is	disrupted34,35.	In	addition,	our	data	showed	that	Muc2	knockout	
mice	are	more	prone	to	the	development	of	AL	than	control	mice,	indicating	that	a	
normal	 functioning	 mucus	 layer	 is	 essential	 for	 anastomotic	 healing	 (see	 also	




absence	 or	 dysfunction	 impairs	 anastomotic	 healing36,37.	Macrophages	 are	 one	 of	
the	main	factors	in	the	inflammatory	response,	and	based	on	their	behaviour,	this	
response	 is	 either	 pro‐inflammatory	 (M1)	 impairing	 wound	 healing	 or	 anti‐
inflammatory	 (M2)	 promoting	 wound	 healing;	 a	 shift	 in	 the	 M2/M1	 index	 can	
influence	 the	 outcome	 of	 anastomotic	 healing38.	 The	 interaction	 between	
intraluminal	content	and	 the	distinct	 layers	of	 the	bowel	wall	with	 their	 separate	
cell	types	and	function,	may	be	key	in	unravelling	the	healing	process.		
In	 summary,	 all	 layers	 of	 the	 bowel	 wall	 seem	 to	 have	 a	 role	 in	 anastomotic	
healing.	The	 submucosa	consists	of	 connective	 tissue	and	has	 the	greatest	 tensile	
strength	 of	 the	 four	 layers.	 Moreover,	 the	 serosa	 seems	 to	 be	 important	 in	
providing	 a	matrix	 for	 fibroblasts,	while	 the	 interaction	 between	 bacteria,	mucus	
and	 the	 mucosal	 layer	 also	 seem	 important	 to	 maintain	 homeostasis	 in	 which	





entirely	 true.	 Already	 in	 1997,	 it	 was	 stated	 by	 Thornton	 that	 unlike	 cutaneous	
healing,	 healing	 of	 the	 gastrointestinal	 tract	 ‐	 more	 specifically	 the	 intestinal	
anastomosis	 ‐	 is	 anatomically	 obscured	 from	 inspection,	 allowing	 the	 surgeon	 to	




The	 classic	 phases	 of	 wound	 healing	 (inflammation,	 proliferation	 and	
remodelling)	 have	 been	 studied	 extensively	 in	 skin40	 and	 many	 researchers	
describe	gastrointestinal	healing	in	terms	of	these	phases29,41.	It	is	true	that	these	3	












and	 changes	 in	 vascular	 perfusion	 that	 are	 more	 abundant	 in	 the	 intestinal	
environment39,43.	
The	 serosal	 layer	 plays	 an	 important	 role	 in	 terms	 of	 strength	 of	 the	 wound	
while	 there	 is	 no	 equivalent	 component	 in	 cutaneous	 healing.	 Not	 only	 are	 the	
components	 not	 similar,	 the	 reaction	 of	 both	 tissues	 also	 differs.	 For	 example,	
Törkvist	 and	 colleagues	 tried	 to	 block	 CD18‐dependent	 neutrophil	 infiltration	 to	
improve	wound	healing	and	concluded	that	neutrophils	may	 influence	the	wound	
healing	process	differently	in	specific	organs,	based	on	diverse	results	 in	skin	and	
intestinal	 tract44.	 One	 of	 the	 explanations	 for	 their	 different	 results	 may	 lie	 in	
differences	 between	 cutaneous	 and	 intestinal	 collagen	 synthesis45,	 however,	 also	
the	skin	flora	and	gut	microbiota	vary	completely,	which	can	play	an	important	role	
in	differences	in	wound	healing46,47.	
In	 conclusion,	 gastrointestinal	 –	 and	 more	 specifically	 anastomotic	 –	 healing	









have	been	 investigating	 this	hypothesis	 for	 some	 time	and	proposed	a	 significant	
role	 for	bacteria	 in	 the	pathophysiology	of	AL	 in	201350.	Over	 the	past	 few	years,	
they	 have	 shown	 that	 virulent	 bacteria	 with	 high	 collagenase	 activity	 may	
contribute	 to	 the	 development	 of	 AL34.	 The	 interaction	 between	 intraluminal	





Already	 in	 1973,	 it	 was	 demonstrated	 by	 Levison	 that	 SCFAs	 inhibited	 in	 vitro	
growth	of	P.	Aeruginosa52	 exactly	 the	pathogen	 that	was	 later	 identified	 as	 being	
able	to	transform	into	tissue	destroying	phenotype	with	high	collagenase	activity35.	
It	 seems	undeniable	 that	bacteria	play	a	role	 in	 the	pathogenesis	of	AL.	However,	
clinical	 implications	 for	 these	 findings	 are	 lacking.	 It	 remains	 to	 be	 elucidated	
whether	eliminating	bacteria	by	perioperative	antibiotics	or	promoting	the	growth	
of	 certain	 species	 with	 probiotics	 can	 improve	 anastomotic	 healing.	 Eliminating	
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bacteria	 and	 faeces	 from	 the	 colon	 prior	 to	 surgery	 can	 be	 achieved	 with	
mechanical	bowel	preparation.	Nevertheless,	mechanical	bowel	preparation	–	that	
was	traditionally	used	together	with	oral	antibiotics	–	did	not	show	any	beneficial	
effect	 according	 to	 several	 randomized	 trials	 and	 was	 therefore	 abandoned.	
Nonetheless,	 a	 recent	 study	 attempted	 to	 clarify	 the	 effect	 of	 mechanical	 bowel	
preparation	with	or	without	antibiotics53,	using	a	large	retrospective	cohort.	Since	
the	use	of	oral	antibiotics	alone	has	not	been	investigated	in	the	majority	of	these	
studies,	 there	 is	 not	 enough	 evidence	 to	 conclude	 anything	 regarding	 oral	
antibiotics	independently	of	mechanical	bowel	preparation.		
In	summary,	given	the	available	data,	there	seems	to	be	a	role	for	bacteria	in	the	
pathogenesis	 of	 anastomotic	 leakage.	 More	 research	 is	 needed	 to	 completely	
elucidate	 this	 role	 and	 the	 interaction	 of	 microbiota	 with	 specific	 cells	 and	
components	at	the	anastomotic	site.			
Surrogate	markers	of	anastomotic	healing	
The	 most	 frequently	 used	 surrogate	 marker	 for	 anastomotic	 healing	 in	 animal	
models	is	bursting	pressure	(BP).	Although	there	are	many	methods	to	test	BP,	it	all	
comes	down	to	inflating	or	filling	the	bowel	segment	including	the	anastomotic	site	
and	 measuring	 the	 intraluminal	 pressure	 at	 which	 either	 air	 or	 fluid	 leakage	 is	
observed	 at	 the	 site	 of	 the	 anastomosis.	 While	 this	 outcome	 measure	 has	 been	
debated	 for	 possibly	 disrupting	 tissue	 samples,	 making	 histological	 evaluation	
difficult	and	 though	critics	have	stated	 that	BP	 is	not	a	 relevant	 indicator	 since	 it	
can	not	be	applied	for	a	anastomosis	that	has	already	leaked54;	it	is	still	considered	
appropriate	by	researchers	in	the	field	since	it	offers	an	actual	surrogate	outcome:	
anastomotic	 strength	 (see	 also	 Chapter	 2).	 Quantitative	 comparison	 of	 BP	 is	 not	




measure	 in	 the	 early	 healing	 phase	 and	 because	 of	 the	 technical	 difficult	
implementation57.			
Histological	 healing	 parameters	 are	 often	 reported	 in	 experimental	 studies	
investigating	 gastrointestinal	 anastomoses,	 mostly	 by	 grading	 scales	 including	
factors	such	as	inflammatory	cell	infiltration,	fibroblast	activity,	collagen	deposition	
and	 vascularity	 or	 neoangiogenesis,	 factors	 that	 are	 mainly	 based	 on	 cutaneous	
wound	 healing29,56‐58.	 These	 parameters	 are	 considered	 helpful	 in	 evaluating	 the	
general	wound	healing	process	at	the	anastomotic	site.	However,	a	limitation	may	









since	 this	 amino	 acid	 is	 found	 in	 few	 proteins	 other	 than	 collagen22.	 Although	
hydroxyproline	content	is	considered	informative	about	the	amount	of	collagen,	 it	
does	not	provide	information	on	collagen	subtypes,	the	maturity	of	the	collagen	and	








mediated	 through	Matrix	Metalloproteinases	 (MMP)	 resulting	 in	 loosening	 of	 the	
matrix	that	may	result	in	AL65.	This	collagenase	activity	of	MMPs	–	especially	MMP9	
is	 associated	 with	 AL	 –	 can	 be	 measured	 by	 quantitative	 gelatin	
zymography34,51,66,67.	 Again	 the	 statement	 of	 the	 spatial	 and	 regional	 context	 of	
measuring	 bacteria	 and	 inflammatory	 mediators	 applies	 here;	 in	 grinding	 up	
tissues	 you	 are	 getting	 the	 average	 of	 the	 entire	 tissue	 sample,	 while	 the	 most	
important	measure	is	likely	to	be	right	at	the	site	of	the	necrosis	and	leak.	However,	
it	has	been	demonstrated	that	it	 is	possible	to	distinguish	between	changes	in	the	
composition	 of	 the	 intestinal	 microbiota	 associated	 with	 anastomotic	 tissue	 and	
microbiota	associated	with	luminal	contents68.		
In	 summary,	 frequently	 used	 surrogate	 markers	 for	 anastomotic	 healing	 in	
animal	 models	 are	 bursting	 pressure,	 tensile	 strength	 and	 a	 generic	 histological	
examination.	 Other	 additional	 analyses	 are	 used	 to	 answer	 specific	 research	




described	 above,	 it	 does	 provides	 new	 insights	 into	 research	 on	 anastomotic	
leakage.	 This	 thesis	 is	 divided	 into	 four	parts	 and	describes	discernments	 gained	





In	 Part	 I,	 the	 use	 of	 animal	 models	 for	 anastomotic	 healing	 in	 the	 lower	
gastrointestinal	tract	is	investigated.	A	systematic	review	of	the	literature	is	given	
providing	an	overview	of	recent	literature	combined	with	recommendations	from	a	
recent	 Delphi	 analysis	 (Chapter	 2).	 These	 recommendations	 enable	 future	
researchers	to	perform	their	research	in	such	a	way	that	it	is	more	comparable	with	
other	animal	studies	and	more	translatable	to	the	human	setting.	Furthermore,	new	
imaging	 techniques	 make	 it	 possible	 to	 focus	 more	 in	 depth	 on	 the	 process	 of	




known	 from	 clinical	 practice	 that	 the	 perioperative	 use	 of	 non‐steroidal	 anti‐
inflammatory	drugs	increases	the	risk	of	developing	anastomotic	leakage,	possibly	
due	to	the	inhibition	of	Cyclooxygenase‐2		(COX‐2).	The	role	of	COX‐2	in	colorectal	




several	 different	 interventions.	 The	 positive	 effect	 of	 butyrate	 on	 the	 strength	 of	
colorectal	 anastomosis	 was	 already	 known,	 so	 new	 approaches	 –	 which	 are	









colorectal	 anastomoses	 in	animals	 (Chapter	8).	Also	 the	use	of	new	biomaterials	
can	 have	 a	 negative	 effect	 on	 the	 abdominal	 environment	 that	 may	 cause	 a	
disruption	in	normal	healing	processes	(Chapter	9).		
Chapter	10	summarizes	the	main	results	and	contributions	as	presented	in	this	
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measures	 in	 research	 on	 anastomoses	 in	 the	 lower	 gastrointestinal	 tract	 (GIT).	 The	





PubMed	 and	 EMBASE	 were	 searched	 for	 experimental	 studies	 investigating	 anastomotic	
healing	in	the	lower	GIT	published	between	January	1,	2000	‐	December	31,	2014	to	assess	






Mice,	 rats,	 rabbits,	 pigs	 and	 dogs	 are	 currently	 being	 used	 as	 animal	models,	with	 a	 large	
variety	in	surgical	techniques	and	outcome	measures.		
Forty‐four	 corresponding	 authors	participated	 in	 the	Delphi	 analysis.	 In	 the	 first	2	 rounds	
39/44	and	35/39	participants	completed	the	survey.	In	the	final	meeting	35	experts	reached	
consensus	on	76/122	 items	 in	6	categories.	Mouse,	rat	and	pig	are	considered	appropriate	




Consensus	 was	 reached	 on	 several	 recommendations	 for	 the	 use	 of	 animal	 models	 and	













are	 vital	 for	 our	 understanding	 of	 anastomotic	 healing	 and	 introduction	 of	 new	
therapies	 for	reduction	of	AL.	However,	over	 the	past	decades	a	variety	of	animal	
models	 have	 been	 used	 which	 leads	 to	 heterogeneity,	 accompanied	 by	 differing	
anatomy	and	physiology	between	species.	Recently,	a	systematic	review	concluded	
that	 animal	 research	on	AL	 is	 of	 poor	quality	 and	 improvement	 is	needed	before	
results	can	be	translated	into	the	human	setting4.		
	
In	 addition	 to	 the	 variety	 of	 animal	models,	 a	 wide	 range	 of	 study	 endpoints	
and/or	 goals	 is	 used.	 The	 majority	 of	 studies	 examined	 the	 effect	 of	 a	 certain	
intervention	on	anastomotic	healing,	for	example	aiming	at	improving	anastomotic	
strength	 or	 reducing	 leakage	 rate	 in	 models	 of	 insufficient	 anastomoses.	 Several	
studies	 have	 focused	 on	 different	 techniques	 to	 perform	 the	 anastomosis,	 for	
example	 evaluating	 or	 enforcing	 suturing	 techniques	 or	 various	 types	 of	
staplers5‐10.	Glues	and	patches	have	also	been	used	to	cover	the	anastomosis	in	an	
attempt	to	decrease	leakage	rate11‐19.	Other	methods	include	stenting	the	lumen	of	
the	 intestine	or	providing	specific	medication	 to	 improve	wound	healing20‐28.	The	
influence	of	specific	drugs	that	may	attenuate	the	anastomotic	healing	process	was	
also	investigated29‐32.	Due	to	the	large	variance	in	study	design,	outcome	measures	
and	 analyses	 for	 surrogate	 markers	 of	 anastomotic	 healing,	 the	 question	 arises	
whether	there	is	one	specific	animal	model	suitable	to	investigate	all	these	different	





AL	 has	 been	 proposed	 by	 Pommergaard	 et	 al	 in	 201133.	 Based	 on	 a	 systematic	
review	the	authors	first	listed	pros	and	cons	for	different	experimental	animals	and	
subsequently	 opted	 for	 the	 mouse	 as	 best	 suited	 to	 mimic	 clinical	 colon	 AL.	
However,	 despite	 this	 recommendation,	 the	 use	 of	 mice	 to	 study	 bowel	








reproducibility	 and	 validity	 of	 a	 model.	 However,	 in	 animal	 research	 regarding	
bowel	 anastomoses	 there	 is	 no	 single	 animal	 model	 that	 is	 evidently	 the	 most	
appropriate	regarding	practical	ease,	costs,	reproducibility	and	clinical	translation.	
Therefore,	 expert	 consensus	 is	 a	 suitable	method	 to	 achieve	 homogeneity	 in	 the	
selection	of	animal	models.	If	consensus	can	be	reached,	there	will	be	more	support	
from	 fellow	 researchers	 leading	 to	 more	 frequent	 use	 of	 similar	 models.	 As	 a	
consequence,	 future	 research	 about	 anastomotic	 healing	 will	 become	 more	
comparable.	
	
The	 aim	 of	 this	 study	 is	 to	 review	 different	 experimental	 studies	 in	which	 an	
animal	 model	 was	 used	 to	 investigate	 either	 intestinal	 anastomotic	 healing	 or	
leakage	 and	 obtain	 information	 on	 the	 used	 animal	 models;	 location	 &	 type	 of	
surgery;	macroscopic	outcome;	histological	assessment;	mechanical	&	biochemical	
outcome	 measures	 and	 animal	 testing	 &	 welfare.	 Further,	 we	 aim	 to	 reach	
consensus	on	these	subjects	by	performing	a	Delphi‐based	analysis	using	an	online	





(MEDLINE)	 and	 OvidSP	 (EMBASE)	 databases	 for	 all	 papers	 related	 to	 animal	
models	 which	 were	 used	 in	 an	 experimental	 setting	 to	 either	 investigate	
anastomotic	 healing	 or	 anastomotic	 leakage	 in	 the	 lower	 gastrointestinal	 tract.	
Search	 terms	 included:	 “anastomosis/anastomotic”,	 “leak/leakage",	 “bowel/	
intestine/colon/colorectal”	 and	 “animal/animals/rat/mouse/mice/pig/dog/goat/	
rabbit/animal	model”.	 English	 and	Dutch	were	 used	 as	 language	 restrictions	 and	
the	 search	 was	 limited	 to	 articles	 published	 between	 January	 1,	 2000	 and	
December	1,	 2014.	The	 following	 inclusion	 criteria	were	 applied	 to	 the	 titles	 and	
abstracts	of	the	search	results:	experimental	setting,	use	of	an	animal	model	and	an	
anastomosis	 made	 in	 the	 lower	 gastrointestinal	 tract	 (GIT)	 (gastroduodenal/	
gastrojejunal	 were	 considered	 upper	 GIT	 and	 therefore	 excluded).	 We	 excluded	
commentary	reports,	 review	articles	and	articles	containing	results	 that	had	been	
previously	 reported	 in	 another	 included	 article.	 All	 articles	 were	 combined	 in	 a	
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single	 list	 of	 which	 JWAMB	 and	 LvB	 identified	 eligible	 reports;	 in	 case	 of	
discrepancy,	agreement	on	inclusion	was	reached	through	discussion	with	MA‐T	as	






















Our	 primary	 outcomes	were	 1)	 type	 of	 animal	 used	 and	 2)	 location	 and	 type	 of	
anastomosis.	 As	 secondary	 outcomes,	 we	 evaluated	 scoring	 models	 used	 for	
macroscopic	 findings	 reporting	on	AL,	 i.e.	 adhesions,	 bursting	 pressure,	 histology	






research	on	anastomoses	 in	 the	 lower	gastrointestinal	 tract,	 specifically	on	which	
animal,	 location	&	type	of	surgery;	macroscopic	outcome;	histological	assessment;	
mechanical	 &	 biochemical	 outcome	measures	 and	 animal	 testing	 &	 welfare.	 The	
Delphi	 technique	 is	 a	widely	 used	 and	 accepted	 consensus	method	 for	 gathering	







Questionnaires	 were	 developed	 and	 distributed	 using	 SurveyMonkey	
(SurveyMonkey	 Inc,	 Palo	 Alto,	 CA;	www.survey‐monkey.com).	 This	 online	 survey	
contained	 several	 questions	 on	 three	 main	 subtopics	 of	 intestinal	 anastomotic	
research:	 the	 first	 part	 consisted	 of	 questions	 regarding	 animal	 model	 used	 and	
reasoning	for	the	choice	of	this	model;	the	second	part	focused	on	macroscopically	
scoring	and	measurements	performed	on	the	anastomosis	(leakage	rate,	adhesion	
evaluation)	 and	 the	 last	 part	 inquired	 about	 histological	 analysis	 and	 additional	

















WA).	 Consensus	was	 reached	 if	 the	 panel	 rated	 the	 subject	 inappropriate	 (panel	






In	 total	 277	 articles	were	 retrieved	 from	 the	 search.	 After	 screening	 167	 articles	













anastomotic	 leakage,	 bursting	 pressure,	 tensile	 strength,	 adhesion	 scores	 and	
histological	parameters	such	as	influx	of	granulocytes	and	collagen	deposition.	We	
summarized	 the	 characteristics	 of	 the	 used	 interventions	 and	 outcome	measures	
that	 were	 used	 in	 these	 studies.	 This	 summary	 was	 sent	 to	 panel	 members	 as	

































responsible	 for	 77	 of	 the	 included	 articles	 from	 the	 major	 research	 groups	
worldwide	 (Figure	 2.3).	 The	 first	 questionnaire	 was	 completed	 by	 39/44	
responders	(89%	response	rate).	After	non‐responders	were	excluded,	the	second	





















Figure	2.3	 Participants	 in	 this	 Delphi	 analysis	 were	 from	 the	 main	 research	 groups	 that	 have	



































































animal	model;	 location	 and	 technique	 of	 the	 anastomosis;	macroscopic	 outcome;	
histological	 assessment;	 mechanical	 and	 biochemical	 outcome	 measures;	 and	
reporting	specifics	on	animal	research.	
	
After	 the	 first	 round,	 consensus	 existed	 on	 58	 of	 the	 items	 (61%)	 and	
disagreement	 or	 uncertainty	 on	 37	 items.	 Based	 on	 additional	 remarks,	 7	 items	
were	 added	and	2	were	 rephrased.	The	7	newly	 introduced	 items	 for	 the	 second	




The	 second	 questionnaire	 was	 based	 on	 the	 first	 and	 consisted	 of	 37	 items	 on	
which	 consensus	 did	 not	 exist	 in	 the	 first	 round	 and	 7	 items	 added	 based	 on	
additional	comments	(total	of	44	items).	The	most	important	item	that	was	added	
in	 round	 2	 and	 on	 which	 immediate	 consensus	 was	 reached	 was	 the	 newly	
introduced	 Anastomotic	 Complication	 Score	 (ACS,	 see	 Table	 2.3),	 which	 was	
proposed	 during	 the	 first	 round	 by	 one	 of	 the	 panel	members.	 After	 the	 second	
round,	 consensus	 existed	 only	 on	 3	 items,	 in	 addition	 to	 the	 58	 items	 on	 which	
consensus	was	reached	in	the	first	round.	
	











Feedback	was	provided	 to	 the	participants	 after	 each	 round.	 In	 the	 final	 round	 a	
clear	 distinction	 was	 made	 between	 positive	 and	 negative	 arguments	 from	 the	
second	 round	 to	 simulate	 a	 discussion	 between	 panel	 members.	 The	 topics	 for	





sufficient	 information	 to	 make	 the	 model	 more	 translational.	 Based	 on	 all	
arguments	 given	 by	 the	 panel	 members	 and	 the	 first	 two	 rounds,	 20	






































































In	 this	 study	 consensus	 was	 reached	 amongst	 researchers	 studying	 intestinal	







evaluated	 macroscopically,	 where	 currently	 used	 scores	 were	 not	 considered	
appropriate	enough.	The	Anastomotic	Complication	Score	as	proposed	by	a	panel	
member	 may	 provide	 an	 objective	 scoring	 measure.	 Obviously,	 this	 new	 score	
needs	 to	 be	 evaluated	 in	 the	 experimental	 setting	 to	 obtain	 information	 about	
veracity	and/or	 inter‐observer	variation,	but	 it	does	seem	to	be	a	promising	 tool.	
Bursting	 pressure	 (or	 tensile	 strength)	 together	 with	 histological	 evaluation	
provides	 further	 information	 about	 the	 anastomosis.	 Additional	 analyses	 can	 be	
helpful	 to	 answer	 specific	 research	 questions	 but	 are	 not	 (yet)	 considered	
appropriate	 as	 surrogate	 markers	 for	 anastomotic	 healing.	 Reporting	 on	 animal	






they	 were	 appropriate	 to	 use	 when	 systemic	 interventions	 are	 tested,	 but	 when	
interested	 in	a	 local	device	a	 larger	animal	 is	preferred.	Although	 it	 is	obvious	 to	




felt	 that	 rats	 cannot	 be	 used	 as	 a	model	 for	 AL	 since	 they	 are	more	 resistant	 to	
infections	and	show	hardly	any	clinical	signs	while	other	panel	members	have	been	
using	rats	for	this	purpose	for	many	years	with	very	good	results.	Even	though	the	
rat	 is	 a	 validated	model	 for	 both	 anastomotic	 healing	 and	 leakage,	 there	 are	 still	
opponents	 that	 claim	 that	 a	 rat	 is	 not	 suitable	 for	 this	 purpose,	mostly	 based	 on	
own	 experiences.	 There	was	 also	 disagreement	 on	 the	 consideration	 of	 practical	
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ease	 in	 large	 animal	 models.	 Some	 believe	 that	 they	 are	 difficult	 in	 terms	 of	















the	 past	 decade,	 despite	 implementation	 of	 the	 3R	 principle	 of	 Replacement,	
Reduction	 and	 Refinement.	 As	 shown	 in	 a	 recent	 systematic	 review,	 reporting	





This	project	used	 the	RAND/UCLA	Appropriateness	method	 (RAM)	 to	develop	






contacted,	and	 the	35	panel	members	were	 responsible	 for	46%	of	 these	studies.	
The	authors	that	became	panel	members	in	this	project	were	enthusiastic	about	the	
subject	 and	working	 in	 one	 of	 the	major	 research	 groups	worldwide	 involved	 in	
experimental	research	regarding	bowel	anastomoses.	Although	this	could	have	lead	
to	 selection	 bias,	 our	 approach	 is	 more	 objective	 than	 the	 ‘snowball	 method’	 in	
which	experts	are	asked	to	provide	email	addresses	of	other	experts.	This	method	
is	also	being	used	to	form	an	expert	panel	in	consensus	studies41.	Even	though	the	








their	 arguments,	 especially	 at	 the	 beginning	 of	 the	 project.	 During	 the	 second	
round,	all	panel	members	were	given	their	own	answers	in	respect	to	the	answers	
of	the	panel	as	well	as	arguments	provided	by	other	panel	members.	Obviously,	all	
researchers	are	 convinced	of	 their	 own	methods,	 believing	 that	 their	models	 and	
techniques	are	best	suited.	However,	during	the	project	panel	members	opened	up	
for	 discussion,	 making	 it	 possible	 to	 indeed	 reach	 consensus	 and	 come	 up	 with	




guidelines	 for	 reporting	 in	 vivo	 experiments	 in	 animals42.	 While	 considered	
appropriate	to	follow	by	the	panel	members	in	this	study,	few	studies	have	actually	
used	 them	 to	 report	 animal	 research43.	 Panel	 members	 suggested	 that	 although	
these	guidelines	can	contribute	to	an	increase	in	standardization,	and	thus	can	be	
useful,	they	are	also	very	detailed	and	complete.	Most	of	the	information	required	
by	 the	 guidelines	 should	 be	 available	 in	 an	 online	 supplementary	 data	 section	
instead	of	 in	 the	manuscript.	The	panel	also	 felt	 that	 it	was	appropriate	to	use	an	




refinement	 and	 reduction	 in	 animal	 experiments	 due	 to	 knowledge	 on	 teething	





We	 recommend	 that	 future	 animal	 research	 that	 focuses	 on	 intestinal	
anastomosis	should	be	conducted	in	either	a	mouse,	rat	or	pig	model	and	provide	
detailed	 information	 on	 analgesia,	 anesthesia,	 antibiotics,	 antiseptic	 measures,	
intestinal	segment	involved,	surgical	technique,	anastomotic	complications	as	well	
as	animal	welfare.	The	ARRIVE	guidelines	should	be	 followed	more	stringently	 to	
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Colorectal	 anastomotic	 leakage	 is	 the	most	 dreaded	 complication	 after	 colorectal	
surgery	because	of	 its	high	morbidity	and	even	–	despite	 improved	postoperative	
care	–	mortality1.	The	 incidence	of	anastomotic	 leakage	has	 remained	stable	over	
the	 last	 decades	 despite	 very	 extensive	 research	 into	 risk	 factors,	 perioperative	
strategies	and	 intra‐operative	 interventions2.	The	pathophysiology	of	anastomotic	
leakage	 is	 largely	 unknown3	 and	 we	 strongly	 advocate	 that	 this	 should	 be	
elucidated	 prior	 to	 conducting	 intervention	 studies4.	 Despite	 some	 evidence	
regarding	 risk	 factors	 and	 some	 insight	 in	 the	 anastomotic	 healing	 process	 that	
involves	the	influx	of	inflammatory	cells,	interaction	with	intestinal	microbiota	and	
matrix	 metalloproteinases,	 it	 remains	 a	 challenge	 to	 study	 such	 complex	
mechanistic	pathways	within	biochemical	and	biological	organisms.		
	
Fortunately,	 rapid	 technological	 advances	 have	 been	made	 in	 recent	 years	 to	
address	these	kinds	of	challenges.		Among	these,	Mass	Spectrometry	Imaging	(MSI)	
has	emerged	as	an	enabling	technique	to	provide	insight	into	the	molecular	entities	
within	 cells,	 tissues,	 and	 whole‐body	 samples	 and	 to	 understand	 inherent	
complexities	 within	 biological	 metabolomes5.	 Mass	 spectrometry	 detects	
molecules,	 following	 ionisation,	 by	 virtue	 of	 the	 different	 mass‐to‐charge	 (m/z)	
rations.	Matrix‐assisted	 laser	desorption/ionization	 (MALDI)	 is	 the	most	common	
approach	 used	 for	MSI	 and	 involves	 the	 use	 of	 UV‐laser	 desorption	 of	 a	matrix‐
coated	tissue	section	to	acquire	mass	spectra	at	various	locations	across	a	sample	
(typically	 every	 50‐100	 µm).	 With	 this	 method,	 it	 is	 possible	 to	 assess	 a	 tissue‐
specific	spatial	molecular	distribution	without	the	need	for	labelling	–	in	contrast	to	
classical	histology	‐	allowing	the	discovery	of	prognostic	markers	and	enabling	the	
determination	 of	 effective	 (and	 personalized)	 therapies6.	 In	 addition,	 MALDI‐
imaging	is	unique	as	an	imaging	technique	since	it	can	determine	the	distribution	of	
hundreds	of	unknown	compounds	in	a	single	measurement7.	With	MALDI	imaging,	
recent	 breakthroughs	 were	 achieved	 as	 it	 became	 possible	 to	 reveal	 disease‐
specific	molecular	features.	This	process	is	known	as	disease	phenotyping	and	has	











A	 total	 of	 28	Wistar	 rats	 with	 an	 average	 body	 weight	 of	 250	 gram	 were	 used.	
Animals	were	housed	at	the	Central	Animal	Facilities	of	the	Maastricht	University.	
All	animals	were	provided	ad	libitum	access	to	food	and	water,	and	were	cared	for	
according	 to	 local	 standards.	 Postoperatively,	welfare	 assessment	was	performed	
twice	daily	using	a	standardized	method	and	animals	were	given	pain	medication	in	
case	 of	 discomfort.	 The	 experimental	 protocol	 complied	 with	 the	 Dutch	 Animal	




anastomotic	 healing	 can	 be	 detected	 by	 means	 of	 MALDI	 MSI	 over	 time.	
Additionally,	we	explored	if	the	components	of	this	healing	process	change	in	case	
of	 anastomotic	 leakage,	 in	 order	 to	 identify	 factors	 that	 are	 essential	 for	 both	
anastomotic	 healing	 and	 anastomotic	 leakage.	 Anastomotic	 healing	 was	
investigated	in	a	rat	model	with	a	sufficient	anastomosis.	The	colon	was	transected	
2	 cm	 distal	 from	 the	 cecum	 and	 an	 end‐to‐end	 anastomosis	 was	 created	 using	





sample	 2	 cm	 distal	 from	 the	 anastomosis)	 were	 embedded	 in	 a	 10%	 glycerol	
solution,	snap	frozen	in	liquid	nitrogen	and	stored	at	‐80°C.	The	samples	were	then	
cut	 into	10	μm	 sections	 for	MS	 analysis,	 and	 into	4	 μm	 sections	 for	 conventional	
staining	using	a	cryomicrotome	(CM	1860	UV,	Leica	Microsystems	GmbH,	Wetzlar,	




then	 placed	 in	 a	 desiccator	 for	 15	 minutes.	 Tissue	 sections	 were	 sprayed	 with	
norharmane	 matrix	 (7	 mg/ml	 in	 1	 2	 methanol	 chloroform)	 using	 an	 automated	










created	 by	 using	 the	 HDI	 v1.4	 software	 (Waters).	 ROI	 were	 based	 on	 the	
histological	 layers	of	 the	gut	and	 in	 specific	 the	mucosal	 layer	 in	 interaction	with	
gut	microbiota,	both	 in	 control	 and	anastomotic	 tissue.	Commensal	microbes	and	
pathogenic	 bacteria	 colonizing	 the	 intestine	 have	 the	 potential	 to	 acquire	 an	









control	 tissue	 of	 the	 same	 animals	were	 conducted	 using	 Biomap	 (Novartis)	 and	
principal	 component	 analysis	 (PCA).	 Total	 ion	 count	 (TIC)	was	 used	 for	 spectral	
normalization	in	all	cases.	In	short,	PCA	is	an	unsupervised	statistical	method	that	
aims	 at	 pooling	 a	 maximum	 amount	 of	 variance	 in	 a	 minimum	 number	 of	
independent	variables.	Data	pre‐treatment	and	PCA	were	performed	using	our	in‐
house	built	ChemomeTricks	toolbox	for	MATLAB	version	2014a	(The	MathWorks,	
Natick,	 MA,	 USA).	 The	 peak	 assignments	 were	 performed	 according	 to	 the	




residual	 matrix.	 Tissue	 specimens	 were	 then	 rehydrated	 with	 graded	 alcohol	 to	
H2O.	The	slides	were	submerged	into	haematoxylin	for	3	minutes	and	rinsed	with	
running	 tap	water	 for	3	minutes.	Subsequently,	 the	slides	were	 counterstained	 in	
eosin	for	30	seconds	and	rinsed	with	running	tap	water	for	one	minute.	Finally,	the	
slides	were	washed	 in	100%	Ethanol	 for	2	minutes	and	dehydrated	 in	xylene	 for	





We	 focused	 on	 differences	 in	 lipid	 profiles	 (lipidomics)	 between	 colonic	 tissues.	
Changes	 in	 the	 distribution	 and	 density	 of	 cellular	 constituents	were	 visible	 as	 a	









































construction	 of	 an	 anastomosis.	 The	 signal	 of	m/z	 725.40,	 which	 is	 likely	 to	 be	
sphingomyelin	 (d18:1/16:013)	 shows	 exclusive	 presence	 in	 damaged	 tissue,	 i.e.	
after	construction	of	the	anastomosis	and	an	increased	expression	over	time.	 	The	
control	 tissue	 on	 day	 7	 shows	 an	 expression	 profile	 that	 is	 more	 similar	 to	 the	
anastomotic	tissue	compared	to	the	control	tissue	on	day	3,	which	shows	relatively	
low	 expression	 of	 most	 mass	 signals.	 Control	 tissue	 that	 has	 been	 exposed	 to	 a	



































































Figure	3.4	 Representative	 combined	mass	 spectrum	 (DF	 2	 spectrum)	 detected	 by	MALDI‐MSI	 from	
both	control	(positive)	and	anastomotic	tissue	(negative)	at	day	3	and	day	7.	













































































































































































































This	 is	 a	 pilot	 report	 of	 a	 discovery	 based	 longitudinal	 experiment	 of	 lipidomic	
molecular	 activities	 in	 healing	 and	 leaking	 intestinal	 anastomoses	 in	 a	 rat	model.	
For	 the	 first	 time,	 localised	 lipid	 differences	 between	 control	 and	 anastomotic	
tissue	has	been	detected	 through	MALDI‐MSI.	These	differences	will	be	expanded	
on	in	the	future.	The	fact	that	control	tissue	after	7	days	showed	similar	expression	
profiles	 to	 the	 anastomotic	 tissue	 suggests	 that	 the	processes	 involved	 in	healing	
are	not	 limited	 to	 the	damaged	 tissue	 at	 the	 anastomotic	 site,	 but	 instead	 spread	
over	 a	 larger	 segment	 over	 time.	 Some	mass	 signals	 show	 specific	 expression	 in	
damaged	tissue,	such	as	m/z	725.40,	sphingomyelin13.	Sphingomyelins	have	several	
structural	and	functional	roles	in	the	cell;	they	are	found	in	the	cell	membrane	and	
play	 a	 role	 in	 apoptosis.	 Recent	 studies	 have	 linked	 marked	 alterations	 in	
sphingolipid	biology	to	several	diseases14,15.	Particularly	detected	lipid	profiles	are	





tool	 to	 identify	 molecules	 that	 are	 involved	 in	 the	 normal	 healing	 process	 or	 in	
anastomotic	 leakage.	 When	 combined	 with	 other	 modalities	 (IHC,	 conventional	
staining,	 proteomics,	 peptidomics,	 metabolomics),	 this	 technique	 can	 be	 used	 to	
map	the	molecular	pathways	 involved	 in	the	normal	anastomotic	healing	process,	
as	 well	 pathways	 involved	 in	 leaking	 which	 are	 currently	 still	 largely	 unknown.	
Current	 studies	 from	 our	 research	 group	 are	 focusing	 on	 unravelling	 the	
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Wildtype,	 COX‐2	 knockout	 and	 COX‐2	 heterozygous	 mice	 were	 subjected	 to	 a	 model	 of	
colonic	anastomotic	leakage,	and	were	treated	with	vehicle,	diclofenac,	or	prostaglandin	E2	
(PGE2),	 the	 most	 important	 COX‐2	 product	 in	 the	 intestine.	 We	 assessed	 anastomotic	
leakage,	 mortality,	 angiogenesis,	 and	 inflammation.	 Furthermore,	 we	 investigated	 the	




Diclofenac,	 a	 nonsteroidal	 anti‐inflammatory	drug	 inhibiting	COX‐2,	 increased	 anastomotic	
leakage	 compared	 to	 vehicle‐treated	mice	 (100%	 vs	 25%,	 respectively).	 Similarly,	 92%	of	
COX‐2‐deficient	 mice	 developed	 anastomotic	 leakage	 (P=0.003)	 compared	 to	 WT.	 PGE2	
partly	 rescued	 this	 severe	 phenotype	 because	 only	 46%	 of	 PGE2‐administered	 COX‐2	
knockout	mice	developed	 anastomotic	 leakage	 (P=0.02).	This	may	be	 related	 to	decreased	
neovascularization,	 because	 decreased	 CD31	 staining,	 indicating	 less	 blood	 vessels,	 was	
observed	 in	 COX‐2‐/‐	 mice	 (2	 vessels/mm2	 vs.	 6	 vessels/mm2	 in	 controls	 (P=0.03)).	 This	
effect	 could	 partly	 be	 reversed	 by	 administration	 of	 PGE2	 to	 COX‐2‐/‐	mice.	 No	 significant	













synthase	 2	 (Ptgs2),	 plays	 an	 important	 role	 in	 gut	 homeostasis.	 In	 general,	
cyclooxygenase	regulates	the	conversion	of	arachidonic	acid	into	prostaglandins,	of	
which	 prostaglandin	 E2	 (PGE2)	 is	 reported	 to	 restore	 intestinal	 integrity	 in	
experimental	 models	 of	 intestinal	 inflammation	 and	 damage1‐5.	 COX‐2‐induced	
production	 of	 prostaglandins	 in	 mesenchymal	 stem	 cells	 in	 the	 colon	 have	 an	
immunomodulatory	 role2,	 and	 these	mesenchymal	 stem	 cells	may	 thereby	 act	 as	
monitors	 of	 the	 colonic	 environment.	 In	 addition,	 they	 might	 have	 important	
functions	in	colonic	wound	healing5.	Furthermore,	COX‐2	expression	is	 induced	in	
macrophages	and	myofibroblasts	upon	exposure	to	proinflammatory	cytokines	and	
bacterial	 products,	 leading	 to	 proliferation	 and	 protection	 against	 apoptosis2,3,6.	
Lastly,	 COX‐2	 and	 PGE2	 production	 by	 endothelial	 cells	 are	 critically	 involved	 in	
vascular	 endothelial	 growth	 factor	 (VEGF)‐induced	 angiogenesis7,8.	 Data	 from	
human	studies	underline	the	importance	of	COX‐2	in	colonic	wound	healing	as	the	
use	of	nonsteroidal	anti‐inflammatory	drugs	(NSAIDs),	especially	those	with	strong	
COX‐2‐inhibiting	 properties,	 is	 correlated	 with	 the	 development	 of	 anastomotic	
leakage	after	colorectal	surgery9‐12.	The	incidence	of	anastomotic	leakage	requiring	
re‐intervention	 is	 around	 7%13,	 making	 anastomotic	 leakage	 the	 primary	
complication	requiring	 re‐intervention	after	 colonic	 surgery.	Anastomotic	 leakage	
carries	 a	 high	 mortality	 of	 15%14.	 The	 pathophysiology	 of	 anastomotic	 leakage	
remains	 largely	 unknown	 and	 is	 supposedly	 multifactorial.	 Studies	 showing	
increased	 anastomotic	 leakage	 due	 to	 NSAID	 use	 are,	 however,	 retrospective	 in	
nature	 and	 a	 recent	 meta‐analysis	 could	 not	 prove	 an	 unambiguous	 detrimental	
effect	of	NSAIDs15.	Although	these	studies	suggest	to	restrict	NSAID	use	in	patients	
with	 intestinal	 anastomoses,	 omission	 of	 NSAIDs	 from	 postsurgical	 care	 in	 these	





We	 provide	 evidence	 that	 COX‐2	 is	 essential	 for	 neovascularization	 of	 the	
colonic	anastomosis	and	thereby	plays	a	crucial	role	in	colonic	anastomotic	wound	
healing.	Both	pharmacological	and	genetic	disruption	of	COX‐2	function,	by	use	of	
NSAIDs	 or	 COX‐2‐/‐	 mice	 respectively,	 increased	 colonic	 anastomotic	 leakage	
significantly	 after	 colonic	 surgery	 in	 mice,	 which	 was	 associated	 with	 severely	
decreased	survival.		
	








All	 animal	 experiments	 were	 approved	 by	 the	 Maastricht	 University	 Animal	
Experiments	Committee.	Mice	heterozygous	for	COX‐2	were	ordered	from	Jackson	
Laboratory	 (Bar	 Harbor,	ME)	 to	 obtain	 littermate	wildtype	 (WT,	 n=32),	 COX‐2+/‐	




adapted	 to	 reach	 an	 anastomotic	 leakage	 rate	 of	 25%	 to	 33%18.	 Briefly,	 10‐	 to	
12‐week‐old	 mice	 were	 anesthetized	 using	 isoflurane	 and	 were	 given	
buprenorphine	 as	 analgesic.	 After	 a	 1	 cm	 midline	 laparotomy,	 the	 cecum	 was	
exteriorized	and	the	right	colon	was	microscopically	transected,	without	damaging	
blood	 supply.	 An	 end‐to‐end	 anastomosis	 was	 performed	 with	 7	 interrupted	
sutures	(Prolene	8–0,	Ethicon,	Somerville,	NJ).	The	colon	was	repositioned	and	the	
abdomen	was	 closed	 in	 2	 layers	 of	 interrupted	 sutures	 (Vicryl	 4–0,	 Ethicon,	 and	
Ethilon	 4–0,	 Ethicon,	 respectively).	 The	 colon	 was	 kept	 moist	 with	 sterile	 saline	
during	 the	procedure.	Two	medically	 trained	researchers	 that	had	equal	skill	and	




WT,	COX‐2+/‐	 and	COX‐2‐/‐	mice	underwent	 laparotomy	with	 colonic	 anastomosis,	
and	 received	 vehicle	 Phosphate‐buffered	 saline	 (PBS),	 16,16‐dimethyl	 PGE2	
(dmPGE2,	 Cayman	 Chemical,	 Ann	 Arbor,	 MI),	 a	 stable	 analogue	 of	 PGE2,	 or	
diclofenac	 sodium	 (Cayman	 Chemical)	 by	 intraperitoneal	 injection.	 Dosage	 of	
dmPGE2	 was	 100mg/kg	 bodyweight,	 twice	 daily,	 and	 dosage	 of	 diclofenac	 was	
10	mg/kg	 bodyweight,	 twice	 daily5,19.	 This	 diclofenac	 dosage	 was	 comparable	 to	
dosages	 used	 in	 humans	 when	 using	 the	 dose	 translation	 formula	 published	 by	
Reagan‐Shaw	et	al20.	Vehicle,	dmPGE2	and	diclofenac	treatment	was	started	1	day	
prior	 to	 laparotomy	and	 continued	until	 the	 end	of	 the	 experiments	 (Figure	4.1).	
	 Cyclooxygenase‐2	is	essential	for	colorectal	anastomotic	healing	
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Anastomotic	 leakage	was	 defined	 as	 either	 fecal	 peritonitis	 or	 abscess	 formation	
around	 the	 anastomosis.	 Two	 independent	 investigators	 who	 were	 blinded	 for	
genotype	at	the	time	of	evaluation	diagnosed	anastomotic	leakage.		
Tissue	preparation	
A	 1	 cm	 segment	 of	 colonic	 tissue	 surrounding	 the	 anastomosis	 was	 dissected	 in	
longitudinal	 direction,	 thereby	 dividing	 it	 into	 equal	 parts.	 One	 part	 was	 fixed	





using	 0.6%	hydrogen	peroxide	 in	methanol	 for	 30	minutes.	Nonspecific	 antibody	
binding	 was	 blocked	 using	 5%	 bovine	 serum	 albumin	 in	 PBS	 [myeloperoxidase	
(MPO)	and	CD31	staining]	or	10%	normal	rabbit	serum	(MAC‐3	staining).	Antigen	
retrieval	was	required	for	CD31	immunohistochemistry	(IHC)	[0.1%	trypsin	(Difco	
Laboratories,	 Detroit,	 MI)	 in	 0.1%	 CaCl2	 solution	 for	 20	 minutes	 at	 37°C]	 and	
MAC‐3	IHC	(10mM	sodium	citrate,	pH	6.0).	Sections	were	incubated	with	primary	
antibodies	 rabbit	 antihuman	 MPO	 antibody	 (MPO,	 Dako‐Cytomation,	 Glostrup,	
Denmark),	which	cross‐reacts	with	mouse,	rat	anti‐mouse	CD31	(BD	Pharmingen,	








The	 Netherlands),	 or	 streptavidin‐biotin‐HRP	 system	 (Vector	 Laboratories,	
Burlingame,	 CA),	 respectively.	 Binding	 of	 primary	 antibody	 was	 visualized	 with	
3,30‐diaminobenzidine‐tetrahydrochloride‐dihydrate	 (Sigma,	 St	 Louis,	 MO)	 and	




200x	magnification	and	expressed	as	 the	number	of	 vessels	per	 total	 area	 (mm2)	
using	 ImageJ	 (NIH	 Software,	 Bethesda,	 MD).	 Staining	 of	 MPO	 was	 quantified	 by	
ImageJ	 as	 well	 and	 staining	 of	 MAC‐3	 was	 quantified	 by	 2	 independent	 blinded	
observers	using	computerized	morphometry	(Leica	QWin	V3,	Cambridge,	UK).	The	
results	 were	 presented	 as	 neutrophils	 per	 field	 of	 view	 (MPO)	 or	 percentage	 of	
positive	cells	per	total	tissue	area	(MAC‐3).	
Real‐time	Quantitative	Polymerase	Chain	Reaction	
RNA	 was	 isolated	 from	 snap‐frozen	 anastomotic	 tissue	 samples	 with	 AllPrep	
DNA/RNA/Protein	kit	 (Qiagen,	Hilden,	Germany)	according	 to	 the	manufacturer’s	
protocol.	 In	 short,	 samples	 were	 crushed	 with	 a	 pestle	 and	 mortar	 in	 liquid	
nitrogen.	 Disruption	 and	 homogenization	 of	 the	 tissue	 was	 performed	 using	 an	




water.	 RNA	 quantity	 was	 measured	 using	 the	 NanoDrop	 spectrophotometer	
(Thermo	Scientific,	Wilmington,DE).	OnlyRNAsamples	with	a	clearly	visible	S28	and	
S18	on	agarose	gel	were	considered	as	intact	RNA	and	were	used.	Total	cDNA	was	
synthesized	 using	 the	 iScriptcDNAsynthesis	 kit	 (Bio‐Rad,	 Hercules,	 CA).	 qPCR	
reactions	were	performed	on	10ng	cDNA	with	300nM	of	gene‐specific	forward	and	
reverse	 primers	 and	 1X	 Absolute	 qPCR	 SYBR	 Green	 Fluorescein	 Mix	 (Bioline,	
London,	United	Kingdom)	using	 the	MyIQ	system	(Bio‐Rad).	 Sequence	of	primers	
for	 VegfA	 were:	 forward	 TATTCAGCGGACTCACCAGC,	 reverse	
CCTCCTCAAACCGTTGGCA).	 Gene	 expression	 levels	 were	 calculated	 with	 IQ5	
software	 using	 a	 ΔCt	 relative	 quantification	 model.	 The	 geometric	 mean	 of	 2	





From	 148	 consecutive	 patients	 who	 underwent	 oncologic	 colorectal	 surgery,	
paraffin‐embedded	 colonic	 or	 rectal	 tissue	 sections	 were	 collected	 from	 the	
pathology	 department’s	 database	 for	 DNA	 extraction.	 In	 all	 cases,	 surgery	 with	
primary	 anastomosis	 was	 performed	 in	 a	 single	 non‐academic	 centre	 with	 a	
dedicated	team	of	colorectal	surgeons	from	January	2010	until	August	2011.	Data	
on	 clinical	 outcome,	 including	 development	 of	 anastomotic	 leakage,	 had	 been	
electronically	and	prospectively	registered	in	detail	for	nationwide	audit	purposes.	
DNA	isolation	from	human	tissue	
Genomic	 DNA	 was	 obtained	 from	 formalin‐fixed	 paraffin‐embedded	 tissue	 using	
either	a	QIAamp	DNA	FFPE	Tissue	Kit	(Qiagen)	or	an	in‐house	protocol.	In	short,	4	
tissue	 sections	 of	 8mm	per	 sample	were	 deparaffinized,	 and	 samples	were	 lysed	
under	 denaturing	 conditions	 with	 proteinase	 K	 (at	 least	 3	 h	 at	 55°C).	 After	
centrifuging	 multiple	 times,	 pure	 genomic	 DNA	 was	 obtained	 and	 concentration	
was	determined	using	Nanodrop.	To	obtain	more	purified	DNA,	 all	 samples	were	




of	 COX‐2	 as	 the	 ‐765C	 allele,	 compared	with	 the	 ‐765G	 allele,	 reduces	 promoter	
activity21.	 In	 this	 study,	 it	was	 also	demonstrated	 that	 the	 ‐765C	 allele	 correlates	
with	lower	C	reactive	protein	levels.	Therefore,	the	presence	of	‐765G>C	may	have	








case	 a	 ‐765C	 allele.	 The	 presence	 of	 homozygous	 PTGS2‐765G>C	 polymorphism	
(‐765CC)	was	then	correlated	to	anastomotic	leakage.	
Statistics	
Statistical	 analysis	 was	 performed	 using	 Prism	 5.0	 for	 Windows	 (Graphpad	
software,	 Inc,	 San	Diego,	 CA)	 and	 SPSS	20.0	 for	Windows	 (SPSS	 Inc,	 Chicago,	 IL).	









To	 study	 whether	 the	 observed	 retrospective	 human	 data	 on	 colonic	 anastomic	
leakage	 in	 patients	 receiving	 COX‐2	 inhibitors	 were	 also	 observed	 in	 mice,	
anastomotic	 leakage	 rates	 in	 mice	 receiving	 either	 vehicle	 or	 NSAIDs	 were	
determined.	Three	of	11	mice	in	the	wildtype	group	developed	anastomotic	leakage	
(27%),	 which	 is	 consistent	with	 previous	 studies	 using	 this	 experimental	model.	
Intriguingly,	 all	 mice	 in	 the	 diclofenac	 group	 (n=9,	 100%),	 however,	 developed	
anastomotic	leakage,	P=0.001	(Figure	4.2A).	As	expected,	survival	was	significantly	
reduced	 in	 the	 group	 receiving	 diclofenac	 compared	 with	 the	 group	 receiving	
vehicle	[hazard	ratio	(HR)	17.9	(95%	confidence	 interval	(CI),	3.7–87.4),	P<0.001,	















Figure	4.2	 Effect	 of	 diclofenac	 on	 experimental	 anastomotic	 healing.	 A.	 Incidence	 of	 anastomotic	





Because	 we	 hypothesized	 that	 the	 adverse	 effects	 of	 NSAIDs	were	 particularly	 a	




had	macroscopic	 leakage	 compared	with	 only	 27%	 of	WT	mice	 (P=0.003,	 Figure	
4.3A).	 Survival	 was	 significantly	 reduced	 in	 COX‐2‐/‐	 mice	 compared	 to	WT	mice	
[HR,	3.5	(95%CI,	1.2–10.3],	P=0.02,	Figure	4.3B].	Because	COX‐2	is	essential	for	the	
production	 of	 PGE2,	 which	 is	 an	 important	 mediator	 in	 gut	 homeostasis,	 we	
investigated	whether	PGE2	administration	could	rescue	COX‐2‐/‐	from	anastomotic	
leakage.	 Indeed,	 supplementation	 with	 dmPGE2	 halved	 the	 anastomotic	 leakage	














Figure	4.3	 Effect	 of	 genotype	 on	 experimental	 anastomotic	 healing.	 A.	 Incidence	 of	 anastomotic	





























cells	 between	WT	 and	 COX‐2‐/‐	 mice	 (Figure	 4.5A).	 On	 average	 148	 cells/field	 of	
view	were	found	vs.	188	cells/field	of	view	at	100x	magnification,	WT	vs.	COX‐2‐/‐,	
respectively	 (Figure	 4.5B).	 Apart	 from	 neutrophils,	 macrophages	 are	 important	
COX‐2	expressing	inflammatory	cells	that	also	play	a	major	role	in	wound	healing.	

































On	 average	 a	 25%	 vs.	 23%	 ratio	 of	 positive	 staining/total	 tissue	 area,	 WT	 vs.	
COX‐2‐/‐,	 respectively	 (Figure	 4.6B).	 These	 data	 indicate	 that	 local	 cellular	
inflammatory	 responses	 after	 colonic	 surgery	 are	 not	 affected	 in	 COX‐2‐/‐	 mice,	








































of	 the	 amount	 of	 blood	 vessels	 showed	 that	 only	 2	 vessels/mm2	were	 stained	 in	
anastomotic	tissue	of	COX‐2‐/‐	mice	compared	to	6	vessels/mm2	 in	wildtype	mice,	
5	days	 after	 surgery	 (P=0.03,	 Figures	 4.7A,	 4.7B).	 This	 effect	 could	 partly	 be	
reversed	 by	 administration	 of	 dmPGE2	 to	 COX‐2‐/‐	 mice,	 because	 significantly	
higher	numbers	of	blood	vessels	were	observed	in	COX‐2‐/‐	mice	receiving	dmPGE2	
compared	to	COX‐2‐/‐	receiving	vehicle	(4	vs.	2	vessels/mm2,	respectively,	P=0.03,	



























Figure	4.7	 COX‐2‐/‐	 mice	 exhibit	 less	 vascularization	 in	 colonic	 anastomotic	 tissue.	 A.	
Immunohistochemical	 staining	 of	 CD31	 on	 sections	 of	 colonic	 anastomotic	 tissue.	 Upper	
panel:	wildtype;	 lower	panel:	 COX‐2‐/‐.	Magnification	40x,	 inlay	100x.	B.	Quantification	of	
MPO	 staining	 of	 wildtype	 and	 COX‐2‐/‐	 mice,	 and	 COX‐2‐/‐	 mice	 receiving	 PGE2.	 Data	 are	
presented	 as	 mean	 with	 SEM.	 CD31	 expression	 was	 significantly	 lower	 in	 COX‐2‐/‐	 mice	
compared	 to	 wildtype	 mice	 and	 compared	 to	 COX‐2‐/‐	 mice	 receiving	 PGE2.	 C.	 Relative	
expression	of	VEGF	mRNA	in	colonic	anastomotic	tissue	of	wildtype	and	COX‐2‐/‐	mice,	and	
COX‐2‐/‐	mice	receiving	PGE2.	Data	are	presented	as	mean	with	SEM.	Relative	VEGF	mRNA	







Of	 148	 patients	 undergoing	 colorectal	 resection	 for	 malignancy,	 7	 were	
























This	 study	 shows	 that	 COX‐2	 is	 of	 critical	 importance	 in	 preventing	 anastomotic	
leakage	after	colonic	surgery	 in	a	mouse	experimental	colonic	anastomosis	model	
using	both	a	pharmacological	and	a	genetic	approach.	Mice	lacking	COX‐2	showed	
increased	 rates	 of	 anastomotic	 leakage	 and	 mortality,	 which	 could	 be	 partly	
counteracted	by	administration	of	PGE2,	supposedly	the	most	important	product	of	
COX‐2	 in	 preserving	 gut	 homeostasis.	 Intriguingly,	 PTGS2‐765G>C	 polymorphism	
in	humans,	associated	with	reduced	COX‐2	expression,	was	associated	with	higher	
anastomotic	 leakage	rates.	 Impaired	angiogenesis	 in	mice	 lacking	COX‐2	seems	 to	





A	 correlation	 between	 the	 use	 of	 COX‐2	 blocking	 NSAIDs	 and	 impaired	
anastomotic	 healing	 after	 colorectal	 surgery	 has	 already	 been	 established	 in	
patients9,11,12.	However,	 these	data	are	of	 retrospective	nature	and	a	 fundamental	
role	 of	 COX‐2	 in	 gut	 healing	 after	 colorectal	 surgery	 has	 never	 been	 established.	
Manieri	 et	 al	 showed	 that	 COX‐2	 is	 critically	 involved	 in	 mucosal	 repair	 after	
intestinal	 biopsies5.	 Furthermore,	 abundant	 evidence	 exists	 showing	 that	 COX‐2	
and	 its	 derived	 prostaglandins	 stimulate	 intestinal	 cancer	 progression	 through	
enhanced	angiogenesis	and	proliferation	and	by	decreasing	apoptosis23‐25.	Although	
these	mechanisms	should	be	counteracted	 to	reduce	cancer	progression,	 they	are	
indispensable	 in	 adequate	 wound	 healing.	 As	 shown	 by	 Binion	 et	 al,	 COX‐2	 and	
PGE2	 stimulate	 angiogenesis	 through	 VEGF	 production	 (by	 endothelial	 cells)8.	
Indeed,	 our	 study	 showed	 that	 mice	 lacking	 COX‐2	 have	 significantly	 lower	
amounts	 of	 CD31+	 vessels	 in	 anastomotic	 tissue	 that	was	 accompanied	 by	 lower	
levels	 of	 VEGF	 mRNA	 levels	 and	 was	 at	 least	 partly	 restored	 by	 PGE2	
administration.	
	
The	 current	 study	has	 several	 important	 implications.	As	 suggested	earlier	by	




other	 therapeutic	 hits	 impairing	 gut	 homeostasis.	 This	 was	 underlined	 in	 the	
current	 study	 by	 the	 increased	 anastomotic	 leakage	 risk	 in	 patients	 carrying	
2	alleles	 of	 the	 PTGS2‐765G>C	 polymorphism.	 Although	 the	 prevalence	 of	 the	
homozygous	‐765C	gene	is	reported	to	be	around	3%26,	selection	and	personalized	
treatment	of	these	patients	should	be	investigated,	for	example,	the	administration	
of	 prostaglandins	 such	 as	 PGE2	 in	 phases	 when	 adequate	 intestinal	 healing	 is	
crucial.		
	





and	mortality.	 Another	 limitation	 was	 the	 lack	 of	 a	 random	 computer‐generated	
multiple‐area	 analysis	 of	 our	 IHC	 data,	which	may	 have	 biased	 our	 observations.	




mice	 receiving	 diclofenac	 developed	 anastomotic	 leakage.	 Although	 this	
	 Cyclooxygenase‐2	is	essential	for	colorectal	anastomotic	healing	
71	
underscores	 the	 importance	 of	 this	 pathway	 in	 anastomotic	 healing,	 such	 high	




The	 survival	 of	 mice	 with	 anastomotic	 leakage	 in	 the	 current	 study	 was	
remarkably	 low,	 with	most	 mice	 dying	 within	 several	 days.	 For	 example,	 higher	
survival	rates	are	reported	for	most	cecal	puncture	and	ligation	protocols,	although	
cecal	 puncture	 and	 ligation	 protocols	 inducing	 high‐grade	 sepsis	 are	 reported	 to	





we	 only	 used	 PGE2	 to	 counteract	 the	 effects	 of	 genetic	 lack	 of	 COX‐2.	 However,	
other	 prostaglandins	 are	 converted	 from	 arachidonic	 acid	 by	 COX‐2,	 as	 well.	 In	
particular,	prostacyclin	(PGI2)	is	expressed	in	colonic	tissue	and	may	therefore	play	
a	 role	 in	 anastomotic	 healing5.	 Another	 explanation	 could	 be	 that	 the	 dose	 or	
frequency	of	PGE2	administration	should	be	increased	for	optimal	effects.	
	
In	 conclusion,	 we	 show	 that	 COX‐2	 inhibition	 is	 deleterious	 for	 anastomotic	
healing	after	colonic	surgery,	which	is	mediated	at	least	in	part	by	PGE2	production.	
Mice	 lacking	 COX‐2	 show	 higher	 rates	 of	 anastomotic	 leakage	 and	 increased	
mortality.	 In	 addition,	 angiogenesis	 is	 significantly	 impaired	 in	 the	 absence	 of	
COX‐2	 and	 PGE2,	 providing	 clues	 for	 the	mechanism	 by	 which	 COX‐2	 influences	
anastomotic	healing.	Importantly,	we	show	that	patients	with	a	polymorphism	that	
is	associated	with	decreased	COX‐2	levels	were	more	likely	to	develop	anastomotic	
leakage,	 which	 further	 supports	 our	 conclusions.	 We	 suggest	 that	 until	 proven	
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mucus	 is	 a	 first	 line	of	defence	 against	 external	 factors	 in	 the	 gastrointestinal	 tract,	 it	was	












with	 less	 collagen	 deposition	 and	 neoangiogenesis.	 A	 tendency	 towards	 higher	 bacterial	
translocation	was	 seen	 in	Muc2‐/‐	mesenteric	 lymph	 node	 and	 spleen.	 Intestinal	 fatty	 acid	








Anastomotic	 leakage	 (AL)	 is	 one	 of	 the	most	 dreaded	 complications	 of	 colorectal	
surgery,	 and	 leads	 to	 high	morbidity	 and	mortality1,2.	 AL	 rates	 remain	 high,	with	
reported	 rates	 ranging	 from	1	 to	 almost	 20	 per	 cent,	 despite	 extensive	 research,	




pathophysiological	mechanisms	 for	 AL	 remain	 unclear7.	 A	 better	 insight	 to	 these	
mechanisms,	 and	 the	 factors	promoting	 anastomotic	healing,	 is	 needed	 to	 reduce	
rates	of	AL8.	
	
The	 colon	 is	 protected	 by	 a	 two‐phase	 mucous	 layer	 built	 around	 the	 gel‐
forming	MUC2	mucin	and	a	limited	number	of	other	components	secreted	from	the	
goblet	 cells9,10.	MUC2	mucin	polymers	 form	net‐like	 sheets	 that,	when	 layered	on	
top	 of	 one	 another,	 form	 an	 inner	 colonic	 mucous	 layer	 that	 is	 impenetrable	 to	
bacteria11.	This	 layer	 is	about	50	µm	thick	 in	mice	and	200	µm	 in	humans,	and	 is	
quickly	renewed12.	The	 inner	 layer	 is	converted	to	an	non‐attached	outer	mucous	
layer,	which	is	penetrable	for	colonic	bacteria	that	use	this	layer	as	their	habitat9,10.	
Muc2	 gene‐deficient	 mice	 lack	 a	 functional	 mucous	 layer,	 and	 have	 bacteria	 in	
direct	contact	with	the	epithelial	cells	in	the	intestine9.	These	mice	develop	colonic	
inflammation	 with	 a	 severity	 that	 depends	 on	 the	 bacterial	 flora	 in	 the	 animal	
housing	facility.	
	
Among	 the	 numerous	 factors	 contributing	 to	 healing	 of	 surgical	 anastomoses,	
the	 intestinal	mucus	 system	has	 been	 largely	 overlooked.	 This	 is	 despite	 the	 fact	











factors	 such	 as	 certain	 algal	 polysaccharides,	 uronic	 acids	 and	 short‐chain	 fatty	




In	 addition,	 prostaglandin	 (PG)	 E2,	 produced	 by	 the	 two	 isoforms	 of	 cyclo‐
oxygenase	 (COX)	1	and	2,	 can	 stimulate	mucous	 secretion	 in	both	 small	 intestine	
and	 proximal	 colon	 ex	 vivo19.	 Non‐steroidal	 anti‐inflammatory	 drugs	 (NSAIDs)	
inhibit	 COX	 enzymes,	 leading	 to	 a	 decrease	 in	 prostaglandin	 synthesis20.	 An	
association	 between	 the	 use	 of	 NSAIDs	 and	 AL	 has	 been	 described	 in	 both	









All	 animal	 experiments	 were	 approved	 by	 the	 Gothenburg	 Animal	 Experiments	
Ethics	 Committee	 (permit	 63‐2014),	 and	 all	 experiments	 were	 performed	 in	







versus	 control	 (Muc2+/−	 and	 Muc2+/+);	 22	 mice	 per	 group).	 Additionally,	 eight	
Muc2−/−	mice	served	as	control	animals	in	the	quantitative	PCR	(qPCR)	experiment	
for	bacterial	 translocation,	 to	distinguish	between	effects	 induced	by	 surgery	and	
the	genotype.	The	mice	had	unlimited	access	 to	standard	mouse	chow	and	water.	
Welfare	of	the	animals	was	assessed	twice	daily	using	extensive	scoring	according	
to	 Pommergaard	 and	 colleagues25.	 Postoperative	 pain	 relief	 treatment	 with	
buprenorphine	 0.1	 mg/kg	 subcutaneously	 (Buprecare®;	 AST	 Farma,	 Oudewater,	
The	Netherlands)	was	administered	when	needed.		
Study	design	
Muc2−/−,	 Muc2+/−	 and	 wild‐type	 (WT;	 Muc2+/+)	 mice	 underwent	 laparotomy	with	
colonic	 anastomosis	 and	 were	 killed	 on	 at	 day	 3	 after	 the	 operation.	 The	









and	 subsequently	 adapted	 by	 Reisinger	 et	 al.27	 to	 obtain	 a	model	 that	 resembles	
clinical	 practice.	 In	 this	 model,	 mice	 undergo	 anaesthesia	 with	 isoflurane	 and	
receive	 pain	 treatment	 with	 buprenorphine	 (0.1	 mg/kg	 subcutaneously)	 before	
surgery	 in	 which	 a	 proximal	 colonic	 anastomosis	 is	 performed	 with	 seven	
interrupted	 extramucosal	 sutures	 (Prolene®	 8‐0;	 Ethicon,	 Johnson	 &	 Johnson,	
Somerville,	 New	 Jersey,	 USA),	 providing	 a	 leakage	 rate	 of	 33.3	 per	 cent.	 During	
surgery,	 the	 colon	 and	 caecum	 are	 kept	 moist	 with	 sterile	 saline.	 The	 body	
temperature	 of	 the	mice	 is	 held	 constantly	 at	 37°C	 using	 a	 heat	 pad.	 The	muscle	
layer	 and	 skin	 are	 closed	using	 interrupted	 sutures	 (Vicryl®	4‐0	 and	Monocryl®	




The	 main	 outcome	 after	 surgery	 was	 macroscopic	 evaluation	 of	 the	
anastomosis,	 evaluated	 as	 follows:	 no	 AL;	 small	 abscess,	 less	 than	 0.5	 cm3;	 large	
abscess,	0.5	cm3	or	more;	or	faecal	peritonitis.	
Tissue	and	blood	sampling	




the	 same	manner,	 serving	 as	 control	 tissue.	Mesenteric	 lymph	nodes	 (MLNs)	and	
spleen	were	snap‐frozen	in	liquid	nitrogen	for	further	analysis.	Blood	samples	were	
taken	by	intracardial	puncture	at	time	of	animal	killing,	collected	in	EDTA	vacuum	





measurements	 of	 mucus	 were	 performed	 as	 described	 previously28,	 with	 some	





mucus	 was	 visualized	 by	 adding	 charcoal	 particles	 on	 top	 of	 the	 mucus.	 The	
thickness	 of	 the	 mucous	 layer	 was	 then	 determined	 by	 measuring	 the	 distance	
between	 the	mucous	 surface	 and	 the	 epithelial	 surface	 by	 a	micropipette	 viewed	
through	 a	 stereomicroscope	 (Leica	 MZ12;	 Leica	 Microsystems,	 Heerbrugg,	
Switzerland).	 Mucus	 was	 measured	 directly	 at	 the	 anastomotic	 site.	 Unaffected	




Tissue	 samples	were	embedded	 in	paraffin	and	cut	 in	4‐μm	sections.	To	evaluate	
the	morphology	 of	 cells	 and	 glycoproteins	 in	 the	 colonic	mucous	 layer,	 standard	
haematoxylin	 and	 eosin,	 and	 periodic	 acid–Schiff–Alcian	 Blue	 (PAS‐AB)	 staining	
was	 performed.	 Specimens	 were	 scored	 based	 on	 inflammation,	 granulocyte	
infiltration,	 fibroblast	 activity	 and	 neoangiogenesis,	 according	 to	 the	 Ehrlich	 and	
Hunt	numerical	scale	(0–4)	as	modified	by	Phillips	et	al.30.	
	
Immunohistochemistry	 for	 Ki‐67	 (proliferation),	 cleaved	 caspase	 3	 (CC‐3)	
(apoptosis)	and	Muc2	(to	confirm	the	phenotype	of	the	animals)	was	performed.	In	
short,	 slides	 were	 deparaffinized	 in	 xylene	 and	 rehydrated	 in	 graded	 ethanol	 to	




specific	 primary	 antibodies	 (Ki‐67	 clone	 Sp6;	 Thermo	 Fisher	 Scientific,	 Life	
Technologies,	Bleiswijk,	The	Netherlands;	CC‐3	Asp175,	Cell	Signalling	Technology,	
Leiden,	The	Netherlands;	or	anti‐MUC2C3	(provided	by	the	Mucin	biology	group)9).	
After	washing,	 swine	antirabbit	 IgG	biotin	 labelled	 (Dako,	Glostrup,	Denmark)	 for	
Ki‐67	and	CC‐3	stainings,	and	fluorophore‐conjugated	CY3	antirabbit	antibody	(Life	
Technologies)	 for	 Muc2	 staining	 were	 used	 as	 second	 antibodies.	 Nuclei	 were	
stained	 using	 (nickel)	 3,3'‐diaminobenzidine	 (DAB)	 or	 4',6‐diamidino‐2‐
phenylindole	 (DAPI).	 All	 staining	 was	 evaluated	 by	 two	 independent	 observers	
using	microscopy;	they	were	blinded	for	the	genotype	of	the	mice.	Ki‐67	expression	
was	 analysed	 using	 ImmunoRatio	 software31,	 which	 calculates	 the	 percentage	 of	






Intestinal	 fatty	 acid‐binding	 protein	 (I‐FABP)	 is	 a	 plasma	 marker	 for	 enterocyte	
damage,	as	these	small	cytosolic	proteins	are	present	in	mature	enterocytes	at	the	
tip	 of	 the	 villus	 and	 released	 into	 the	 circulation	 following	 loss	 of	 enterocyte	
membrane	 integrity32.	 Patients	 who	 developed	 AL	 after	 colorectal	 surgery	 were	
shown	 to	 have	 raised	 I‐FABP	 plasma	 levels	 before	 the	 operation33.	 I‐FABP	 was	
measured	 in	 plasma	 using	 a	 commercially	 available	 sandwich	 enzyme	




be	 PGE2‐mediated27.	 To	 investigate	 whether	 PGE2	 has	 a	 positive	 influence	 on	
anastomotic	healing,	mice	 received	 either	 vehicle	 (PBS)	or	 100	μg/bodyweight	of	





Total	 DNA	 was	 extracted	 from	 snap‐frozen	 MLN	 and	 spleen	 tissue	 using	 a	
combination	 of	 sodium	 dodecyl	 sulphate	 and	 proteolytic	 digestion	 with	 bead	
beating	and	phenol/chloroform	DNA	purification,	 as	previously	described34.	Bead	
beating	was	performed	using	Lysing	Matrix	E	tubes	in	a	FastPrep‐24™	instrument	
(MP	 Biomedicals,	 Thermo	 Fisher	 Scientific,	 Göteborg,	 Sweden).	 DNA	 was	
precipitated	using	0.2	mol/l	sodium	chloride	and	isopropanol,	then	resuspended	in	
100	µL	 Tris–EDTA	 buffer	 and	 quantified	 using	 a	 NanoDrop™	 ND‐1000	
spectrophotometer	(Thermo	Fisher	Scientific,	Göteborg,	Sweden).	DNA	extractions	
from	 tubes	 containing	 no	 tissue	 served	 as	 contamination	 controls.	 Purified	 and	
quantified	16S	DNA	from	Escherichia	coli	was	used	as	a	standard.	Initially,	bacterial	
ribosomal	 DNA	 (rDNA)	 was	 enriched	 from	 host	 DNA	 by	 limited‐cycle	 (LC)	 PCR	
amplification	 of	 16S	 rDNA	 using	 the	 universal	 16S	 rDNA	 primer	 pair	 27F	
(AGAGTTTGATCMTGGCTCAG)	and	1492r	(CGGTTACCTTGTTACGACTT).	Briefly,	50‐
µl	PCR	mixtures	 containing	480	ng	DNA,	0.2	µmol/l	primers	 and	HotStarTaq	Plus	
Mastermix	 (Qiagen,	 Sollentuna,	 Sweden)	were	 subjected	 to	 5	min	 at	 95°C	 and	 16	
cycles	of	94°C	for	1	min,	55°C	for	1	min	and	72°C	for	1.5	min,	followed	by	10	min	at	
72°C.	 Sample,	 standard	 and	 control	 LC‐PCRs	were	 then	 compared	by	 qPCR	using	





Sundbyberg,	Sweden)	and	subjected	 to	95°C	 for	5	min,	 then	30	cycles	of	95°C	 for	
15	s,	61.5°C	 for	15	s	and	72°C	 for	20	s,	with	EvaGreen®	 fluorescence	measured	at	
the	final	step	of	each	cycle.	qPCR	thermocycling	and	fluorescence	measurement	was	
performed	on	 a	 CFX96™	 instrument	 (Bio‐Rad).	 Sample	 amplification	 curves	were	
compared	with	 contamination	 control	 curves,	 and	 samples	were	 considered	16S‐










All	 mice	 (n=44)	 completed	 follow‐up	 of	 3	 days.	 After	 killing,	 the	 abdomen	 was	
reopened	and	the	anastomotic	site	evaluated.	Evaluation	showed	a	wide	range	from	
normal	 healing/no	 AL	 to	 small	 and	 large	 abscesses,	 and	 even	 faecal	 peritonitis	
(Figure	 5.1A–C).	 Muc2−/−	 mice	 had	 AL	 more	 frequently	 (score	 greater	 than	 2)	





the	 two	 experimental	 groups,	 and	 remained	 so	 over	 time	 (Figure	 5.2B).	 A	



























at	 baseline	 in	 the	 two	 experimental	 groups	 and	did	not	 differ	 over	 time.	 C)	A	 significant	





measured	 by	 means	 of	 a	 glass	 capillary	 attached	 to	 micrometer,	 observed	 via	 a	
stereomicroscope	(Figure	5.3A).	A	mucous	layer	was	observed	in	Muc2+	animals,	at	
the	site	of	anastomosis	as	well	as	in	the	proximal	and	distal	colonic	tissues	(Figure	
5.3B).	 In	 the	 proximal	 colon,	 the	 mean	 mucous	 layer	 thickness	 was	 greatest	
between	 folds	 (238(17)μm)	 and	 lowest	 on	 top	 of	 the	 folds	 (71(25)μm).	 Mean	
thickness	 of	 the	 mucous	 layer	 at	 the	 anastomotic	 site	 was	 119(65)μm.	 In	 the	
control	 group,	 no	 significant	 difference	 was	 found	 in	 mucous	 layer	 thickness	
between	heterozygous	(Muc2+/−)	and	WT	(Muc2+/+)	mice,	or	between	mice	that	had	
AL	and	those	that	did	not.	As	Muc2‐deficient	mice	lack	the	structural	component	of	
























Muc2−/−	mice	showed	a	 tendency	 for	more	 leucocyte	 infiltration	and	 less	collagen	
deposition	and	neoangiogenesis	at	killing	on	POD	3	compared	with	Muc2+	animals	
(Figure	5.4B).	 In	addition,	 continuation	of	 the	 intestinal	 tissue	was	evident	 in	 the	
case	of	normal	 anastomotic	healing,	whereas	AL	 caused	disruption	or	dehiscence	
(Figure	 5.4B).	 There	 was	 no	 difference	 in	 proliferation	 determined	 by	 Ki‐67	
staining	between	Muc2−/−	and	control	mice	at	the	serosal	tissue	of	the	anastomosis	
or	 in	 the	 enterocytes	 (Figure	 5.4C,D).	 CC‐3	 staining	 showed	 no	 differences	 in	
apoptosis	between	Muc2−/−	and	control	mice	(Figure	5.4E,F).	
	
A	 normal	 inner	 mucous	 layer,	 as	 shown	 by	 PAS‐AB	 staining,	 was	 clearly	
observed	in	the	Muc2+	control	mice,	but	was	absent	in	Muc2−/−	mice	(Figure	5.5A).	
In	 addition,	 goblet	 cells	 in	 Muc2−/−	 mice	 showed	 only	 PAS‐positive	 staining,	
whereas	 those	 from	 control	 animals	 also	 had	 positive	 AB	 staining.	

































Figure	5.4	 A)	 Inflammatory	 parameters	 (mean(s.d.)	 scored	 on	 day	 3	 after	 surgery	 did	 not	 differ	
significantly	between	experimental	groups.	B)	In	Muc2+	animals	with	normal	anastomotic	
healing	 there	 was	 continuation	 of	 the	 intestinal	 tissue,	 whereas	 anastomotic	 leakage	 in	
Muc2−/−	 mice	 caused	 disruption	 or	 dehiscence	 (arrows)	 (haematoxylin	 and	 eosin	 stain).	
C+D)	There	was	no	difference	in	proliferation	measured	by	Ki‐67	staining	between	Muc2−/−	






























staining,	 was	 clearly	 observed	 in	 the	 Muc2+	 control	 mice	 (arrows),	 but	 was	 absent	 in	
Muc2−/−	 animals.	 C+D)	 Immunohistochemistry	 revealed	 the	 presence	 of	 Muc2‐positive	
goblet	 cells	 in	 control	 animals,	 but	 in	 Muc2−/−	 mice	 there	 was	 no	 expression	 of	 Muc2,	
indicating	 no	 Muc2‐positive	 goblet	 cells.	 The	 minimal	 staining	 found	 in	 Muc2−/−	 is	
attributed	 to	 slight	 cross‐reactivity	of	 the	 anti‐MUC2C3	antiserum	with	 the	mouse	Fcgbp	
protein	(Fc	fragment	of	IgG‐binding	protein).	
Epithelial	cells	were	damaged	in	Muc2	deficient	mice		
When	 enterocytes	 are	 damaged	 they	 leak	 one	 of	 their	main	 cytosolic	 proteins,	 I‐
FABP.	 Hence,	 measurement	 of	 I‐FABP	 in	 plasma	 gives	 an	 estimate	 of	 intestinal	
tissue	damage.	Muc2−/−	mice	 showed	 significantly	 higher	plasma	 levels	 of	 I‐FABP	
compared	with	 control	 animals	 (3.88(2.63)	 versus	 1.82(1.83)ng/ml	 respectively;	
P=0.011)	(Figure	5.6A),	indicating	greater	enterocyte	damage	in	the	Muc2−/−	mice.	
PGE2	administration	did	not	reduce	anastomosis	leakage	in	this	model	
dmPGE2	was	 administered	1	day	before	 surgery	 and	on	 every	postoperative	day	

































Figure	5.6	 A)	 The	 concentration	 of	 intestinal	 fatty	 acid‐binding	 protein	 (I‐FABP)	 was	 significantly	
increased	in	Muc2−/−	mice	compared	with	that	in	control	animals	(mean(s.d.)	 	3	 .88(2.63)	
versus	 1.82(1.83)ng/ml	 respectively),	 indicating	 more	 epithelial	 damage.	 *P=0.011	
(Student’s	 t	 test).	 B)	 Following	 prostaglandin	 (PG)	 E2	 supplementation	 ,	 there	 was	 no	
reduction	in	the	anastomotic	leakage	(AL)	rate	for	Muc2−/−	mice	(10	of	11	for		both	vehicle	
and	 PGE2	 ),	 and	 the	 reduction	 in	 the	 AL	 rate	 in	 control	 animals	 was	 not	 significant	
(P=0.362,	Student’s	t	test	per	experiment	as	well	as	2‐way	ANOVA	with	post	hoc	testing	).	
*P<0.001.	 C)	 Bacterial	 translocation	 to	 the	 mesenteric	 lymph	 node	 was	 present	 in	 both	
control	and	Muc2−/−	animals	that	underwent	surgery,	but	not	in	Muc2−/−	mice	that	had	no	
operation.	 *P<0.050	 (Kruskal–Wallis	 test).	 Box‐and‐whisker	 plots	 represent	 median	 and	











increased	 bacterial	 translocation	 to	 the	 intestinal	 lymphatics	 (Figure	 5.6C).	 No	
significant	difference	was	detected	between	control	and	Muc2−/−	mice,	although	the	
median	 16S	 load	 was	 4.4	 times	 lower	 in	 control	 mice	 compared	 with	 Muc2−/−	
mice.	 Spleen	 load	 was	 similar	 in	 the	 three	 groups,	 with	 approximately	 100	 16S	
rDNA	copies	per	mg	tissue	detected	in	most	animals	(Figure	5.6D).	However,	three	
of	 11	 mice	 in	 the	 Muc2−/−	 surgery	 group	 had	 more	 than	 104	 16S	 copies/mg,	
indicating	that	more	bacteria	had	penetrated	the	systemic	tissue	 in	a	subgroup	of	
these	 animals.	 Thus,	 the	 surgical	 procedure	 increased	 translocation	 of	 bacteria	




the	 introduction	 of	 new	 surgical	 techniques	 and	 the	 construction	 of	 a	 diverting	
stoma	in	high‐risk	patients35.	Many	risk	factors	are	being	investigated,	but	the	first	








possible.	 It	 should	 be	 noted	 that	 Muc2−/−	 mice	 develop	 spontaneous	 colitis,	
although	 this	 often	 remains	 asymptomatic	 in	 the	 animal	 facility36.	 The	 effects	
observed	 in	Muc2−/−	mice	are	 therefore	ascribed	to	the	development	of	AL	rather	




without	AL	 start	 to	 gain	weight,	whereas	mice	with	 AL	 start	 to	 gain	weight	 only	
after	POD	525.	Not	only	did	 the	Muc2−/−	mice	show	more	clinical	 symptoms	of	AL	
than	 control	 mice,	 they	 also	 had	 significantly	 higher	 I‐FABP	 levels,	 indicating	
	 Mucus	and	colonic	anastomotic	leakage	
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enterocyte	 damage	 and	more	 bacterial	 translocation.	 The	 damaged	 epithelia	 and	
increased	 translocation	 could	 indicate	 that	 the	 mucous	 layer	 is	 important	 for	
reducing	 the	 number	 of	 bacteria	 that	 reach	 the	 vulnerable	 anastomosis	 site,	 and	
hence	 is	 important	 in	 the	healing	process.	 In	 line	with	 this,	 there	 is	accumulating	
evidence37,38	that	bacteria	are	involved	in	the	pathogenesis	of	AL.	
	
It	was	hypothesized	 that	 supplementation	with	dmPGE2	would	 reduce	 the	AL	
rate	by	increasing	mucous	secretion.	However,	dmPGE2	did	not	reduce	the	AL	rate	
in	either	Muc2−/−	or	control	mice.	It	has	been	suggested	that	dmPGE2	can	prevent	
AL	 when	 COX‐2	 activity	 is	 decreased,	 induced	 either	 by	 drug	 treatment	 (COX	
inhibitors)	or	by	knocking	out	the	COX‐2	gene27.	In	the	present	study,	no	difference	
in	 AL	 rate	 was	 observed	 following	 PGE2	 administration,	 despite	 using	 a	 stable	
analogue	of	PGE2	in	the	same	dosage	that	had	an	effect	in	a	Cox2‐deficient	mouse	
model.	 Perhaps	PGE2	 is	 effective	only	when	 there	 is	 a	 severe	deficiency	of	PGE2,	





In	 the	present	study	only	anastomoses	 in	 the	proximal	colon,	and	not	 in	other	
parts	 of	 the	 gastrointestinal	 tract,	 were	 investigated.	 Interestingly,	 Yauw	 and	 co‐
workers40	recently	showed	that	diclofenac,	a	commonly	used	NSAID,	caused	AL	in	







membrane	 protein	 profiling	 has	 demonstrated	 distinctive	 regional	 differences	 in	
the	colon42.	These	different	observations	suggest	that	the	healing‐promoting	effect	
of	PGE2	might	differ	along	the	gastrointestinal	tract,	and	that	this	might	also	be	the	
case	 for	the	healing‐promoting	effect	of	a	 functional	mucous	 layer	suggested	here	
for	the	proximal	colon.	
	
Potentially	 interesting	 factors	 that	 can	 influence	 the	 colonic	mucous	 layer	 are	
certain	bacteria	or	SCFAs.	A	frequent	colonizer	of	the	human	colonic	mucous	layer	
is	 Akkermansia	 muciniphila,	 a	 mucin‐degrading	 bacterium	 that	 is	 suggested	 to	
increase	the	thickness	of	the	inner	mucous	layer18.	The	presence	of	A.	muciniphila	
correlated	with	increased	Muc2	gene	expression,	suggesting	that	A.	muciniphila	can	






SCFAs	 from	 bacteria	 in	 the	 distal	 colon	 are	 important	 as	 the	 primary	 energy	
source	for	colonic	epithelial	cells,	but	also	stimulate	mucous	secretion16.	One	of	the	
most	 abundant	 SCFAs	 in	 the	 colon,	 butyrate,	 can	 strengthen	 distal	 anastomoses	
when	 given	 in	 enema	 form44,	 perhaps	 through	 stimulated	 mucous	 secretion16.	
Thus,	commensal	bacteria	in	the	outer	mucous	layer	of	the	distal	colon	may	help	to	
prevent	AL	in	animal	models	by	producing	SCFAs.	Furthermore,	mucins	have	been	
suggested	 to	 have	 a	 trophic	 effect,	 as	 they	 are	 not	 readily	 digested	 and	 can	 be	
considered	 an	 important	 nutrient	 source	 for	 many	 intestinal	 organisms.	 Colonic	
mucus	 also	 contains	 trefoil	 factor	 (TFF)	 3,	 a	 molecule	 known	 to	 have	 a	 trophic	
effect	in	the	colon45.	Mucus	acts	as	a	diffusion	barrier,	thereby	hindering	molecules	




When	 inflammation	 and	 cell	 proliferation	 were	 studied	 with	 immuno‐
histochemistry,	 no	 differences	 were	 observed	 between	 the	 two	 experimental	
groups.	 This	might	 be	 explained	 by	 the	 fact	 that	mice	were	 killed	 on	 day	 3.	 It	 is	
known	 from	 other	 experiments26,27	 that	 day	 3	 is	 early	 in	 the	 intestinal	 healing	
process	 and	 that	 potential	 differences	 become	 evident	 in	 later	 phases	 of	 healing.	
However,	 POD	 3	was	 chosen	 for	 killing	 in	 the	 present	 study	 in	 order	 to	 prevent	
animal	suffering.	
	
Results	 from	 animal	 experiments	 cannot	 be	 translated	 directly	 to	 the	 human	
setting.	 Paradoxical	 to	 the	 observation	 that	 the	 thick	 mucous	 layer	 in	 the	 distal	
colon	may	be	protective	 is	 that	distal	 tumour	 location	 in	patients	 is	a	known	risk	





recovers	 quickly	 after	 this	 time13.	 Owing	 to	 the	 slow	 biosynthesis	 of	 mucins,	 a	
second	period	of	ischaemia	should	be	avoided47.	
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Muc2+/−	 at	 the	 Experimental	 Biomedicine	 animal	 facility	 at	 the	 University	 of	
Gothenburg	and	offspring	were	genotyped.		
 Mice	were	kept	under	 standard	 conditions	 and	were	provided	with	 food	and	
water	 ad	 libitum.	 Mice	 were	 housed	 together	 with	 their	 littermates,	 with	 a	
maximum	of	6	companions	per	cage.	The	general	health	of	mice	was	monitored	














of	 scoring,	while	 the	 other	 researcher	performed	preparation	of	 the	PGE2	or	
placebo	syringes	for	peritoneal	injection.	












 In	 total	 there	were	52	mice	used	 in	 this	 study.	We	used	11	per	 experimental	
group,	 and	 4	 groups	 (knockout	 vs	 control	 mice,	 with	 and	 without	 dmPGE2	








































































Despite	 extensive	 research,	 anastomotic	 leakage	 (AL)	 remains	 one	 of	 the	 most	 dreaded	





patch;	 2)	 a	 single	 injection	 of	 hyaluronan‐butyrate	 (HA‐But)	 prior	 to	 construction	 of	 the	
proximal	 anastomosis;	 and	 3)	 rectal	 hyaluronan‐butyrate	 (HA‐But)	 enemas	 designed	 for	
distal	 anastomoses.	 The	 main	 outcome	 was	 AL	 and	 secondary	 outcomes	 were	 bursting	




Neither	 the	 patches	 nor	 the	 injections	 led	 to	 a	 reduction	 of	 AL	 in	 experiment	 1	 and	 2.	 In	
experiment	 3,	 a	 significant	 reduction	 of	 AL	 was	 accomplished	 with	 the	 (HA‐But)	 enema	
compared	 to	 the	 control	 group	 together	 with	 a	 higher	 bursting	 pressure.	 Histological	
analysis	 detected	 only	 an	 increased	 inflammation	 in	 experiment	 2	 in	 the	 hyaluronan	
injection	group	compared	 to	 the	control	group.	No	other	differences	were	 found	regarding	
wound	healing.	Zymography	identified	a	decreased	pro‐enzyme	of	MMP9	when	HA‐But	was	




Butyrate	 enemas	 are	 effective	 in	 the	 enhancement	 of	 colonic	 anastomosis.	 Enhanced	
butyrate‐based	approaches	designed	 to	reduce	AL	 in	animal	models	 for	both	proximal	and	
distal	 anastomoses	were	not	more	 effective	 than	butyrate	 enemas	 alone.	 Further	 research	






Despite	 extensive	 research,	 anastomotic	 leakage	 (AL)	 remains	 one	 of	 the	 most	
dreaded	complications	after	colorectal	surgery.	It	still	results	in	high	morbidity	and	
mortality,	 and	 causes	prolonged	hospital	 stay	and	high	health	 care	 costs1‐3.	Many	
studies	have	been	performed	regarding	this	subject,	all	aiming	at	 improvement	of	
anastomotic	 healing,	 and	 thereby	 preventing	 leakage.	 Since	 the	 incidence	 of	




of	 the	predominant	 short	 chain	 fatty	 acids	 (SCFAs)	 ‐,	 results	 in	 a	higher	 bursting	




been	 reported	 in	 which	 patients	 received	 postoperative	 butyrate	 enemas	 to	
enhance	 anastomotic	 strength.	 This	 is	 not	 surprising,	 when	 you	 consider	 that	
clinicians	are	not	keen	on	enemas	directly	after	surgery,	especially	when	a	 fragile	
rectal	 anastomosis	 is	 involved.	Water‐soluble	 contrast	 enemas	 are	 often	 used	 to	
determine	 the	presence	of	 colorectal	AL,	mostly	after	 rectum	resection.	However,	
these	 enemas	 are	 never	 given	 in	 the	 very	 early	 postoperative	 phase	
(<postoperative	 day	 5)	 due	 to	 the	 potential	 risk	 of	 complications5.	 Another	
disadvantage	 of	 the	 use	 of	 enemas	 is	 the	 low	 compliance	 rate	 and	 the	 short	 and	
discontinuous	exposure	of	butyrate	to	the	colonic	mucosa.		
	




of	 the	 fermentation	 process	 by	 bacteria	 that	 occurs	 mainly	 in	 the	 distal	 colon.	
Because	 it	 serves	 as	 the	 most	 important	 energy	 source	 for	 colonocytes11,	 our	
hypothesis	is	that	increasing	the	concentration	of	butyrate	will	lead	to	an	enhanced	
anastomotic	healing	in	the	colon.	A	number	of	studies	indicate	that	butyrate	affects	
the	 composition	 and	 thickness	 of	 the	 colonic	 mucus	 layer	 through	 alteration	 of	
mucin	 gene	 expression12	 and	 nutritional	 deficiency	 of	 the	 colonic	 epithelium	 and	
that	 butyrate	 also	 can	 act	 as	 a	 signalling	 molecule	 through	 specific	 G‐protein	
coupled	 receptors	 that	 are	 involved	 in	 the	 immune	 surveillance	 of	 the	 colonic	
mucosa	 towards	microbial	 activity13.	More	 recently,	 it	 has	 been	 shown	 that	mice	
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with	 an	 insufficient	 mucus	 layer	 on	 the	 colonic	 mucosa	 (Muc2‐/‐)	 suffered	 more	
often	from	anastomotic	leakage	compared	to	control	mice14.	
	
Furthermore,	 animal	 studies	 showed	 that	 butyrate	 enemas	 have	 a	 significant	
positive	 effect	 on	 the	 left	 colonic	 anastomoses,	 but	 this	 effect	was	weaker	on	 the	
right	 side	 of	 the	 colon8.	 Obviously,	 not	 the	 same	 volume	will	 reach	 the	 proximal	
anastomotic	 site	 compared	 to	 the	 distal	 anastomosis,	 which	 may	 explain	 these	
findings.	Another	explanation	might	be	that	the	butyrate‐producing	bacteria	mainly	
reside	 in	 the	mucus	 layer	 at	 the	 distal	 part	 of	 the	 colon,	 that	 the	 proximal	 colon	
does	 not	 respond	 to	 a	 higher	 amount	 of	 butyrate,	 simply	 because	 the	 proximal	
enterocytes	are	not	familiar	to	having	that	energy	source	available	and	are	not	able	
to	use	it.	To	increase	the	beneficial	effect	of	butyrate,	we	added	hyaluronan	(HA),	a	
glycosaminoglycan	 that	 is	 known	 to	 promote	 neovascularization,	 to	 enhance	 the	
process	 of	 scarring,	 and	 has	 beneficial	 effects	 on	 cell	 proliferation	 in	 several	
tissues15,16.	Hyaluronan	also	plays	a	role	in	the	downregulation	of	the	inflammatory	
response.	 Its	 free‐radical	 scavenging	and	antioxidant	properties	 and	 its	 supposed	
inhibiting	 effect	 on	 proteinases	 such	 as	 MMPs,	 seem	 to	 be	 responsible	 for	 this	
downregulation,	stabilizing	the	granulation	tissue	during	the	healing	process16.	
	
In	 this	 study,	we	 investigated	 several	ways	 to	 improve	 the	proximal	 anastomotic	
strength	by	applying	butyrate	near	this	anastomosis:	using	a	patch;	injections;	and	
enemas.	 Our	 aim	was	 to	 develop	 a	method	 that	 resulted	 in	 a	 lower	 anastomotic	




Eighty‐four	Wistar	 rats	with	 a	 body	weight	of	 250‐300	 gram	were	used.	Animals	
were	housed	and	cared	for	at	the	Central	Animal	Facility	of	Maastricht	University.	
All	animals	were	provided	ad	libitum	access	to	food	and	water,	and	were	cared	for	
according	 to	 local	 standards.	 Postoperatively,	welfare	 assessment	was	performed	
twice	daily	using	a	standardized	method	and	animals	were	given	pain	medication	in	
case	 of	 discomfort.	 The	 experimental	 protocol	 complied	 with	 the	 Dutch	 Animal	







Primary	 objective	 of	 the	 study	 was	 to	 investigate	 if	 anastomotic	 leakage	 can	 be	
reduced	in	a	leakage	model	by	application	of	either	an	intraluminal	butyrin‐eluting	
patch,	 a	 single‐time	 intraluminal	 administration	 of	 butyrate	 or	 a	 daily	 HA‐But	
enema.	For	the	proximal	anastomoses	we	used	both	an	intraluminal	butyrin‐eluting	
patch	that	covered	the	anastomosis	and	a	single‐time	 intraluminal	administration	
of	 hyaluronan‐butyrate	 (HA‐But).	 Since	most	 research	 is	 performed	 in	 the	 distal	
part	of	 the	colon,	we	also	used	a	 left‐colon	anastomosis	model	 to	 test	 the	HA‐But	
enemas.	This	resulted	in	the	following	3	experiments:	
	
Experiment	1:		 Butyrin	 eluting	 patches	 (20	 massa%	 tributyrin)	 versus	 placebo		
patches	(n=12/group).	
Experiment	2:		 HA‐But	 injection	 (5%	 HA,	 60mM	 butyrate)	 versus	 HA	 injection		
(5%	HA)	versus	Saline	injection	(0.9%	NaCl)	(n=8/group).	
Experiment	3:		 5mL	 of	 HA‐But	 enema	 (5%	 HA,	 60mM	 butyrate)	 versus	 5mL	
sodium	 Butyrate	 (60	 mM)	 enema	 versus	 a	 control	 group	 that	
received	no	enemas	(n=12/group).	




All	 rats	 received	 0.05mg/kg	 buprenorphine	 as	 analgesic	 and	 were	 anesthetized	
using	 isoflurane.	 To	 acquire	 access	 to	 the	 abdominal	 cavity,	 a	 5	 cm	 craniocaudal	
midline	 incision	 of	 the	 skin	 and	 abdominal	 musculature	 was	 made	 in	 all	
experiments.	The	 cecum	was	 then	 identified	and	moved	outside	of	 the	peritoneal	
cavity	 and	 onto	 sterile	 gauzes	 that	 were	 hydrated	with	 sterile	 saline	 solution	 to	
prevent	 dehydration.	 For	 proximal	 anastomoses:	 the	 colon	 was	 transected	 two	
centimeters	 distal	 from	 the	 cecum	 and	 an	 end‐to‐end	 anastomosis	 was	 created	
using	 4	 interrupted	 polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	
Johnson)	 (Exp	 1	 &	 2,	 see	 Supplementary	 Data	 S6.1).	 In	 Experiment	 3,	 the	
anastomosis	was	 performed	 in	 similar	 fashion	 but	 at	 4	 centimeters	 ab	 ani.	 After	








complete	 dehiscence	with	 peritonitis/death	 due	 to	 fecal	 peritonitis.	 Adhesions	 to	
the	anastomotic	site	were	assessed	according	to	van	der	Ham	et	al.18.		
Bursting	pressure	
Bursting	 pressure	 was	 measured	 as	 previously	 described19.	 In	 short,	 a	 5‐cm	










pressure)	 with	 a	 0.5	 cm	margin	 at	 each	 site	 of	 the	 anastomosis.	 Tissue	 samples	
were	divided	in	three	equal	pieces,	one	for	qPCR,	one	for	zymography	purposes	and	
one	 for	 immunohistochemistry	 purposes.	 This	 latter	 one	 was	 cut	 in	 longitudinal	
direction	and	tissue	was	stretched	and	pinned	onto	a	cork	layer	in	order	to	secure	a	
straight	 anastomotic	 line	 and	 improve	 quality	 of	 histological	 assessment	 prior	 to	








assessment	 on	 the	 obtained	 tissue,	 scoring	 (from	 0‐4)	 histological	 sections	 on	
inflammation,	 granulocyte	 influx,	 fibroblast	 activity	 and	 collagen	 deposition.	
Collagen	 ration	 was	 calculated	 using	 an	 in‐house	 software	 program	 on	 pictures	
obtained	with	 a	polarized	 light	microscope	 (Leica	DM5000B,	 Leica	Microsystems,	
Wetzlar,	Germany).	
MMP2,	pro‐MMP9	and	MMP9	activity	analysis	using	zymography	
MMP‐2	 and	 MMP‐9	 activity	 were	 assessed	 using	 gelatin	 zymography	 since	 it	







for	30	min	at	 room	temperature.	The	gel	was	 then	placed	 in	developing	buffer	at	
37°C	overnight.	Colouring	of	the	gel	took	place	the	following	night	with	PAGE‐Blue	
protein	staining	solution	(Thermo	Scientific,	the	Netherlands).	At	day	3,	the	staining	
was	 decoloured	 with	 MQ,	 revealing	 MMP‐2	 and	 MMP‐9	 activity.	 The	 gels	 were	
scanned	 using	 a	 Bio‐Rad	 GS‐800	 Densitometer	 and	 digitally	 quantification	 was	
done	 using	 ImageJ	 software	 (ImageJ	 Software,	 U.	 S.	 National	 Institutes	 of	Health,	
Bethesda,	Maryland,	USA).	
MMP2,	MMP9,	TFF3	and	Muc2	expression	analysis	using	qPCR	
The	expression	of	matrix	metalloproteinases	2	 (MMP2)	 and	9	 (MMP9)	 as	well	 as	
Mucin	2	 (MUC2)	and	 trefoil	 factor	3	 (TFF3)	was	determined	using	qPCR	 to	 see	 if	
exogenous	butyrate	had	an	effect	on	the	expression	of	 these	MMPs;	 the	abundant	
secretory	mucin	MUC2	as	well	as	its	associated	trefoil	factor.	All	qPCR‐experiments	
were	 carried	 out	 by	 a	 dedicated	 technician	 (BB)	 and	 are	 reported	 as	 detailed	 as	
possible	 according	 to	 the	 MIQE	 guidelines21.	 RNA	 was	 isolated	 from	 the	 tissue	
sample	 using	 TRI	 reagent	 (Sigma‐Aldrich,	 the	 Netherlands)	 and	 treated	 with	
RNase‐Free	 DNase	 Set	 (Qiagen).	 The	 purity	 of	 RNA	 was	 tested	 using	 Nanodrop	
Spectrophotometer	 (Thermo	 Scientific)	 by	 260/280	 absorbance	 (A260/A280)	
ratios,	 ranged	 from	 1.89	 to	 2.02.	 Therefore,	 the	 purity	 of	 the	 isolated	 RNA	 was	
satisfactory	for	further	studies.	RNA	of	750ng	was	converted	to	DNA	with	sensifast	
cDNA	Synthese	kit	(Bioline,	London,	UK).	qPCR	was	performed	on	10ng	cDNA	with	
0,3µM	primers	 	 in	Sensimix	SYBR	&	Fluorescein	Kit	 (Bioline,	London,	UK)	using	a	
white	 384	wells	 qPCR	 plate.	 Primer	 sequences	 are	 listed	 in	 Table	 6.1.	 Reference	
genes	included	were	glyceraldehyde‐3‐phosphate	dehydrogenase	(GAPDH)	and	B‐
actin.	Reactions	were	run	on	the	LightCycler480	(Roche).	PCR	conditions	used	were	
10	 min	 at	 95°C,	 followed	 by	 40	 amplification	 cycles	 of	 15s	 at	 95°‐60°C‐72°C	
followed	by	a	melting	curve	to	validate	the	amplifications.	The	cycle	threshold	(Ct)	









Diego,	 CA).	 Normality	 was	 tested	 using	 Kolmogorov‐Smirnov.	 All	 continuous	
Chapter	6	
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variables	 are	 presented	 as	 mean	 and	 standard	 error	 of	 the	 mean	 (SEM)	 and	



















In	 experiment	 1,	 two	 rats	 in	 the	 butyrin	 patch	 group	 died	 prior	 to	 completing	
follow‐up	due	to	faecal	peritonitis.	All	animals	in	experiment	2	completed	the	7‐day	
follow	up.	In	experiment	3,	three	rats	(1	in	the	HA‐But	group,	2	 in	the	But	group)	
were	 euthanized	 because	 they	 had	 reached	 humane	 endpoints,	 due	 to	 faecal	
peritonitis.	 An	 overview	 of	 the	 types	 of	 anastomotic	 leakage	 within	 each	
experimental	 group	 can	 be	 found	 in	 Figure	 6.1A.	 Adhesions	 occurred	 in	 every	
experiment	 and	 there	 were	 no	 significant	 differences	 between	 experiments	
(proximal	versus	distal	anastomoses)	nor	within	each	experiment	(Figure	6.1B).	It	
became	evident	 that	animals	receiving	a	patch	(either	butyrin	eluting	or	placebo)	






























Figure	6.1	 Butyrate‐enriched	 enemas	 reduced	 AL	 in	 Exp.	 3,	 no	 other	 butyrate‐based	 intervention	
caused	 a	 decrease	 in	 AL	 rates	 (A).	 Adhesion	 scores	 did	 not	 differ	 significantly	 between	
groups	in	Exp.	1,2	or	3	(B).	Weight	loss	was	most	prominent	in	Exp.	1	where	placement	of	
the	patches	caused	a	sudden	change	in	calibre	of	the	colon;	Animals	receiving	enemas	had	
the	 lowest	 percentage	 of	 weight	 loss	 but	 also	 received	 a	 different	 type	 of	 anastomosis	
compared	 to	 animals	 in	 Exp.	 1	 and	 2	 (distal	 vs	 proximal	 respectively)	 (C).	 The	

















Inflammatory	 parameters	 were	 scored	 as	 a	 surrogate	 marker	 of	 anastomotic	
healing,	 as	 indicated	 appropriate	 by	 a	 recent	 Delphi	 consensus	 method22.	
Histological	 analysis	 (Figure	 6.2)	 only	 detected	 an	 increased	 inflammation	 in	
experiment	 2	 in	 the	 hyaluronan	 injection	 group	 (2.18±0.22)	 compared	 to	 the	
control	 group	 (3.27±0.27,	 P<0.05).	 No	 other	 differences	 were	 found	 regarding	


















Figure	6.2	 Histological	 analysis	 detected	 only	 an	 increased	 inflammation	 in	 experiment	 2	 in	 the	
hyaluronan	 injection	 group	 (2.18±0.22)	 compared	 to	 the	 control	 group	 (3.27±0.27,	




Zymography	 revealed	 no	 differences	 between	 MMP2	 and	 MMP9	 activity	 within	
each	experiment	between	control	and	intervention	groups	(Figure	6.3).	There	was	
relatively	large	variability	within	the	samples	of	each	group	as	can	be	seen	by	the	
error	 bars/whiskers	 in	 the	 different	 graphs.	 In	 experiment	 3,	 the	 addition	 of	
hyaluronan	 to	 the	butyrate	enema	did	decrease	 the	activity	of	pro‐MMP9	 (40.6	±	






Experiment	1	 Butyrin	patch	 Placebo	patch	 	 P‐value	
Collagen	percentage	(%)	 32.25	(±2.69)	 28.64	(±2.00)	 		 0.239	
Red/green	ratio	 464.83	(±278.36)	 361.42	(±207.96)	 	 0.861	
Experiment	2	 Saline	injection	 HA‐But	injection	 HA	injection	 P‐value	
Collagen	percentage	(%)	 53.22	(±2.04)	 45.29	(±4.51)	 46.50	(±4.83)	 0.361	
Red/green	ratio	 66.89	(±16.76)	 39.66	(±7.88)	 95.64	(±44.43)	 0.340	
Experiment	3	 Control	 HA‐But	enema	 Butyrate	enema	 P‐value	
Collagen	percentage	(%)	 42.84	(±	4.75)	 35.57	(±	4.23)	 35.93	(±	2.12)	 0.343	

















Figure	6.3	 Zymography	 revealed	 no	 differences	 between	 MMP2	 and	 MMP9	 activity	 within	 each	
experiment	 between	 control	 and	 intervention	 groups.	 The	 addition	 of	 hyaluronan	 to	 the	
butyrate	enema	did	decrease	the	activity	of	pro‐MMP9	(40.6±8.2)	compared	to	the	butyrate	






that	 received	 a	 butyrin	 patch	 (0.35	 ±	 44.4)	 and	 the	 placebo	 patch	 group	 (1.14	 ±	
0.34,	 P<0.07,	 Figure	 6.4).	 The	 other	 tested	 matrix‐metalloproteinase	 MMP9	 also	
showed	 a	 trend	 between	 these	 two	 groups,	 0.39	 ±	 0.21	 versus	 1.14±0.34	
respectively,	P<0.08.	No	differences	were	found	regarding	MUC2	and	TFF3.		














Figure	6.4	 Overview	 of	 relative	 gene	 expression	 where	 the	 level	 of	 MMP2	 expression	 of	 the	 saline	





This	 study	 is	 the	 first	 study	 as	 far	 as	 we	 know	 that	 aims	 to	 improve	 butyrate	
supplementation	 in	 animal	 models	 to	 overcome	 the	 reservation	 of	 surgeons	 to	
optimize	their	patients	with	butyrate	prior	or	during	gastrointestinal	surgery.	We	
investigated	 different	 administration	 routes	 besides	 enemas	 that	 could	 enable	
surgeons	to	incorporate	butyrate	in	the	surgical	procedure.	Unfortunately,	a	single	








and	 thereby	 ameliorate	 the	development	 of	 colitis	 as	 shown	by	Furusawa	 et	 al23.	
More	 recently,	 it	 has	 been	 shown	 that	 exogenous	 butyrate	 restoration	 improved	
intestinal	 epithelial	 cell	 junctional	 integrity,	 decreased	 apoptosis	 and	 mitigated	
graft‐versus‐host‐disease	after	allogeneic	bone	marrow	transplant24.	Especially	the	
restorative	 effect	 of	 butyrate	 on	 the	 epithelial	 integrity	 and,	 consequently,	 a	
decreased	 translocation	 of	 luminal	 contents	 are	 of	 great	 interest	 in	 the	 field	 of	
anastomotic	 leakage.	 It	 was	 often	 assumed	 that	 butyrate	 increases	 collagen	
synthesis	and	maturation	and	that	this	reduced	the	risk	of	anastomotic	leakage6‐8,	







the	 same	 levels	 of	 butyrate	 in	 proximal	 anastomoses.	 In	 addition,	 butyrate	 is	
metabolized	 rapidly	 as	 soon	 as	 it	 enters	 the	 colonocyte	 via	 its	 active	 transport	
system.	This	could	be	the	reason	that	experiment	2	was	not	successful;	the	amount	





difficult	 to	 incorporate	 butyrate	 in	 an	 eluting	 patch,	 butyrin	 was	 used	 instead,	
making	 sure	 that	 there	were	 high	 concentrations	 available	 at	 the	 site	 of	 release.	
Unfortunately	 the	 attachment	 of	 a	 patch	 into	 the	 colon	 caused	 extension	 of	 the	
bowel	proximal	to	the	location	of	the	patch,	indicating	colonic	stenosis.	This	effect	
of	 patches	 or	 fleeces	 has	 been	 previously	 described26,	 however	 in	 that	 study	 the	
authors	 used	 an	 external	 fleece	 and	 in	 experiment	 1	 the	 film‐like	 resorbable	
patches	were	attached	intraluminally.	This	stenosis	effect	–	clinically	translatable	to	





the	 result	 of	 both	 its	 physicochemical	 properties	 and	 its	 biological	 interactions,	
depending	on	molecular	weight28.	Despite	 the	 logical	hypothesis	 that	the	addition	





successful	 –	 is	 the	 translation	 to	 the	 human	 setting.	 While	 butyrate	 can	 be	
administered	as	a	rectal	enema,	this	is	rather	invasive	and	not	the	preferred	choice	
in	drug	administration.	The	risk	of	anastomotic	dehiscence	in	a	recent	constructed	
anastomosis	 remains,	 which	 could	 be	 an	 explanation	 of	 the	 fecal	 peritonitis	 that	





only	 in	 a	 rat	model29.	Other	 articles	 that	describe	oral	 administration	of	 butyrate	




and	 well	 tolerated32.	 The	 question	 remains	 if	 butyrate	 can	 be	 administered	 as	 a	
local	agent	at	the	site	of	the	anastomosis,	without	potential	harmful	effects	when	it	
enters	 the	 systemic	 circulation.	 Van	 Beek	 et	 al.	 have	 recently	 demonstrated	 that	
splanchnic	 butyrate	 release	 was	 prevented	 in	 patients	 after	 colonic	 butyrate	





different	 fields	 of	medicine34,35.	 Imaginably	 in	 the	 future	 butyrate	 tablets	 become	
standard	 perioperative	 treatment	 and	 due	 to	 nanotechnology	 the	 release	 of	
butyrate	will	only	take	place	at	the	site	of	interest,	the	colonic	anastomosis.		
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and	 was	 approved	 by	 the	 Animal	 Experimental	 Committee	 of	 Maastricht	
University	 Medical	 Center.	 Protocols	 for	 institutional	 animal	 use	 and	 care	
guidelines	were	followed	(permit	DEC	2013‐101).	
Study	design	
 In	 total	 there	 were	 84	 rats	 used	 in	 this	 study.	 We	 used	 8	 or	 12	 rats	 per	
experimental	group,	 and	2‐3	groups	per	experiment,	 as	 is	 shown	 in	 the	 table	
below:	
	



















































 We	 have	 chosen	 for	 male	 rats,	 since	 it	 is	 known	 that	 female	 estrogens	 and	
androgens	have	an	 important	 influence	on	wound‐healing	 (Ashcroft	GS,	 et	al.	
Estrogen	modulates	cutaneous	wound	healing	by	downregulating	macrophage	
migration	 inhibitory	 factor.	 The	 Journal	 of	 clinical	 investigation.	 2003,	
111:1309‐1318).	
Housing	and	husbandry		
 An	acclimatization	period	of	one	week	was	observed	prior	 to	 the	start	of	 the	
experiment.	
 Rats	were	 kept	 under	 standard	 conditions	 and	were	 provided	with	 food	 and	
water	ad	 libitum.	Rats	were	housed	2	animals	per	cage.	The	general	health	of	
rats	 was	 monitored	 several	 times	 per	 week	 for	 signs	 of	 inflammation	 and	




 Discomfort	 was	 scored	 using	 a	 standard	 scheme	 (zie	 below).	 Humane	
endpoints	 were	 defined	 according	 to	 Roughan	 &	 Flecknell	 (Roughan,	 J.	 V.	&	






















 Animals	 were	 randomized	 by	means	 of	 taking	 a	 card	 out	 of	 an	 envelope	 on	
which	either	1‐2‐3	was	printed.	For	each	animal	a	card	was	drawn	and	the	rat	
received	 the	 assigned	 treatment.	 We	 had	 3	 separate	 envelopes	 for	 each	
experiment	a	new	envelope	(with	either	2	or	3	types	of	card	in	there).	
Numbers	analysed		
 All	 analyses	 were	 performed	 according	 to	 an	 intention‐to‐treat	 analysis.	
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Posture	 Normal	 Huddled	up,	stretching	 Imbalance,	twitching		 Fall	over,	circle	
Physical	
condition	










Hydratation	 Normal	 Loss	of	skin	elasticity		 Reduced	skin	turgor	 Severly	reduced	turgor	+	
sunken	eyes	


































































Tissue	 adhesives	 (TA)	 may	 be	 useful	 to	 strengthen	 colorectal	 anastomoses,	 thereby	








and	 no	 TA	 seal.	 After	 7	 days	 rats	 were	 sacrificed	 and	 scored	 for	 presence	 of	 AL	 as	main	




The	 highest	 AL	 rate	was	 found	 in	 the	 Glubran	 2	 group	 (7/11),	 followed	 by	 the	 4‐sutures	
group	 without	 TA	 (5/11)	 and	 the	 Omnex	 group	 (5/11).	 Histoacryl	 Flexible	 showed	 the	
lowest	AL	rate	(2/11).	In	the	control	group	only	1	rat	showed	signs	of	AL.	Histologically,	the	
highest	 influx	 of	 inflammatory	 cells	 was	 found	 in	 the	 4‐suture	 group	 without	 TA	 and	 for	

















sheets	 of	 plastic	 covering	 the	 anastomosis3	 and	 exotic	 techniques	 such	 as	 tissue	
welding4	 have	 all	 been	 proposed,	 but	 most	 were	 quickly	 abandoned	 after	 their	
introduction	due	to	inefficacity	or	high	complication	rate.	
	
More	 recently,	 the	 idea	 of	 sealing	 an	 anastomosis	 externally	 with	 a	 tissue	
adhesive	has	been	in	the	spotlight,	and	has	been	linked	to	promising	results5.	The	
benefit	of	such	a	technique	is	that	a	surgeon	can	create	an	anastomosis	in	a	normal	






exothermic	 polymerization	 and	 tissue	 toxicity7,8.	 Newer	 CA	 formulations	 have	
eliminated	 this	 highly	 exothermic	 curing	 process	 by	 shortening	 the	 length	 of	 the	





Several	 experimental	 studies	 have	 been	 performed	 using	 CAs	 to	 prevent	 AL,	
yielding	ambiguous	results5,6.	This	may	be	due	to	a	large	spectrum	of	experimental	
methodology	 in	 the	 various	 studies,	 in	 which	 large	 differences	 exist	 in	 the	 used	
animal	models,	TA	dosage	and	experimental	end‐points,	which	is	a	well‐recognized	
problem	in	the	field	of	experimental	research	on	colorectal	anastomoses11.	



















system.	 Data	 are	 reported	 according	 to	 the	 ARRIVE	 guidelines	 (see	 also	
supplemental	data)13.	A	power	analysis	was	calculated	based	on	a	reduction	of	20%	
(δ)	 in	 inflammation,	 as	 scored	 on	 histological	 data,	 between	 the	 different	
experimental	 groups	 with	 a	 variance	 of	 ±16%	 (σ).	 The	 number	 of	 animals	 per	











3	 Histoacryl	Flex	 4	sutures	 n‐butyl‐2‐cyanoacrylate	 B.	Braun	(Tuttingen,	
GER)	










Male	 specific‐pathogen‐free	Wistar	 rats	 (250‐350	 g)	 were	 housed	 at	 the	 Central	
Animal	Facility	of	 the	Maastricht	University	Medical	Centre,	 the	Netherlands.	Rats	
were	 housed	 according	 to	 standard	 laboratory	 conditions,	 including	 individually	
ventilated	 cages	 with	 unrestricted	 access	 to	 standard	 rat	 chow	 and	 water.	 The	





Experienced	 researchers,	 certified	 for	 animal	 research,	 performed	 all	 surgical	
procedures.	 Rats	 received	 buprenorphine	 0.1	mg/kg	 (Temgesic,	 Schering‐Plough,	
USA)	 pre‐operatively	 for	 analgesia	 which	 was	 repeated	 when	 necessary	
postoperatively.	 Anesthesia	 was	 induced	 by	 inhalation	 of	 isoflurane	 5.0	 vol%	
(Forene,	Abbott	 Laboratories,	USA),	 followed	by	 a	maintenance	dose	of	2.5	 vol%.	
The	 abdominal	 skin	 was	 shaved,	 disinfected	 with	 iodine	 1%	 and	 covered	 with	
sterile	 drapes.	 A	 5‐cm	midline	 incision	was	made	 through	which	 the	 cecum	was	
identified	and	exteriorized	onto	sterile	gauzes.	The	ascending	colon	was	transected	
2‐cm	 distally	 to	 the	 cecum,	 without	 damaging	 the	 mesenteric	 vessels.	 An	
insufficient	end‐to‐end	colonic	anastomosis	was	created	using	4	evenly	distributed	
polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	 Johnson,	 USA).	 After	




into	 the	 abdominal	 cavity	 after	 repositioning	 of	 the	 abdominal	 contents.	 The	
abdominal	 wall	 was	 closed	 using	 a	 running	 suture	 of	 polyglactine	 4/0	 (Vicryl,	






The	 main	 outcome	 of	 the	 study	 was	 anastomotic	 leakage	 (AL),	 including	
macroscopic	 anastomotic	 dehiscence,	 fecal	 peritonitis	 or	 large	 anastomotic	
abscesses.	 After	 7	 days	 or	 when	 humane	 endpoints	 were	 reached,	 rats	 were	
sacrificed	using	an	overdose	of	 carbon	dioxide.	The	abdomen	was	 re‐opened	and	
the	 abdomen	 was	 macroscopically	 inspected	 for	 signs	 of	 leakage	 or	 TA‐related	
complications,	 that	 is,	 the	presence	of	 intraperitoneal	abscess	or	 fecal	matter	and	
ileus	 formation.	 Abscess	 formation	 was	 scored	 using	 the	 following	 parameters:	
1)	one	 or	 several	 millimetric	 abscesses;	 2)	 abscess	 up	 to	 ¼	 of	 anastomotic	
circumference;	 3)	 Large	 abscess	 >1/4	 of	 anastomotic	 circumference;	 4)	 intra‐
abdominal	abscess	formation.	Based	on	our	previous	research,	 in	which	we	found	
that	an	abscess	score	of	1	was	not	associated	with	any	clinical	complications	and	








4/0	 suture.	 The	 distal	 colonic	 segment	 was	 clamped	 to	 ensure	 an	 airtight	
compartment.	 Pressure	was	 gradually	 increased	 in	 the	 anastomotic	 compartment	
using	 an	 automatic	 pressure	 pump	 (IDEE,	Maastricht,	 the	Netherlands).	ABP	was	
monitored	 and	 recorded	 using	 a	 digital	 manometer	 until	 the	 colon	 bursted/air	
bubbles	appeared.	The	maximum	bursting	pressure	was	recorded	for	each	rat.	
Histological	evaluation	
After	 ABP	 testing,	 the	 anastomotic	 segment	 was	 subsequently	 resected	 and	
prepared	 for	 histological	 evaluation.	 Tissue	 samples	 were	 embedded	 in	 paraffin	
and	 cut	 in	 4μm	 sections.	 To	 evaluate	morphology	 of	 cells,	 standard	 hematoxylin‐
eosin	 (H&E)	 staining	 was	 performed.	 Specimens	 were	 scored	 based	 on	
inflammation,	 fibroblast	 activity,	 collagen	 deposition	 and	 neoangiogenesis	
according	to	the	Ehrlich	and	Hunt	numerical	scale	(0‐4)	as	modified	by	Phillips	et	










with	Entellan.	 Images	of	 the	anastomotic	 region	were	 taken	 (200x	magnification)	
using	 cross	 polarization	 light	 microscopy	 (Leica	 DM5000B,	 Leica	 Microsystems,	
Switzerland).	Collagen	percentages	of	anastomotic	tissue	were	calculated.	Maturity	

















4‐suture	non‐TA	group	4	 rats	 showed	signs	of	AL,	with	an	abscess	score	of	2	 in3	
rats	and	an	abscess	score	of	4	in	1	rat.	In	the	TA	groups	there	was	a	large	difference	
in	 AL‐rate.	 Glubran	 2	 had	 the	 highest	 AL‐rate,	 consisting	 of	 1	 total	 anastomotic	
dehiscence	 and	 subsequent	 fecal	 peritonistis,	 and	 6	 cases	 of	 abscess	 formation.	
Abscess	scores	in	this	TA	group	ranged	from	1	to	4.	Five	rats	in	the	Omnex	group	
and	 two	rats	 in	 the	Histoacryl	Flexible	group	showed	signs	of	AL,	with	maximum	
abscess	scores	of	4	and	2,	respectively.	Statistical	analysis	shows	that	Glubran	2	had	
a	significantly	higher	amount	of	abscesses	when	compared	to	the	positive	control	









2	 showing	 the	highest	 ileus	 rate,	 significantly	 higher	 than	when	 compared	 to	 the	
negative	control	group	(P=0.01).	The	number	and	Zuhlke	score	of	adhesions	did	not	





























Figure	7.1	 A)	Histoacryl	Flexible	had	the	 lowest	amount	of	anastomotic	 leakage	(2/11)	compared	to	
the	other	intervention	groups	Omnex	5/11	and	Glubran2	7/11	and	the	no	TA	group	5/11.	
The	 control	 group	 with	 12	 sutures	 only	 showed	 one	 case	 of	 AL	 (Χ2=9.43,	 P=0.05).	
B)	Weight	loss	was	monitored	as	a	measure	of	discomfort	and	the	percentage	weight	loss	
was	 highest	 in	 the	 no	TA	 group,	 followed	 by	 the	Glubran	 2	 group	with	was	 significantly	
higher	 than	 the	 Histoacryl	 Flexible	 group	 and	 the	 control	 group.	 C)	 No	 significant	
differences	were	 found	between	the	experimental	groups	regarding	anastomotic	bursting	


























1)	12	sutures	 11	 0	 1	 4,4	 3	
2)	4	sutures	 11	 1	 0	 5	 3	
3)	Histoacryl	Flex	 11	 0	 1	 5,5	 3	
4)	Omnex	 11	 0	 1	 5,7	 3	




The	 use	 of	 a	 4‐suture	 anastomosis,	 with	 or	without	 the	 presence	 of	 a	 TA,	 led	 to	
more	inflammation	when	compared	to	the	12‐suture	control	group	(Figure	7.2A).	A	
significantly	 higher	 inflammation	 score	 was	 found	 in	 the	 Omnex	 and	 Glubran	 2	
groups	when	compared	to	the	control	group	(P<0.01).	Significantly	more	collagen	
deposition	 was	 found	 in	 the	 Histoacryl	 Flexible	 group	 and	 the	 Omnex	 group	 in	
comparison	with	 the	 control	 group	 (Figure	 7.2B,	P<0.01).	 Fibroblast	 activity	 and	
neoangiogenesis	 did	 not	 differ	 between	 the	 experimental	 groups	 (Figure	 7.2C	 &	
7.2D).	
	
Picro	 Sirius	 red	 staining,	 which	 depicts	 the	 level	 of	 collagen	 maturity,	 of	 the	
































to	 the	 control	 group.	 B)	No	 differences	were	 found	 between	 groups	 regarding	 fibroblast	
acitivity.	 C)	More	 collagen	 deposition	was	 found	 in	 the	Histoacryl	 group	 and	 the	Omnex	














Figure	7.3	 A)	No	differences	were	 found	between	groups	 in	 the	relative	collagen	area	(quantified	as	
the	percentage	of	total	tissue	surface).	B)	Maturity	of	collagen	was	estimated	by	calculating	






as	 a	 promising	 method	 for	 the	 prevention	 of	 anastomotic	 leakage	 by	 forming	 a	
mechanical	barrier	that	can	protect	from	the	leakage	of	intraluminal	contents	into	
the	 peritoneum,	 giving	 the	 anastomosis	 time	 to	 heal20.	 Of	 the	 large	 amount	 of	
available	TAs,	recent	research	has	provided	evidence	that	cyanoacrylate	(CA)	TAs	
may	 be	 useful	 in	 the	 prevention	 of	 AL6.	 In	 the	 current	 study,	 we	 selected	 three	
clinically	available	CAs	to	seal	insufficient	colonic	anastomoses	in	a	rat	model,	also	
including	 a	 positive	 control	 group	 in	which	 a	 12	 suture	 colonic	 anastomosis	was	
used	as	well	as	a	negative,	4‐suture,	control	group.	We	evaluated	the	effectiveness	




this	 study	 AL	 was	 mostly	 presented	 as	 peri‐anastomotic	 abscess	 formation.	 The	
described	abscess	 score	was	used	 to	 score	 the	 severity	and	amount	of	abscesses;	
generally	 an	 abscess	 score	 of	 <2	was	 not	 associated	with	 any	 clinical	 symptoms,	
and	therefore	not	considered	clinically	relevant.	Histoacryl	Flexible,	a	combination	
of	n‐butyl‐2‐cyanoacrylate	and	a	softener,	showed	the	lowest	rate	of	AL,	occurring	
in	 2	 rats.	 Furthermore,	 the	maximum	 abscess	 score	with	Histoacryl	 Flexible	was	
lower	than	with	the	other	TAs,	and	consisted	only	of	punctiform	abscesses	around	
the	 anastomosis,	 which	 did	 not	 have	 any	 clinical	 consequences.	 The	 histological	
evaluation	showed	that	this	TA	resulted	in	the	least	 inflammation	and	the	highest	
level	of	collagen	formation	and	healing	of	the	TA	groups.	Overall,	Histoacryl	Flexible	




Glubran	 2,	 based	 on	 an	 n‐butyl‐2‐cyanoacrylate	 and	 methacryloxy	 sulfolane	
mixture,	showed	the	poorest	results	in	our	study.	In	terms	of	AL,	the	use	of	this	TA	
resulted	 in	 one	 case	 of	 premature	 death	 due	 to	 fecal	 peritonitis	 as	 well	 as	 the	
highest	 rates	 of	 abscess	 formation	 and	 severity.	 Furthermore,	 its	 use	 was	
associated	 with	 higher	 incidence	 of	 mechanical	 ileus,	 occurring	 in	 five	 rats,	
significantly	higher	 than	 in	the	4‐suture	control	group.	Rats	 in	 this	group	showed	
the	most	weight	loss	of	all	study	groups.	Histological	analysis	associated	Glubran	2	
use	with	 the	highest	 degree	 of	 inflammation,	 and	 a	 significantly	more	 premature	
collagen	 ratio,	 indicating	 less	 healing	 capability.	 Glubran	 2	 induced	 an	 extended	
inflammatory	 response	 with	 mild	 local	 muscle	 lysis	 as	 deep	 as	 the	 submucusal	
colonic	 layer.	 This	 finding	 was	 also	 reported	 in	 a	 previous	 study	 by	 Kayaoglu21.	
Omnex,	 a	 2‐octyl‐cyanoacrylate	 /	 butyl‐lactoyl‐cyanoacrylate	 mixture,	 showed	
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similar	 results	 to	 the	 negative	 control	 group	 in	 terms	 of	 AL	 rate,	 clinical	 effects,	
mechanical	 strength	 and	 histological	 analysis.	 Presence	 of	 this	 TA	 thus	 did	 not	
improve	outcomes	nor	lead	to	any	complications	when	used	on	the	colon.		
	
Results	 of	 this	 study	 are	 in	 line	 with	 previous	 research	 on	 the	 use	 of	 CA	 in	
experimental	AL	models.	 In	a	previous	study	 from	our	group	the	same	set	of	CAs	
were	applied	on	rat	colon	without	the	presence	of	a	colonic	defect	and	followed	for	
1	 or	 4	 weeks12.	 That	 study	 showed	 that	 Histoacryl	 Flexible	 retained	 the	 lowest	
complication	rate	and	a	relatively	inert	histological	profile,	with	a	limited	local	host	
reaction	and	an	increase	in	inflammatory	markers	at	7	days,	a	finding	which	did	not	
persist	 at	 28	 days	 when	 no	 ongoing	 inflammation	 reaction	 was	 found.	 In	 the	
present	 study,	 Histoacryl	 Flexible	 was	 associated	 with	 a	 higher	 inflammatory	
reaction	 than	 the	12‐suture	controle	group	at	7	days,	 comparable	 to	 the	4‐suture	
no‐TA	 group.	 The	 longterm	 inflammatory	 reaction	 of	 this	 TA	 in	 an	 anastomosis	
model	may	be	an	interesting	subject	for	further	research.		
	
All	 three	 TAs	 included	 are	 modern	 CAs,	 clinically	 in	 use.	 When	 examing	 the	
chemical	 composition	 of	 each	 CA	 (as	 depicted	 in	 table	 1),	 one	may	 note	 that	 the	
main	ingredients	of	the	included	CAs	are	similar	to	one	another.	Glubran	2	(n‐butyl‐
2‐cyanoacrylate/methacryloxysulfolane)	 does	 not	 differ	 considerably	 from	 either	
Histoacryl	 Flexible	 (n‐butyl‐2‐cyanoacrylate)	 or	 Omnex	 (n‐octyl‐
cyanoacrylate/butyl/lactoyl	 acrylate),	 while	 differences	 exist	 in	 the	 various	
additives	 and	 softeners.	 As	 reported	 in	 previous	 research,	 Glubran	 2	 elicits	 a	




Our	 study	 has	 several	 limitations.	 Firstly,	 we	 opted	 for	 a	 follow‐up	 time	 of	 7	
days	 to	 evaluate	 short‐term	 effectiveness	 after	 creation	 of	 an	 anastomosis.	




which,	 in	 fact,	 may	 reflect	 perioperative	 spillage	 of	 bowel	 contents	 instead	 of	
postoperative	 anastomotic	 leakage.	 Secondly,	 as	 a	 large	 number	 of	 colorectal	
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Plasticizers	 are	 commonly	used	 to	 improve	 the	mechanical	 characteristics	 of	 biomaterials.	
We	 studied	 two	 biomaterials	 designed	 as	membranes	 able	 to	 reduce	 colonic	 anastomotic	













Both	patches	 containing	glycerol	 induced	 large	abscess	 formation	and	severe	adhesions	 in	
the	 leakage	model	(n=20),	while	these	parameters	were	present	only	at	a	 limited	extent	 in	
control	 animals	 (n=10).	 In	 animals	 that	 did	 not	 show	 AL,	 encapsulation	 of	 the	 glycerol	
patches	 was	 evident.	 CAM	 assay	 identified	 glycerol	 as	 the	 cause	 of	 adverse	 patch‐host	











Anastomotic	 leakage	 (AL)	 is	 a	 complication	 occurring	 in	 up	 to	 10%	 of	 patients	
undergoing	colorectal	surgery,	a	type	of	surgery	that	is	commonly	used	to	remove	
the	 affected	 part	 of	 intestine	 in,	 e.g.	 colorectal	 cancer	 or	 inflammatory	 bowel	
disease.	AL	causes	higher	rates	of	morbidity	and	mortality	in	patients1,2,	making	AL	
a	 dreaded	 complication	 for	 the	 surgeon.	 It	 is	 commonly	 accepted	 that	 AL	 is	 a	
consequence	of	 improper	anastomotic	healing3.	A	conceivable	solution	 to	prevent	
or	limit	the	occurrence	of	AL	is	the	use	of	an	external	patch	composed	of	bioactive	




In	 the	 EU	 AnastomoSEAL	 project4,	 two	 promising	 membranes	 consisting	 of	
natural‐based	 biopolymers	 were	 proposed	 for	 reinforcement	 of	 the	 anastomotic	






tissues7,8.	 Alginate	 is	 widely	 used	 in	 biomedical	 applications	 due	 to	 its	 excellent	
biocompatibility	 and	 low	 toxicity9,10.	 The	 combination	 of	 HA	 and	 alginate	 is	 of	
particular	 interest	 as	 it	 combines	 the	 gel‐forming	 ability	 of	 the	 biologically	 inert	




similar	hyaluronan‐based	membrane	was	 recently	 shown	 in	vivo	 not	 to	exert	any	
adverse	reaction	in	direct	contact	with	intestinal	serosa13.		
	
Porcine‐derived	 gelatin	 is	widely	 used	 by	 surgeons	 as	 hemostatic	material	 to	
stop	 bleeding	 in	 wound	 surfaces6.	 It	 can	 be	 postulated	 that	 gelatin	 enhances	
anastomotic	 healing,	 mainly	 by	 achieving	 quick	 hemostasis	 assisting	 the	 wound	
healing	process14.	This	aim,	early	hemostasis,	is	also	the	rationale	behind	the	use	of	
fibrin	sealants,	which	are	designed	to	mimic	the	final	steps	of	the	blood	coagulation	
cascade,	 forming	 a	 stable	 physiological	 fibrin	 clot	 leading	 to	 early	 hemostasis15.	
While	 the	 theory	 behind	 it	 seems	 promising,	 fibrin	 sealants	 have	 not	 shown	 a	





The	 addition	 of	 a	 plasticizer	 agent	 to	 biodegradable	 blend	 films	 represents	 a	
feasible	 approach	 to	 enhance	 the	 pliability	 of	 biopolymer‐based	 membranes17.	
Glycerol	 is	 commonly	 recognized	as	one	of	 the	most	 suitable	plasticizers,	 since	 it	
has	low	molecular	weight	with	low	volatility,	causing	an	increase	in	free	volume	of	
the	polymer	matrices	as	well	as	enhancement	of	molecular	mobility	of	polymers	by	
disrupting	 the	 hydrogen	 bonding	 interaction	 between	 polymer	 chains18.	 Glycerol	
has	been	safely	used	 in	many	 industrial	and	pharmaceutical	applications	 for	over	
100	years	and	is	generally	recognized	for	its	low	risk	health	effects19‐22.	
	
Given	 these	 premises,	 we	 investigated	 the	 effects	 of	 two	 glycerol‐plasticized	





Sodium	 alginate	 from	 Laminaria	 hyperborea	 (Alginate	 Pronova	 UP	 LVG,	 relative	
molecular	mass,	MW,	~120.000;	fraction	of	guluronic	G	residues,	FG=0.69;	fraction	
of	guluronic	diads,	FGG=0.59;	number	average	of	G	residues	in	G‐blocks,	NG>1=16.3)	
was	 kindly	 provided	 by	 Novamatrix/FMC	 Biopolymer	 (Sandvika,	 Norway).	 HA	
(MW∼240.000,	 Phylcare	 Sodium	 Hyaluronate	 extra	 LW)	 was	 kindly	 provided	 by	





of	 the	 authors5.	 Briefly,	 alginate	 and	HA	were	dissolved	 in	 deionized	water	 (final	
concentration=15	 g/l	 of	 each	 polysaccharide)	 and	 glycerol	 was	 added	 as	 a	
plasticizer	 (final	 concentration=5%	 v/v).	 Then,	 CaCO3	 (final	 concentration	 of	
Ca2+=20	mM)	and	GDL	(final	concentration=40	mM)	were	added	to	the	mixture	to	
enable	 the	 in	 situ	 gelation	 of	 the	 solution.	 After	 gelation,	 the	 membranes	 were	
obtained	 by	 freeze‐drying.	Membranes	without	 the	 addition	 of	 glycerol	 (samples	
HA‐A	 and	 A)	 were	 also	 prepared.	 The	 resulting	 freeze‐dried	 materials	 were	
rehydrated	 with	 saline	 solution	 before	 application.	 The	 gelatin‐glycerol	 (Ge‐G)	
sample	 was	 prepared	 by	 soaking	 the	 gelatin‐based	 membrane	 in	 10	 ml	 of	 an	




solution	 of	 HA	 (1.5%	w/v)	 for	 1	min,	 followed	 by	 freeze‐drying.	 All	 the	 samples	
were	sterilized	by	gamma	radiation	(25	kGy).	
Animals	
Sixty‐six	 male	Wistar	 rats	 with	 an	 average	 body	 weight	 of	 250‐300	 grams	 were	
used.	 Animals	 were	 housed	 at	 the	 Central	 Animal	 Facilities	 of	 the	 Maastricht	
University,	 where	 they	 were	 provided	 ad	 libitum	 access	 to	 food	 and	 water,	 and	
were	 cared	 for	 according	 to	 local	 standards.	 Postoperatively,	welfare	 assessment	
was	performed	 twice	daily	 using	 a	 standardized	method	 and	 animals	were	 given	
pain	 medication	 in	 case	 of	 discomfort.	 At	 7	 days	 follow‐up	 or	 when	 humane	
endpoints	 were	 reached,	 animals	 were	 sacrificed.	 The	 experimental	 protocol	
complied	with	the	Dutch	Animal	Experimental	Act	and	was	approved	by	the	Animal	
Experimental	 Committee	 of	 Maastricht	 University	 Medical	 Center.	 This	 article	












using	 isoflurane	 (5%	 induction,	 2‐2.5%	 maintenance).	 To	 acquire	 access	 to	 the	
abdominal	cavity,	a	5	cm	craniocaudal	midline	 incision	of	the	skin	and	abdominal	
musculature	 was	 made	 in	 all	 experiments.	 The	 cecum	 was	 then	 identified	 and	
moved	outside	of	the	peritoneal	cavity	and	onto	sterile	gauzes	that	were	hydrated	





experiment	 1	 and	 2,	 rats	 assigned	 to	 control	 groups	 received	 no	 patch.	 After	






Anastomotic	 leakage	 was	 evaluated	 with	 the	 following	 scoring	 system:	 0=no	
anastomotic	 leakage,	 1=small	 abscess	 at	 the	 anastomotic	 site	 (<1	 cm3),	 2=large	
abscess	 at	 the	 anastomotic	 site	 (>1	 cm3),	 3=complete	 dehiscence	with	 peritonitis	
and	 4=death	 due	 to	 fecal	 peritonitis.	 Adhesions	 to	 the	 anastomotic	 site	 were	
assessed	according	to	van	der	Ham	et	al.23:	0=no	adhesions,	1=minimal	adhesions	





In	 anesthetized	 rats,	 the	 anastomotic	 site	was	 dissected	with	 a	 0.5	 cm	margin	 at	
each	site	of	the	anastomosis.	Tissue	samples	were	cut	in	longitudinal	direction	and	




Sections	 were	 deparaffinized	 in	 xylene	 and	 rehydrated	 in	 graded	 ethanol	 to	
distilled	water	and	subsequently	stained	with	standard	hematoxylin‐eosin	staining	
and	 Ki67	 immunohistochemistry.	 For	 the	 latter,	 endogenous	 peroxidase	 activity	
was	 blocked	 by	 incubating	 slides	 in	 0.6%	 hydrogen	 peroxide/methanol	 for	 15	
minutes.	 Antigen	 retrieval	 was	 performed	 using	 target	 retrieval	 solution	 (Dako,	
Denmark)	at	95C	for	20	min.	Non‐specific	antibody	binding	was	blocked	using	5%	
fetal	 calf	 serum	 in	 PBS.	 Antibodies	 were	 Ki67	 Clone	 Sp6	 (Thermo	 Scientific,	 the	
Netherlands)	 and	 rabbit	 IgG	 biotine	 labelled	 (Dako,	 Denmark)	 as	 primary	 and	
secondary	 antibodies,	 respectively.	 Binding	 of	 primary	 antibody	 was	 visualized	
with	 3,3′‐diaminobenzidine‐tetrahydrochloride‐dihydrate	 (Sigma,	 St	 Louis,	 MO)	
and	counterstained	with	hematoxylin.	No	staining	was	detected	in	slides	incubated	
without	 primary	 antibody.	 An	 independent,	 experienced	 animal	 pathologist	 (MG)	
performed	blinded	histological	assessment	on	the	obtained	tissue,	scoring	sections	






The	 biocompatibility	 of	 each	 patch	 component	 (alginate,	 hyaluronan,	 gelatin	 and	
glycerol)	was	tested	by	performing	the	chicken	embryo	chorioallantoic	membrane	
(CAM)	assay	on	patches	with	different	 compositions	 (Table	8.1).	 Samples	HA‐A‐G	
and	Ge‐G	are	the	original	patches	tested	in	vivo.	Samples	HA‐A	and	Ge	are	controls	
introduced	 to	verify	 the	effect	of	 the	 removal	of	glycerol;	patch	A	 is	 composed	of	
only	alginate,	and	was	used	to	test	its	specific	effect	on	CAM;	patch	Ge‐HA,	obtained	
by	 adding	 hyaluronan	 (at	 the	 same	 concentration	 of	 the	 HA‐A‐G	 patch)	 to	 the	
gelatin	 matrix,	 was	 studied	 to	 verify	 the	 effect	 of	 HA	 released	 from	 a	 different	
substrate.	 Pure	 sterile	 glycerol	 was	 also	 tested	 (sample	 G).	 For	 the	 assay,	 the	
fertilized	 eggs	 were	 disinfected	 (ethanol	 70%	 v/v)	 and	 placed	 in	 an	 incubator	
(38°C,	 60%	 relative	 humidity).	 At	 day	 3	 of	 incubation,	 a	 window	 opening	 was	
performed	at	the	blunt	end	of	the	egg,	to	select	the	living	embryos.	The	window	was	
covered	 with	 a	 polyethylene	 film	 glued	 with	 albumen,	 to	 avoid	 water	 loss	 and	
microbial	 contamination.	 At	 day	 6	 of	 incubation,	 the	 samples	 (round	 pieces	 of	
















A	 system	 composed	 of	 a	 Leica	WILD	M32	 stereomicroscope,	 equipped	with	 a	
WILD	PLAN	1X	lens,	and	connected	to	a	Leica	DFC	320	camera,	was	used	to	follow	
the	 effects	 of	 the	 samples	 on	 the	 CAM	 (at	 time	 points	 t=24	 h,	 48	 h).	 A	 blinded	
evaluation	was	carried	out	by	 two	 independent	experts,	by	considering	 the	tissue	
damage	and	the	inflammatory	response,	in	particular	vascular	changes	in	the	CAM	
such	 as	 hemorrhages,	 neoangiogenesis,	 and	 the	 occurrence	 of	 vessels	 devoid	 of	
blood	flow	(ghost	vessels).	Each	sample	has	been	assayed	at	least	in	6	replicates.	
Cell	culture	
To	test	 the	hypothesis	 that	glycerol	 in	 the	patch	was	harmful	 to	or	could	activate	





cells	 (hMADS)	 isolated	 from	human	visceral	adipose	 tissue.	 	One	obtained	 from	a	
male	lean	donor	(BMI	25.1)	and	the	other	from	a	male	obese	donor	(BMI	39.6).	Rats	
have	 a	 relatively	 large	 amount	 of	 fat	 tissue,	 especially	 scrotal	 fat,	 which	 is	 the	
reason	 why	 two	 different	 donorsets	 of	 hMADS	 were	 chosen.	 As	 a	 control,	 cells	
cultured	in	plain	medium	were	considered.	Cells	were	plated	at	a	density	of	2x103	
cells/cm2	 and	 kept	 in	 proliferation	medium	 (DMEM‐HAM’s	 F12	 (Gibco,	 Blijswijk,	
the	 Netherlands)/10%FBS	 (Bodinco	 BV,	 the	 Netherlands)/1xAnti‐Anti	 (Gibco,	
Bleiswijk,	the	Netherlands)).	Both	cell	lines	were	maintained	at	37°C,	5%	CO2	in	a	
humidified	 incubator	 as	 described	 previously26.	 After	 24h,	 proliferation	 medium	
was	 replaced	by	proliferation	medium	supplemented	with	 sterile	 glycerol	 (Sigma	




One‐way	 ANOVA	 was	 used	 in	 case	 of	 continuous	 variables,	 with	 a	 Dunnett's	
Multiple	 Comparison	 Test	 as	 post‐hoc	 analysis	 to	 compare	 groups	 versus	 the	
control	 group.	A	Kruskal‐Wallis	one‐way	analysis	of	 variance	was	used	 in	 case	of	
dichotomous	variables.	A	P‐value	≤0.05	was	considered	statistically	significant.	All	
analyses	were	performed	using	IBM	SPSS	Statistics,	version	21.0	for	Mac	(IBM	SPSS,	





anastomotic	 site	 caused	 adverse	 tissue	 reactions	 –	 which	 lead	 to	 higher	
anastomotic	 leakage	 rates	 compared	 to	 the	 control	 groups	 (Figure	 8.1A).	 In	
Experiment	 1	 (leaking	 model),	 four	 rats	 of	 the	 experimental	 groups	 reached	
humane	endpoints	and	were	 sacrificed	before	 the	 end	of	 follow‐up.	 Inspection	of	
the	 abdominal	 cavity	 following	 sacrifice	 confirmed	 that	 the	 4	 rats	 suffered	 from	
extensive	fecal	pollution;	therefore	the	cause	of	death	was	stated	to	be	sepsis	as	a	
result	 of	 fecal	 peritonitis.	 Remaining	 animals	were	 sacrificed	 at	 follow‐up	 day	 7.	
Control	animals	recovered	readily	from	surgery	and	additional	pain	treatment	was	
hardly	necessary	while	membrane‐receiving	rats	showed	clear	signs	of	discomfort,	




extensive	 adhesions,	 whilst	 control	 animals	 had	 significantly	 less	 signs	 of	 AL	
(Figure	8.2).	In	Experiment	2	(healing	model),	no	animals	died	and	the	anastomosis	
healed	 properly	 in	 both	 the	 intervention	 and	 the	 control	 group.	 All	 membranes	






























Figure	8.1	 Anastomotic	 leakage	rate	were	approximately	70%	 in	 the	control	group	with	a	4‐sutures	
anastomosis	 (A).	 Patches	 did	 not	 reduce	 anastomotic	 leakage	 rates,	 not	 in	 the	 healing	
model	 nor	 in	 the	 leakage	model,	 but	 showed	 an	 increase	 in	 the	 amount	 of	 animals	 that	
suffered	from	anastomotic	leakage.	Weight	loss	was	more	severe	in	the	leakage	model	(B),	
but	 also	 increased	 by	 adding	 a	 patch	 (HA‐A‐G	 vs	 control,	 P<0.05).	 In	 the	 sufficient	
anastomosis	model,	 weight	 loss	was	 significantly	 higher	 in	 the	 HA‐A‐G	 compared	 to	 the	
control	group	(P<0.05).	Severe	adhesions	with	abscess	formation	were	mostly	found	in	the	
leakage	group,	but	also	in	the	sufficient	anastomosis	group	in	animals	that	received	patches	

































model,	 In	 the	healing	model,	 similar	 results	were	 found,	 but	 here	 there	were	no	 evident	




A	 trend	 in	 increase	 in	 inflammatory	 cells,	 such	as	granulocytes	and	macrophages	
was	 observed	 in	 all	 interventions	 groups	 compared	 to	 control	 animals	 with	 a	
significant	 difference	 in	 inflammation	 between	 control	 and	 Ge‐G	 patches	 (Figure	
8.1D,	 P=0.03	 in	 the	 4	 sutures	 group	 and	 P=0.05	 in	 the	 12	 sutures	 group).	





















anastomotic	 site,	 no	 differences	 could	 be	 found	 in	 the	 percentage	 of	 Ki67+	 cells	
between	membrane	 (%)	and	 control	 groups	 (%)	 (P=0.12,	 Figure	8.3B).	However,	
when	 the	 focus	 was	 transferred	 to	 the	 serosal	 tissue,	 a	 trend	 towards	 a	 higher	










presence	of	 the	plasticized	membranes,	a	 further	biological	 insight	was	tackled	to	
elucidate	 the	cause	of	 such	behaviour.	To	 this	end,	 the	chorioallantoic	membrane	
(CAM)	assay	was	employed	to	evaluate	the	biological	response	to	the	materials.	The	
CAM	assay	is	a	test	that	has	shown	a	renewed	interest	in	the	biomaterial	field25,27,28	






observed.	 This	 reaction	 corresponds,	 generally,	 to	 toxicity	 and/or	 inflammatory	




the	 treatment,	 changes	 in	 the	structure	of	 the	CAM	(thickening	of	 the	membrane,	
formation	of	 a	white	 callus,	 and	presence	of	 red	blood	 cells)	were	observed,	 as	 a	





Next,	 hMADS	were	 treated	with	 increasing	 glycerol	 concentration	 (1‐8%	 v/v)	 to	




the	 control	 group.	 In	 both	 experimental	 setups,	 8%	 v/v	 glycerol	 was	 toxic	 and	
caused	cell	death,	 shortly	after	adding	glycerol	 to	 the	plate.	Both	 the	2%	v/v	and	



































































Figure	8.6	 hMADS	were	 exposed	 to	 glycerol	 and	 cell	 viability	was	measured	by	 counting	 cells/well.	




Several	 attempts	 have	 been	 made	 to	 seal	 off	 the	 anastomotic	 site	 in	 order	 to	
prevent	 anastomotic	 leakage	 in	 patients	 undergoing	 colorectal	 surgery.	 Previous	
studies	have	shown	that	the	use	of	membranes	around	the	anastomosis	can	cause	
stenosis	or	bowel	obstruction29,30	making	it	crucial	that	the	patches	be	flexible	and	
do	not	 interfere	with	 intestinal	motility.	 For	 that	 reason,	 glycerol	was	added	as	a	
plasticizer.	 Glycerol	 is	 a	 commonly	 used	 plasticizer,	 even	 in	 medical	 and	
pharmaceutical	 applications	 and	 is	used	 to	 increase	 the	process‐ability,	 flexibility	




In	 this	 study,	 two	 membranes	 based	 on	 hyaluronan/alginate	 and	 porcine‐
derived	 gelatin	 plasticized	with	 glycerol	were	 tested	 in	 animal	models	 of	 colonic	
anastomoses	 to	 promote	 anastomotic	 healing.	 In	 both	 experiments	 (leaking	 and	
healing	model),	 the	plasticized	membranes	did	not	reduce	AL	rates,	however,	rats	
receiving	 membranes	 experienced	 more	 discomfort,	 showed	 encapsulation/	







Morphologically,	 a	 clear	 encapsulation	 of	 the	 patch	with	 indurated	 tissue	was	
observed	 in	 both	models.	 This	 tissue	 remodeling	 has	 been	 described	 by	Wilkosz	
and	 colleagues	 during	 adhesion	 formation32.	 In	 their	 experiment,	 collagen	
deposition	and	 fibrotic	 foci	were	predominantly	present	 at	day	7,	 an	observation	
that	 could	 also	 be	 found	 in	 this	 study.	 A	 possible	 explanation	 for	 the	 observed	
morphological	changes	is	that	glycerol	in	the	patch	can	activate	the	omentum	which	
lead	to	rapid	extension	and	expansion,	resulting	in	encapsulation	of	the	patch	as	if	
to	 protect	 the	 adjacent	 internal	 organs	 from	 contact	 with	 it.	 This	 biological	
response	can	prevent	the	potential	beneficial	effects	from	the	patch	on	the	healing	
process33.	This	was	evident	 in	 the	healing	model,	where	no	 leakage	occurred,	but	
even	 the	 construction	 of	 a	 sufficient	 anastomosis	 causes	 serosal	 damage	 due	 to	




which	 lines	 the	peritoneal	 cavity32,35.	 If	 encapsulation	occurs	 simultaneously	with	
AL,	 an	 abscess	 can	develop	with	 extensive	 adhesions,	which	was	observed	 in	 the	
leakage	 model	 of	 this	 study.	 To	 evaluate	 if	 the	 omentum	 reacts	 to	 glycerol,	 we	




The	 latter	 observation	 suggests	 a	 dose‐dependent	 effect	 of	 glycerol.	
Interestingly,	 it	 has	 been	 demonstrated	 that	 high	 concentrations	 of	 glycerol	 can	
cause	 damage	 to	 cell	 membranes36.	 Garcia	 and	 colleagues	 suggested	 that	 this	
damage	could	be	related	to	an	osmotic	effect36.	Indeed,	glycerol	is	often	used	in	the	
clinical	 setting	 to	 treat	 diarrhea	 since	 it	works	 as	 an	 osmotic	 diuretic.	 Therefore,	
extracellular	hyperosmolarity	might	also	be	a	potential	reason	for	the	unexpected	
results.	 It	has	been	described	that	 inflammation	occurs	when	cells	are	exposed	to	
high	 osmolarities	 (>300	 mOsm)37.	 Epithelial	 cells,	 such	 as	 normal	 colorectal	
epithelial	 cells	 can	 induce	 proinflammatory	 cytokine	 secretion	 through	
hyperosmolarity37.		
	
The	 glycerol‐containing	membranes	 caused	 adverse	 reactions	 in	 rats	 and	 the	
CAM	assay	showed	clear	negative	effects	of	glycerol.	This	was	also	found	in	the	cell	
culture	 experiment,	 in	 which	 the	 percentage	 of	 glycerol	 had	 an	 obvious	 harmful	






concentrations	 of	 glycerol	 (>75%)	 in	 a	 commercially	 available	 bone	matrix	 could	
lead	 to	 myonecrosis	 and	 rhabdomyolysis	 which	 resulted	 acute	 renal	 failure	 in	
experimental	 animals40.	 Despite	 the	 obvious	 differences	 between	 animal	 models	
and	 the	 clinical	 setting,	 the	 combination	 of	 detrimental	 effects	 observed	 both	 in	




biocompatibility	 in	 vitro5,	 unexpected	 adverse	 reactions	 could	 take	 place	 in	 real	
surgical	models:	 the	 CAM	 assay	might	 provide	 a	 useful	mean	 to	 predict	 possible	
adverse	effects	of	single	components	of	the	biomaterials.		
	
From	 this	 study,	 we	 can	 conclude	 that	 glycerol	 can	 have	 a	 pro‐inflammatory	
effect	 in	 vivo	 and	 that	 it	 reduces	 viability	 of	 human	multipotent	 adipose‐derived	
stem	 cells	 (hMADS).	 The	 widespread	 use	 of	 glycerol	 as	 a	 plasticizer	 should	 be	
limited	to	only	cases	in	which	it	 is	100%	certain	that	its	use	is	safe	and	causes	no	
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evaluated	 the	 efficacy	 of	 a	 new	 Poly(trimethylene	 Carbonate)	 (PTMC)	 film	 as	 an	 anti‐




A	validated	rat	adhesion	model	with	peritoneal	 ischemic	buttons	was	used	 to	compare	 the	
new	 PTMC	 film	 with	 a	 Hyaluronate	 Carboxymethylcellulose	 (HA‐CMC)	 sheet,	 Icodextrin	
solution,	and	a	control	group.	Primary	endpoint	was	occurrence	of	adhesions	at	the	ischemic	
buttons	 after	 14	 days	 in	 44	 rats	 (n=11	per	 group).	 To	 evaluate	 safety	 of	 the	 film,	 both	 an	






when	 compared	 to	 control	 group	 (median:	 4	 buttons,	 P<0.001)	 and	 Icodextrin	 group	
(median:	4.5,	P<0.001).	The	amount	of	adhesions	was	similar	to	the	HA‐CMC	group	(median:	










Adhesion	 formation	 after	 abdominal	 surgery	 is	 a	major	 clinical	 problem,	with	 an	
incidence	 of	 over	 93%	 of	 all	 patients	 undergoing	 a	 laparotomy1‐3.	 These	




Unfortunately,	 the	 appearance	 of	 adhesion	 formation	 still	 is	 an	 underestimated	
clinical	 problem5‐7.	 Many	 different	 materials	 have	 been	 developed	 for	 the	
prevention	 of	 postoperative	 adhesions8‐10.	 Of	 these	materials	mainly	 the	 “barrier	
type”	materials,	 like	 Hyaluronate	 Carboxymethylcellulose	 (HA‐CMC)	 (Seprafilm®)	
have	been	 found	 to	be	effective	 in	 reducing	 the	amount	of	 severe	adhesions8,11,12.	




inactive	 barrier	 between	 tissues	 to	 reduce	 adhesion	 formation	without	 providing	
bioactive	 properties,	 allowing	 the	 peritoneum	 to	 heal,	 while	 inducing	 minimal	
foreign	 body	 reaction14,15.	 Although	 these	materials	 show	 significant	 reduction	 in	
amount	 of	 adhesions,	we	 believe	 these	 results	 can	 be	 improved	 by	 using	 a	more	
stable	 barrier	 material.	 This	 could	 be	 achieved	 by	 using	 poly(trimethylene	
carbonate)	 (PTMC),	 an	 inert,	 slow	 degrading	 polymer	 with	 excellent	
biocompatibility16.	 In	 addition,	 it	was	 shown	 that	 the	polymer	 is	phagocytised	by	
macrophages	 and	 that	 at	 12	weeks	 PTMC	 is	 degraded	while	 only	 a	 small	 area	 of	
inflammatory	cells	could	be	observed	at	 the	site	of	 implantation16‐17.	Unlike	other	
materials	 that	 can	 be	 used	 to	 produce	membrane,	 such	 as	 collagen,	 this	 polymer	
degrades	 through	 surface	 degradation,	 allowing	 it	 to	 retain	 its	 mechanical	
characteristics	 throughout	 the	 degradation	 process16‐18.	 Furthermore,	 in	 bone	
regeneration	 studies	 PTMC	 promoted	 bone	 healing,	 without	 leading	 to	 osseous	
depositions	 inside	 the	 film	 due	 to	 solid	 composition,	 in	 contrast	 to	 collagenous	












be	 investigated	 if	 the	 use	 of	 the	 PTMC	 film	 is	 safe	 in	 the	 presence	 of	 bowel	





study,	 we	 additionally	 investigated	 safety	 of	 use	 of	 the	 PTMC	 film	 both	 in	 the	




Poly(1,3‐trimethylene	 carbonate)	 (PTMC)	 was	 polymerized	 at	 150°C	 by	 ring	
opening	 polymerization	 of	 1,3‐trimethylene	 carbonate	 (For	 You	 Medical,	 P.R.	
China).	Ring	opening	polymerization	was	performed	under	a	nitrogen	blanket	using	
stannous	 octoate	 (Sigma	 Aldrich,	 U.S.A.)	 as	 a	 catalyst.	 Subsequently,	 the	 PTMC	
polymer	was	compression	molded	 into	 films,	without	additional	purification.	This	
was	 done	 at	 160°C	 using	 a	 LabEcon	 600	 press	 (Fontijne	 Grotness,	 The	
Netherlands).	 Films	 produced	 had	 an	 average	 thickness	 of	 150	 μm.	 Sterilization	
with	 simultaneous	 cross‐linking	 was	 performed	 under	 inert	 atmosphere	 using	
gamma‐radiation	from	a	60Co	source	with	a	dose	of	25kGy.		An	A‐B‐A	PTMC‐PEG‐
PTMC	 tri‐block	 co‐polymer	 was	 synthesized	 at	 140°C	 by	 ring	 opening	
polymerization	 of	 1,3‐trimethylene	 carbonate	 using	 poly(ethylene	 glycol)	 (PEG)	
(Sigma	Aldrich,	U.S.A)	as	initiator.		
	
Commercially	 available	 products	 of	 Hyaluronate	 Carboxymethylcellulose	
(Seprafilm®,	 Genzyme	 Biosurgery,	 Sanofi,	 The	 Netherlands)	 and	 Icodextrin	 4%	
(Adept®	Adhesion	Reduction	 Solution,	Baxter,	 The	Netherlands)	were	purchased	
and	 used	 according	 to	 the	 manufacturer’s	 instructions.	 Prior	 to	 surgery,	
Hyaluronate	 Carboxymethylcellulose	 sheets	 were	 cut	 to	 5x7	 cm	 patches	 under	
sterile	 conditions.	 The	 experimental	 PTMC	 sheets	 were	 provided	 as	 individually	








to	 form	 adhesions	 quite	 easily.	 Furthermore,	 studies	 have	 showed	 that	 female	
hormones	can	affect	adhesion	 formation21,22.	Animals	were	cared	 for	according	to	









migration	 of	 the	 film,	 additional	 fixation	 of	 the	 corners	 to	 the	 abdominal	wall	
using	4	polyglactin	4‐0	(Vicryl®)	sutures	was	applied.		
•	 Group	 2	 had	 the	 HA‐CMC	 film	 implanted	 intraperitoneally.	 Application	 of	 the	
film	was	done	according	to	manufacturer’s	instructions.		









Prior	 to	 surgery,	 all	 animals	 received	 a	 subcutaneous	 injection	 of	 0,05	 mg/kg	
Buprenorphine.	Anaesthesia	was	induced	with	Isoflurane	5%	and	maintained	with	
Isoflurane	2.5%.	The	abdomen	was	shaved	and	disinfected,	and	the	animals	were	











Subsequently,	 a	 1x1	 cm	 portion	 of	 the	 tip	 of	 the	 cecum	was	 abraded	 using	 a	
sterile	 cotton	 swab	 until	 petechial	 lesions	 occurred25,26.	 After	 euthanasia	with	 an	
inhalation	 overdose	 of	 carbon	 dioxide,	 the	 abdomen	 was	 opened	 through	 an	 H‐
shaped	 incision	along	 the	old	midline	 incision,	and	 towards	 the	 flanks	caudal	and	
cranial	 of	 the	 ischemic	 buttons.	 Care	 was	 taken	 to	 avoid	 dissection	 through	 the	








polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	 Johnson)	 (Figure	 9.2a),	
after	which	the	intestines	were	repositioned	into	the	abdominal	cavity.		
	
To	 induce	a	controlled	 infection	cecal	 ligation	and	puncture	was	performed	as	
previously	 described27,28.	 In	 this	 model,	 the	 cecum	 was	 carefully	 manipulated	
outside	 the	 abdominal	 cavity	 and	 ligated	 just	 distal	 to	 the	 ileocecal	 valve	with	 a	




Both	 intervention	 groups	 received	 the	 PTMC	 film,	 which	 was	 fixed	






Adhesions	 to	buttons	were	 scored	by	 two	 independent	observers.	The	amount	of	
buttons	 with	 adhesions	 present	 was	 recorded.	 Data	 were	 presented	 as	 mean	
















































the	 anastomotic	 site	 <	 1	 cm3,	 2=large	 (>1	 cm3)	 abscess	 at	 the	 anastomotic	 site,	
3=faecal	 pollution	 of	 the	 abdomen,	 4=complete	 dehiscence	 with	 peritonitis.	
Adhesions	at	the	anastomotic	site	were	evaluated	in	a	blinded	fashion	according	to	
the	 scoring	 scale	 of	 van	 der	Ham29.	 After	 sacrifice,	 the	 anastomotic	 segment	was	
resected	 and	 paraffin‐embedded	 sections	 were	 prepared.	 Sections	 were	 stained	
with	 haematoxylin	 and	 eosin	 using	 standard	 histological	 techniques.	 Specimens	
were	 randomly	 scored	 according	 to	 the	 0–4	Ehrlich	 and	Hunt	 numerical	 scale	 as	
modified	by	Phillips	et	al.30.		
Bursting	pressure	
A	5‐cm	segment	of	 intestine	 including	 the	anastomosis	with	and	adherent	organs	
was	resected	en	bloc.	The	colon	distally	of	the	anastomosis	was	clamped,	a	plastic	
tube	was	 inserted	 in	 the	proximal	 end	 and	 ligated	with	 a	 single	 polyglactine	4/0	
suture	(Vicryl,	Ethicon).	Each	anastomosis	was	immersed	in	1x	phosphate	buffered	






the	midline	 incision,	 and	a	 culture	 swab	of	 the	 abdominal	 cavity	was	obtained	 to	
conﬁrm	fecal	peritonitis.	At	sacrifice,	this	action	was	repeated	to	measure	infection	
at	day	7.	Swabs	were	analyzed	using	broad‐range	16S	ribosomal	RNA	(rRNA)	gene	
polymerase	 chain	 reaction	 (PCR)	 for	 detection	 and	 identification	 of	 bacterial	




using	 the	 Kolmogoroc‐Smirnov	 test	 were	 performed.	 Non‐parametric	 data	 was	
analysed	using	the	Kruskal‐Wallis	test.	For	categorical	data	a	Fisher’s	exact	test	was	
performed.	 In	 case	 of	 significance,	 the	 difference	 was	 confirmed	 by	 the	 Mann‐








died	 preoperatively,	 possibly	 due	 to	 an	 overdose	 of	 anaesthetic.	 Another	 animal	
from	 group	 1	 died	 five	 days	 after	 the	 initial	 operation;	 this	 was	 due	 to	 a	 severe	
sepsis	 caused	 by	 leakage	 of	 bowel	 content	 through	 a	 cecal	 perforation.	 All	 other	
animals	showed	a	normal	postoperative	recovery.	In	the	safety	studies,	all	animals	
completed	the	7‐day	 follow‐up.	Welfare	of	animals	 in	both	the	efficacy	and	safety	
studies	 was	 assessed	 using	 extensive	 scoring,	 but	 no	 humane	 end	 points	 were	




be	 explanted	at	 sacrifice.	The	 film	was	 still	 in	 situ	 in	all	 of	 the	 surviving	 animals.	
Contrary	 to	 PTMC,	 the	 Icodextrin	 and	 HA‐CMC	 were	 completely	 resorbed	 after	
14	days.	None	of	 the	 surviving	 animals	 in	 the	 efficacy	 study	 showed	macroscopic	






statistically	 significant	 to	 both	 the	 control	 group	 (median:	 4	 range:	 2‐6)	 and	







Number	 of	 buttons	 with	 adhesions	 per	 group.	


















































omental	 and	 scrotal	 fat	 origin.	 None	 of	 these	 adhesions	 required	 aggressive	 or	
sharp	 dissection.	 No	 adhesions	 of	 visceral	 organs	 to	 the	 buttons	 were	 found	 in	
these	 groups.	 In	 contrast,	 the	 control	 and	 Icodextrin	 groups	 showed	 more	
pronounced	dense	adhesions.	These	adhesions	required	more	aggressive	blunt	and	
sharp	 dissection.	 Adhesions	 of	 liver,	 cecum	 and	 small	 intestine	 to	 the	 ischemic	
buttons	were	recorded	besides	the	usual	fatty	adhesions	in	these	groups.	The	use	of	
sutures	to	fix	the	PTMC	to	the	abdominal	wall,	however,	seems	to	increase	the	risk	
of	undesirable	adhesions	 to	 these	sutures.	Although	the	 film	seems	 to	protect	 the	
ischemic	 buttons	 from	 adhesions	 forming	 to	 these	 buttons,	 the	 sutures	 are	 not	
protected.	 All	 of	 the	 eleven	 animals	 in	 the	 PTMC	 group	 had	 adhesions	 present	
attached	to	sutures	fixing	the	film.	These	adhesions	were	denser	and	more	difficult	
to	 dissect	 than	 those	 to	 the	 ischemic	 buttons	 in	 the	 same	 animals.	 Furthermore,	
most	adhesions	 to	 ischemic	buttons	 in	 this	group	seemed	 to	be	closely	 related	 to	
adhesions	 formed	 to	 these	 sutures.	 No	 differences	 were	 found	 in	 the	 amount	 of	
adhesions	adhered	 to	 the	abraded	cecum.	 In	all	but	 the	PTMC	group,	4	out	of	 the	
total	 11	 animals	 have	 some	 sort	 of	 adhesion	 towards	 the	 abraded	 cecum.	 In	 the	
PTMC	group	only	2	animals	 showed	adhesions	 towards	 the	cecum.	No	significant	
results	were	found	between	the	groups	using	the	Fisher’s	exact	test	(Figure	9.5A).	
Equal	anastomotic	leakage	in	both	PTMC	and	control	group	
The	 anastomoses	 in	 the	 PTMC	 group	needed	 higher	 pressure	 to	 burst	 (249±14.2	
mBar	 versus	 195±22.0	mBar),	 however	 this	was	 not	 significant	 (P=0.067,	 Figure	
9.5B).	We	found	no	higher	anastomotic	leakage	rate	in	the	PTMC	group	compared	


































Figure	9.5	 Results	 of	 safety	 study.	 No	 differences	 were	 detected	 between	 groups	 in	 percentage	 of	
animals	 per	 group	 with	 adhesions	 present	 from	 the	 abraded	 cecum	 to	 other	 structures	
within	the	peritoneal	cavity	(Figure	A).	Bursting	pressure	was	slightly	greater	in	the	PTMC	
group	 (249	 ±	 14	 mBar)	 compared	 with	 the	 control	 group	 (195	 ±	 22	 mBar;	 P=0.067,	
Figure	B),	 There	 was	 no	 difference	 in	 anastomotic	 leakage	 rate	 between	 the	
poly(trimethylene	carbonate)	(PTMC)	and	control	group	(Figure	C	+D).	When	the	severity	
of	 anastomotic	 leakage	 was	 studied	 into	 more	 detail,	 a	 complete	 dehiscence	 of	 the	
anastomosis	could	only	be	found	in	the	PTMC	group	(P=0.695).	Bacterial	load	at	day	7	did	





In	 this	 study	 we	 investigated	 a	 new	 anti‐adhesive	 barrier	 composed	 of	 PTMC	
(co)polymers	 and	 compared	 it	 to	 commercially	 available	 anti‐adhesive	 therapies.	
Prevention	of	 intraperitoneal	 adhesions	 remains	an	 integral	part	of	daily	 surgical	
practice6.	 Postoperative	 adhesions	 are	 known	 to	 have	 a	 devastating	 impact	 on	
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quality	 of	 life	 and	 increases	 the	 risk	 for	 reoperations31.	 Even	 though	 the	 use	 of	
minimally	invasive	techniques	seems	to	reduce	the	risk	of	adhesion	formation,	this	
is	not	sufficient	to	adequately	prevent	all	postoperative	adhesions,	indicating	there	
is	 still	 need	 for	 additional	 adhesion	 prevention1,15,32,33.	 PTMC	 is	 a	 highly	
biocompatible	 and	 versatile	 material	 with	 highly	 favourable	 characteristics34,35.	
Contrary	 to	 currently	 available	 materials,	 the	 PTMC	 film	 degrades	 by	 surface	
degradation,	 not	 by	 bulk	 degradation.	 This	 allows	 the	 material	 to	 retain	 its	
mechanical	 characteristics	 and	give	prolonged	 separation	of	 adhering	 tissues34‐36.	
Furthermore,	 degradation	 of	 PTMC	 induces	 only	 mild	 inflammatory	 reaction	
leading	 to	 the	 hypothesis	 that	 intraperitoneal	 placement	 of	 PTMC	 film	 gives	 a	
reduction	 of	 postoperative	 adhesions	 comparable	 to	 or	 even	 better	 than	
commercially	available	materials34.		
	





of	 tissues	 since	 degradation	 happens	 through	 surface	 erosion.	 This	 reduction	 is	
significant	compared	 to	 the	control	group,	 indicating	 the	application	of	a	physical	
barrier	 is	 beneficial	 in	 adhesion	 prevention.	 Surprisingly,	 the	 liquid	 adhesion	
barrier	 did	 not	 lead	 to	 a	 reduction	 in	 the	 amount	 of	 adhesions.	 Although	 human	
trials	 are	 inconclusive37,	 Icodextrin	 (Adept®)	does	 seem	 to	 be	 effective	 in	 several	
other	studies8,38.	
	
Furthermore,	 there	 are	 experimental	 studies	 indicating	 that	 Icodextrin	 is	 also	
effective	 in	 rat	 models,	 showing	 less	 adhesion	 formation	 compared	 to	 Ringers	
lactate13,39.	 However,	 in	 these	 studies	 Icodextrin	 solution	 was	 either	 provided	 in	
higher	volumes	or	in	higher	concentrations,	possibly	allowing	the	liquid	to	remain	
effective	 for	 longer	 periods	 of	 time.	 It	 is	 assumed	 that	 the	 reason	 for	 a	 reduced	
effectiveness	 in	 rats	 is	 the	 presence	 of	 α‐amylase	 in	 the	 peritoneal	 fluid	 of	 rats,	
leading	to	a	faster	resorption	of	the	Icodextrin	fluid,	reducing	the	duration	the	fluid	
remains	 present	 in	 the	 abdominal	 cavity13,40.	 This	 could	 have	 resulted	 in	 the	
ineffectiveness	of	the	fluid	in	our	study.	
	
Another	strong	aspect	of	 the	new	PTMC	 film	 is	 its	handling.	 In	contrast	 to	 the	
HA‐CMC	 film,	PTMC	 is	highly	 flexible	with	 sufficient	 tensile	 strength,	 allowing	 for	
easy	 positioning	 and	 repositioning	 within	 the	 first	 few	 minutes	 after	







until	 the	 14th	 day.	 Although	 peritoneal	 wound	 healing	 is	 completed	 after	 7	 to	
10	days,	the	HA‐CMC	material	loses	its	structural	integrity	within	the	first	24	hours	
by	 turning	 into	 a	 hydrophilic	 gel14,42,43.	 Because	 the	 PTMC	 material	 degrades	
through	 surface	 erosion	 it	might	 provide	 adequate	 tissue	 separation	 for	 a	 longer	
period	of	time16,34.		
	
Since	 damage	 to	 mesothelial	 lining	 and	 the	 subsequent	 fibrotic	 response	 are	
considered	 to	 be	 key	 components	 in	 adhesion	 formation,	 the	 main	 focus	 of	
adhesion	prevention	should	lie	within	the	first	7	to	10	days14,42.	For	this	reason,	we	
think	a	follow‐up	of	14	days	provides	adequate	information	on	the	effect	of	PTMC	
barrier	 on	 adhesion	 prevention.	 Besides,	 after	 14	 days,	 the	 presence	 of	 an	 intact	
barrier	 shows	 PTMC	 exceeds	 the	 duration	 of	 protection	 of	 both	 HA‐CMC	 and	
Icodextrin.	 Even	 though	 adhesion	 formation	 can	 cause	 long	 term	 detrimental	









positioning	 throughout	 the	 follow‐up.	Although	 the	PTMC	 reduced	 the	 amount	of	
adhesions	to	the	ischemic	buttons	significantly,	unprotected	sutures	fixing	the	film	





Another	 limitation	 in	 this	 study	 is	 the	 possible	 lack	 of	 power	 to	 detect	 any	
significant	differences	 in	amount	of	adhesions	 to	 the	cecal	abrasion.	Although	 the	








A	 new	 PTMC	 film	 with	 a	 tacky	 PTMC‐PEG	 layer	 is	 effective	 in	 reducing	
postoperative	 adhesions	 to	 the	 abdominal	 wall	 in	 a	 rat	 ischemic	 button	 model.	
Furthermore,	 the	 use	 of	 this	 film	 does	 not	 compromise	 anastomotic	 healing	 nor	
peritonitis.	The	proven	efficacy,	safety	and	easy	handling	of	the	PTMC	film	make	it	a	
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every	 year,	 making	 it	 the	 most	 common	 oncological	 disease	 in	 20151.	 Due	 to	
national	 screening	 programs	 and	 a	 growing	 elderly	 patient	 population	 the	
incidence	of	CRC	is	expected	to	rise	in	the	coming	years,	increasing	the	frequency	of	
colorectal	 cancer	 treatable	 by	 surgery2.	 Two	 thirds	 of	 patients	 with	 CRC	 will	
undergo	 surgical	 treatment	 involving	 resection	 of	 the	 tumour,	 since	 surgery	
remains	 the	 cornerstone	 of	 treatment.	 Therefore,	 the	 perioperative	 course	 of	
colorectal	surgery	is	of	great	importance	and	relates	strongly	with	clinical	outcome	
in	terms	of	mortality	and	functional	recovery.	In	recent	decades,	perioperative	care	
has	 significantly	 improved	 due	 to	 advances	 in	 anaesthesia,	 minimally	 invasive	
surgical	 techniques	 and	 the	 introduction	 of	 'fast	 track'	 protocols3.	 However,	
complications	 after	 colorectal	 surgery	 still	 occur	 regularly,	 of	 which	 anastomotic	
leakage	 (AL)	 is	 the	 most	 feared.	 AL	 develops	 when	 the	 construction	 of	 two	
intestinal	ends	–	the	anastomosis	‐	does	not	heal	properly;	subsequently,	intestinal	
content	leaks	into	the	abdominal	cavity	causing	abscess	formation	and	peritonitis.	
In	2014,	712	of	 the	10.426	 (6.8%)	nationwide	 registered	 cancer	patients	who	
underwent	colorectal	resection	developed	severe	AL	(447/7580	[5.9%]	colon	and	
265/2846	[9.3%]	rectum)	that	required	re‐intervention	(Dutch	Surgical	Colorectal	





Despite	 extensive	 observational	 and	 experimental	 research	 in	 both	 animal	
models	and	in	humans,	the	incidence	of	AL	has	remained	unchanged	over	the	past	
decades.	There	 is	 still	no	 solution	 for	 this	 important	 clinical	problem,	despite	 the	
increasing	 amount	 of	 studies	 that	 have	 investigated	 numerous	 interventions	 to	
promote	anastomotic	healing.	We	suggest	that	this	is	largely	because	causal	factors	
leading	to	colorectal	AL	are	still	not	recognized.	And	although	some	patient	factors	






substantial	differences,	as	 intestinal	healing	 is	1)	 faster	than	cutaneous	healing	2)	
other	 types	 of	 cells	 and	 substances	 are	 involved,	 and	 3)	 both	 the	 skin	 and	 the	




to	 come	 to	understanding	of	AL,	not	 to	mention	 to	 find	a	 solution	 for	 the	 clinical	
burden	of	AL.	Interaction	between	intraluminal	content	and	the	layers	of	the	bowel	
wall,	 with	 their	 separate	 cell	 types	 and	 function,	 may	 be	 key	 in	 unravelling	 the	
healing	process.	Thus	far,	certain	cell	types	are	known	to	play	a	role	in	anastomotic	
healing	 such	 as	 matrix	 metalloproteinases	 (MMPs)9,10,	 inflammatory	 cells	 as	
macrophages11	 and	 intestinal	 microbiota12,13	 but	 the	 interaction	 between	 these	
different	 types	 and	 their	 exact	 role	 in	 time	 during	 the	 healing	 process	 is	 not	 yet	




anastomotic	 leakage;	 several	 models	 exist	 in	 which	 an	 anastomosis	 is	 being	
constructed.	 However,	 none	 of	 these	 models	 are	 completely	 translatable	 to	 the	
human	 setting	 and	 it	 is	 difficult	 to	 compare	 models	 between	 different	 species.	
There	 is	 still	 debate	 on	 which	 models	 are	 suitable	 for	 research	 on	 anastomotic	
healing	and	leakage	in	the	lower	gastrointestinal	tract.	
To	generate	more	clarity	on	animal	models	for	AL	and	to	obtain	comparability	
between	 different	 studies,	 it	 is	 crucial	 that	 researchers	 agree	 on	 what	 outcome	






to	 revise	 their	 earlier	 answers	 in	 light	 of	 the	 replies	 of	 other	 members	 of	 their	
panel.	It	is	believed	that	during	this	process	the	range	of	the	answers	will	decrease	
and	the	group	will	converge	towards	the	"correct"	answer14.	We	reasoned	that	such	
an	 approach	 could	 lead	 to	 consensus	 among	 experts	 investigating	 AL	 in	 animal	
models	 regarding	 anastomoses	 in	 the	 lower	 gastrointestinal	 tract,	 specifically	 on	
which	 animal,	 location,	 and	 type	 of	 surgery;	 macroscopic	 outcome;	 histological	
assessment;	 mechanical	 and	 biochemical	 outcome	 measures;	 and	 animal	 testing	
and	welfare.	
	
One	of	 the	main	outcomes	of	 the	Delphi	analysis	 is	 that	dog	and	rabbit	animal	
models	 should	 no	 longer	 be	 considered,	 and	 thus	 used,	 as	 validated	 models	 for	
research	 into	 anastomotic	 healing	 of	 the	 lower	 gastrointestinal	 tract.	 The	mouse,	
rat	 and	 pig	 models	 are	 considered	 appropriate,	 but	 experiments	 ought	 to	 be	
executed	 according	 to	 current	 legislation	 and	 reported	 more	 into	 detail.	 The	
macroscopic	 result	 of	 anastomotic	 leakage	 should	 always	 be	 one	 of	 the	 main	
outcome	 parameters,	 together	 with	 the	 different	 grades	 of	 leakage	 (small/large	
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abscesses,	 faecal	 peritonitis,	 complete	 dehiscence).	 None	 of	 the	 available	 scoring	
systems	 in	 literature	 regarding	AL	were	considered	 to	be	appropriate,	however	a	
new	‘anastomotic	complication	score’	was	proposed	by	one	of	the	panel	members	
and	was	directly	considered	as	an	appropriate	and	useful	tool	by	the	other	experts,	
although	 the	 usability	 has	 yet	 to	 be	 proven	 in	 practice	 (i.e.	 external	 validation	 is	
required).	This	score	also	 implicates	adhesions	 to	the	anastomotic	site,	which	are	
considered	 relevant	 to	mention	as	 they	might	 cover	 signs	of	 leakage.	Histological	
assessment	of	the	anastomotic	site	such	as	amount	of	inflammation,	vascularisation	
and	collagen	deposition	is	very	valuable	and	considered	as	an	appropriate	outcome	
measure,	 especially	 in	 studies	 that	 focus	 on	 anastomotic	 healing.	 Both	 bursting	
pressure	 and	 tensile	 strength	 are	 considered	 appropriate	 measurements	 for	
anastomotic	 strength,	 where	 it	 should	 be	 mentioned	 that	 these	 measurements	
could	be	 compared	within	one	experiment	but	due	 to	heterogeneity	not	between	
different	experiments.	There	were	no	additional	outcome	measures	(e.g.	amount	of	
collagen,	 specific	 immunohistochemical	 stainings,	 ELISA	 measurements	 or	 qPCR	
regarding	 specific	 genes)	 considered	 appropriate	 as	 a	 surrogate	 marker	 for	
anastomotic	 healing,	 but	 they	 can	 provide	 information	 on	 a	 specific	 research	
question.		
All	 animal	 studies	 should	 be	 reported	 according	 to	 the	 Animal	 Research:	
Reporting	 of	 In	 Vivo	 Experiments	 (ARRIVE)	 guidelines15.	 This	 improves	
transparency	and	increases	the	quality	of	animal	studies.	In	addition,	blinding	and	
randomization	 procedures	 should	 be	 reported	 in	 animal	 studies	 as	 in	 human	
studies.	 A	 publicly	 available	 online	 registry	 (comparable	 to	 clinicaltrials.gov	 for	
human	studies)	together	with	standardized	protocols	per	animal	model	can	aid	in	
advancing	 the	 field	 of	 animal	 research	 on	 bowel	 anastomoses.	 Also,	 innovative	
methods	such	as	 intestinal	organoids	or	 the	use	of	human	tissue	 that	 can	replace	
animal	 models	 should	 be	 further	 investigated	 to	 reduce	 the	 use	 of	 animals,	
according	to	the	3R	(Replacement,	Reduction	and	Refinement)	principle.	This	was	
incorporated	in	the	recently	published	report	by	the	National	Advisory	Committee	





are	 involved12.	To	study	anastomotic	healing	and	 leakage	 in	depth,	a	 technique	or	
approach	 is	 required	 that	 can	 1)	 provide	 an	 overview	 of	 the	 healing	 process	 at	
different	 time	points,	2)	differentiate	between	 inflammatory	markers	and	various	






(Chapter	 3).	 This	 technique	 will	 enable	 us	 to	 identify	 specific	 substances	 in	 the	
various	 layers	 of	 the	 intestinal	 wall	 as	 potential	 leverage	 to	 further	 unravel	 the	









In	 the	 past	 decades,	 important	 risk	 factors	 for	 AL	 such	 as	 male	 gender16,	
neoadjuvant	 chemotherapy17,	 tumor	 size18,	 malnutrition19,	 smoking20,	 steroid	
treatment21	and	the	use	of	non‐steroidal	anti‐inflammatory	drugs	(NSAIDs)22	have	
been	identified.	
In	 this	 thesis,	 the	 association	 between	 NSAIDs	 and	 a	 higher	 AL	 rate	 is	 partly	
elucidated.	 In	 chapter	 4	 it	 has	 been	 demonstrated	 that	 depletion	 or	 inhibition	 of	
Cyclo‐oxygenase	2	 (COX‐2)	 leads	 to	 an	 increase	 in	 the	percentage	of	AL	 rate	 in	 a	
mouse	model,	 possibly	 by	 affecting	 the	 blood	 flow	 of	 the	 intestinal	 anastomosis,	
since	 neoangiogenesis	 was	 diminished	 in	 these	 animals,	 as	 investigated	 through	
CD31	 immunohistochemistry.	 Additionally,	 COX‐2	 plays	 a	 major	 role	 in	 the	
inflammatory	 phase	 of	 the	 healing	 process	 and	 is	 therefore	 considered	 to	 be	
essential	 in	the	healing	process	after	anastomotic	surgery.	Moreover,	 in	this	same	
study,	we	 translated	our	 findings	 from	 the	 animal	 study	 to	 the	 clinical	 setting	by	
identifying	 that	patients	with	a	 specific	COX2	polymorphism	were	more	prone	 to	
develop	colorectal	anastomotic	leakage.		
	
Among	 the	 numerous	 factors	 contributing	 to	 healing	 of	 surgical	 anastomoses,	
the	 intestinal	mucus	 system	has	 been	 largely	 overlooked.	 This	 is	 despite	 the	 fact	






We	 noticed	 that	 in	 Muc2	 knockout	 mice,	 which	 lack	 the	 main	 component	 of	
mucus	 in	 the	 colon,	 the	 rate	 of	 AL	 was	 significantly	 higher	 than	 that	 of	 control	





have	 tried	 to	 enhance	 the	mucus	 layer	with	 prostaglandine	 E2	 (PGE2),	 since	 it	 is	
known	that	this	can	stimulate	mucus	secretion	in	both	small	intestine	and	proximal	
colon	 ex	 vivo.	 Furthermore,	 Non‐steroidal	 anti‐inflammatory	 drugs	 (NSAIDS)	
inhibit	 COX	 enzymes,	which	 leads	 to	 a	decrease	 in	 prostaglandin	 synthesis.	 Since	
there	 is	 an	 association	 between	 the	 use	 of	 NSAIDs	 and	 AL	 there	 must	 be	 an	
interaction	between	prostaglandins	and	anastomotic	healing.	Unfortunately,	we	did	
not	find	a	positive	influence	of	PGE2	on	anastomotic	healing.	However,	other	factors	
might	 influence	 the	 mucus	 layer	 stronger	 than	 prostaglandins.	 For	 example,	
experimental	 studies	 suggest	 a	 positive	 effect	 of	 antibiotics	 on	 the	 strength	 of	
colonic	anastomosis25,26.	 It	 is	widely	accepted	that	the	mucus	 layer	 in	 the	colon	 is	
the	natural	habitat	for	a	variety	of	bacteria	and	that	these	bacteria	are	essential	in	
order	 to	 maintain	 the	 natural	 balance	 in	 the	 intestine.	 One	 of	 the	 tasks	 of	 the	
bacteria	in	the	gut	is	to	break	down	dietary	fibers	into	smaller	particles	that	we	can	
extract	 energy	 from.	 As	 a	 consequence	 short‐chain	 fatty	 acids	 (SCFAs)	 are	 being	
released.	 These	 are	 elements	 that	 can	 be	 used	 again	 by	 the	 intestinal	 cells	 as	 a	
nutrient.	 If	 these	 SCFA‐producing	 bacteria	 are	 inhibited,	 this	 may	 lead	 to	 a	
diminished	function	of	enterocytes	due	to	a	lack	of	energy27.	The	balance	between	
pathogenic	 and	 commensal	 bacteria	 has	 been	 described	 in	 the	 frame	 of	 different	
pathologies28‐30.	Recently,	the	group	of	professor	Alverdy	postulated	the	hypothesis	
that	 bacteria	play	 a	 significant	 role	 in	 the	pathophysiology	 of	AL31.	Over	 the	past	
years,	 they	 have	 shown	 that	 virulent	 bacteria	with	 high	 collagenase	 activity	may	
contribute	 to	 developing	 AL12.	 These	 results	 strengthen	 the	 statement	 of	 the	
previous	chapter	that	in	depth	research	into	the	pathophysiology	of	AL	may	lead	to	
new	 insights	 and	 potential	 targets	 that	 can	 improve	 anastomotic	 healing	 after	
colorectal	surgery.		
Reducing	colorectal	anastomotic	leakage	rate:	glues	and	enema	interventions	
Many	 attempts	 have	 been	made	 to	 prevent	AL	 after	 colorectal	 surgery,	 either	 by	
enhancing	 the	 healing	 process	 through	 different	 pharmaceutical	 approaches,	
mechanically	strengthen	the	anastomosis	or	by	preventing	the	sequelae	of	leakage	




unclear	 why	 successful	 attempts	 have	 not	 been	 investigated	 further.	 Recent	
advances	that	seem	to	be	promising	are	to	strengthen	the	anastomotic	line,	either	
directly	 by	 the	 applications	 of	 sealants	 or	 glues	 around	 the	 anastomosis	 or	 by	





One	 of	 the	most	 abundant	 short	 chain	 fatty	 acids	 in	 the	 intestine	 is	 butyrate,	
which	is	also	produced	by	bacteria	in	the	process	of	digestion35.	This	SCFA	has	often	
been	 investigated	 in	 the	 intestine	 and	 it	 has	 been	 shown	 that	 it	 enhances	
anastomotic	 strength	when	 it	 is	 given	as	 an	 enema	 in	 rats36.	During	 the	 research	
performed	 for	 this	 thesis,	 an	 attempt	 has	 been	 made	 to	 come	 up	 with	 a	 better	
method	 than	 enemas	 (Chapter	 6).	 This	 is	 of	 interest,	 since	 surgeons	 are	 often	
reluctant	to	give	enemas	when	an	intestinal	anastomosis	is	constructed.	Clinicians	
are	 concerned	 that	 the	 enema	 by	 direct	 mechanical	 forces	 or	 through	 increased	
tension	 on	 the	 seam	 just	 causes	 a	 dehiscence	 of	 the	 anastomosis,	 in	 fact	 causing	
mechanical	 AL.	 The	 possibility	 to	 strengthen	 proximal	 anastomosis	 with	 topical	
application	 prior	 to	 construction	 of	 the	 anastomosis	was	 investigated,	 as	well	 as	
enrichment	of	the	butyrate	enemas	with	other	substances	such	as	hyaluronan	since	
it	 is	 known	 that	 hyaluronan	 contributes	 significantly	 to	 cell	 proliferation	 and	
migration37.	 Unfortunately,	 these	 experiments	 yielded	 few	 new	 insights	 and	 it	
seems	that	butyrate	supplementation	via	an	enema	remains	the	best	option.		
Numerous	 attempts	 have	 been	 made	 to	 reinforce	 the	 colonic	 anastomosis	
during	 surgery	 in	 order	 to	 prevent	 AL.	 Commonly	 used	 materials	 are	 tissue	
adhesives	(TAs),	adhesive	strips	or	patches	consisting	of	biological	materials33,38,39.	
It	 is	 known	 that	 certain	 adhesives	 such	 as	 fibrin	 glue	 do	 not	 lead	 to	 a	 lower	
anastomotic	 leakage	 rate40	 and	 that	 the	 application	 of	 cyanoacrylate	 in	
gastrointestinal	anastomoses	seems	promising41.	This	is	why	our	colleagues	at	the	
Erasmus	Medical	Centre	started	a	stepwise	approach	to	detect	which	TA	is	the	most	
promising	 to	 translate	 from	 the	 experimental	 setting	 into	 the	 clinical	 situation.	
First,	 they	 investigated	ex	vivo	 that	 cyanoacrylate	 is	 indeed	capable	of	 increasing	
the	 mechanical	 strength	 of	 anastomoses,	 both	 in	 a	 normal	 and	 a	 technical	
insufficient	situation42	and	compared	several	 types	of	TAs	 in	a	rat	study43.	 In	 this	
latter	study	it	was	shown	that	cyanoacrylates	are	indeed	the	most	promising	group	
of	 TAs	 for	 colonic	 sealing,	 however	 certain	 types	 of	 cyanoacrylate	 may	 have	 a	
negative	 influence	on	anastomotic	healing44,45.	 In	Chapter	7,	we	examined	several	
cyanoacrylate	 based	 commercially	 available	 glues	 and	 their	 effect	 on	 the	
occurrence	 of	 AL,	 stenosis	 and	 general	well	 being	 of	 the	 animals	 in	 a	model	 of	 a	
mechanically	 insufficient	 colonic	 anastomosis.	 Of	 the	 three	 TAs	 Histoacryl	 Flex,	
Glubran	 2	 and	Omnex,	 the	 first	 showed	 the	 lowest	 leakage	 rate	 compared	 to	 the	
other	TAs	whereas	Glubran	2	showed	the	highest	AL	rate	and	caused	an	increased	
inflammatory	 response.	 Despite	 positive	 findings	 in	 literature,	 it	 has	 also	 been	
reported	 that	 Glubran	 2	 causes	 severe	 inflammation,	 with	 multiple	 micro‐
abscedation	 in	 a	 model	 for	 experimental	 hernia	 repair46.	 Thus	 far,	 it	 remains	
unclear	why	Glubran	2	has	a	pro‐inflammatory	effect,	especially	since	there	are	also	
reports	 on	 the	 beneficial	 effects	 of	 this	 adhesive	 for	 intestinal	 healing43,47.	
Histoacryl	 Flex	 was	 associated	 with	 the	 presence	 of	 more	 mature	 collagen,	
suggesting	 to	 promote	 anastomotic	 healing	 without	 any	 harmful	 reaction.	
	 General	discussion	
187	
Additional	 in	vivo	 testing	has	 to	be	performed,	especially	 in	a	 large	animal	model	
before	 this	 tissue	 adhesive	 can	 be	 implemented	 in	 clinical	 practice,	 which	 is	
something	that	is	currently	being	investigated	in	Rotterdam.	The	big	advantage	of	
Histoacryl	Flex	 seems	 to	be	 that	 it	has	an	enhanced	 flexibility	 compared	 to	other	
adhesives	and	that	they	appear	to	adapt	easier	three‐dimensionally.	This	is	of	great	





Tissue	 adhesives	 are	 studied	 as	 preventive	 measures	 for	 AL,	 since	 their	 main	
functions	 are	 to	 repair	 injured	 tissues,	 reinforce	 surgical	 wound	 or	 even	 replace	
common	 suturing	 techniques.	 Biopolymers	 can	 also	 reach	 these	 aims48.	 These	
polymeric	materials	can	be	constructed	 into	 three‐dimensional	networks	 that	can	
physically	of	chemically	bind	to	the	target	tissue	and	act	as	hemostats,	adhesives	or	
sealants.	In	this	perspective,	we	also	examined	the	option	of	a	sealing	patch	able	to	
reduce	 AL,	 which	 was	 developed	 in	 the	 framework	 of	 the	 European	 project	
'AnastomoSEAL'	where	we,	 as	 a	 research	 group,	were	 responsible	 for	 the	 animal	
experiments.	In	this	project,	different	consortium	members	developed	a	patch	with	
bioactive	 components	 from	 scratch.	 A	 patch	 is	 a	 three‐dimensional	 network	
consisting	of	several	(bio)polymers	and	the	combination	of	these	polymeric	agents	
has	 a	 big	 influence	 on	 adhesion	 mechanisms,	 mechanical	 performance	 and	
resistance	 to	 body	 fluid.	 Therefore,	 these	 various	 aspects	 should	 be	 taken	 into	
account	 to	 choose	 the	 most	 suitable	 formulation	 for	 the	 target	 application.	 The	
most	difficult	 aspect	 in	 the	specific	development	of	materials	 for	 intra‐abdominal	
use	 is	 the	 degree	 of	 adhesion.	 The	 aimed	material	 needs	 to	 be	 sticky	 enough	 to	
adhere	in	a	moist	environment,	but	should	not	be	too	adhesive	since	that	may	cause	
stenosis	or	adhesions	between	the	intestines	and	the	abdominal	wall.	In	addition,	it	
is	 a	 risk	 to	 insert	 a	 foreign	 body	material	 in	 the	 vicinity	 of	 a	 complex	 biological	





the	 ‘AnastomoSEAL’	 project,	 we	 noticed	 severe	 adverse	 events	 in	 the	 animal	
experiments	 when	 patches	 were	 tested	 that	 contained	 glycerol	 as	 a	 plasticizer	
(Chapter	 8).	 The	 addition	 of	 a	 plasticizer	 agent	 to	 biodegradable	 blend	 films	
represents	 a	 feasible	 approach	 to	 enhance	 the	 pliability	 of	 biopolymer‐based	










are	 being	 developed,	 but	 is	 of	 particular	 importance	 when	 these	 materials	
intervene	with	 complex	biological	processes.	As	 stated	 in	 the	 introduction	of	 this	
thesis,	 the	 so‐called	 collagenous	 equilibrium	 (the	 balance	 between	 collagen	
synthesis	and	lysis)	is	critical	to	anastomotic	healing.	It	has	been	shown	that	certain	
anti‐adhesive	 products	 may	 predispose	 to	 peritonitis	 and	 anastomotic	
dehiscence50,51.	In	this	thesis,	a	newly	developed	anti‐adhesive	material	was	placed	
in	both	the	presence	of	a	colonic	anastomosis	as	well	as	 in	a	model	for	controlled	
infection	 to	 evaluate	 both	 efficacy	 and	 safety	 of	 this	 potential	 adhesion	 barrier	









not	 cause	 any	 increase	 in	 AL	 rate,	 nor	 did	 it	 aggravate	 the	 induced	 infection.	
Prevention	of	 intraperitoneal	 adhesions	 remains	 an	 integral	part	 of	 daily	 surgery	
and	new	materials	are	being	developed	that	may	reduce	the	devastating	impact	of	
adhesions	 on	 quality	 of	 life	 and	 diminish	 the	 risk	 for	 reoperations.	 However,	 it	
should	 always	 be	 taken	 into	 account	 that	 it	 is	 all	 a	 matter	 of	 balance	 between	





decades.	Most	strikingly,	 leakage	continues	 to	occur	 in	patients	 treated	under	 the	
most	 expert	 care,	 without	 the	 presence	 of	 any	 known	 risk	 factors55.	 The	 lack	 of	
knowledge	 regarding	 the	 pathophysiological	 process	 of	 AL	 and	 the	 process	 of	
normal	 intestinal	 healing	 hampers	 the	 development	 of	 novel	 predictive	 and	
preventive	methods.	AL	has	significant	impact	on	morbidity	and	mortality,	quality	
of	 life,	 health	 care	 costs	 and	 is	 suggested	 to	negatively	 interfere	with	 oncological	





Therefore,	 we	 have	 designed	 a	 study	 that	 focuses	 on	 predictive	 factors	 for	
anastomotic	 leakage	 (REVEAL‐study)	 after	 colorectal	 surgery.	 This	 prospective,	
observational	 study	 is	 based	 on	 the	 hypothesis	 that	 AL	 is	 partly	 due	 to	 patient‐
derived	factors	such	as	a	derailed	immune	response,	genetical	predisposition	and	a	
deficient	 microbiota	 composition,	 and	 that	 the	 clinical	 course	 can	 be	 further	
influenced	by	surgical	stress,	ischemia	and	a	compromised	systemic	response.	This	
study	aims	at	1)	broadening	our	understanding	of	the	pathophysiological	process	of	
AL	 by	 introducing	 novel	 biomarkers	 of	 intestinal	 damage	 and	 2)	 decreasing	 the	
clinical	burden	of	AL	by	individual	risk	assessment	in	the	future.	Study	enrolment	
of	588	patients	undergoing	colorectal	surgery	with	the	creation	of	an	anastomosis	




operation31.	Although	 it	 is	generally	accepted	that	 the	presence	of	a	colostomy	or	
ileostomy	reduces	the	sequelae	of	AL	and	the	need	for	re‐intervention	(surgery)	in	




which	a	 significant	percentage	 (19‐40%)	will	never	have	 their	 temporary	ostomy	
reversed63,64.	 Possible	 benefits	 of	 a	 deviating	 stoma	 should	 be	 weighed	 against	
stoma‐related	morbidity,	the	impact	on	quality	of	life	and	the	mortality	rates	after	
stoma	closure65,66.	An	adequate	preoperative	risk	analysis	could	aid	surgeons	and	
their	 patients	 in	 the	 decision	 making	 process	 regarding	 the	 construction	 of	
temporary	ostomies.		
There	 are	 already	 some	 prediction	 measures	 available	 for	 clinical	 practice,	
however	these	are	designed	to	detect	anastomotic	leakage	in	an	early	stage,	such	as	
the	 DULK	 score	 or	 the	 PREDICS	 study67,68.	 Both	 scores	 are	 based	 on	 clinical	
markers,	indicating	a	‘sick’	patient	at	risk	of	having	AL.	Moreover,	these	studies	also	
suggest	 using	 their	 scores	 as	 a	 tool	 for	 safe	 and	 early	 discharge	 after	 elective	
colorectal	 surgery,	 just	as	 the	 IMACORS	study69.	 In	 this	 study	procalcitonin	 (PCT)	
and	C‐reactive	protein	 (CRP)	was	 studied	 and	 showed	 that	CRP	 is	more	 accurate	
than	PCT	for	the	detection	of	infectious	complications.	However,	their	conclusion	is	









has	 not	 been	 found71.	 Perhaps	 the	 Dutch	 Taskforce	 on	 Anastomotic	 Leakage	 can	
play	a	 role	 in	 analysing	which	 score	 is	most	 accurate	 for	 the	detection	of	AL	 and	
implement	 one	 of	 these	 scores	 into	 the	 Dutch	 guidelines	 for	 postoperative	 care	
after	colorectal	surgery.	
Recently,	a	new	prognostic	 index	called	PROCOLE	was	designed	 to	predict	 the	
risk	 of	 a	 certain	 individual	 developing	 AL	 after	 colorectal	 surgery72.	 The	 big	
difference	with	our	REVEAL	study	is	that	the	PROCOLE	is	solely	based	on	potential	
risk	 factors	 already	 described	 in	 literature	 and	 is	 therefore	 –	 until	 now	 –	 only	 a	
theoretical	index,	not	taken	individual	measurements	into	account.		
The	 successful	 implementation	of	 risk	 assessment	 tools	 that	 can	be	 the	 result	
from	the	REVEAL‐study	would	have	a	positive	influence	on	morbidity	and	mortality	
rates,	 duration	 of	 hospital	 stay,	 number	 of	 readmissions,	 re‐interventions	 and	




be	 to	 completely	 elucidate	 the	 healing	 process	 and	 the	 multifactorial	
pathophysiology	that	leads	to	anastomotic	leakage.	In	the	future	there	should	be	an	
interplay	between	clinical	findings	and	experimental	results	that	will	continuously	
influence	 one	 another;	 observed	 risk	 factors	 in	 the	 clinic	 should	 be	 further	





Numerous	 studies	 have	 focused	 on	 the	 effect	 of	 a	 certain	 intervention	 on	 the	AL	
rate,	 without	 studying	 the	 biochemical	 process	 of	 anastomotic	 healing	 first.	 An	
international	 summit	 on	 intestinal	 AL	 concluded	 that	 research	 into	 the	
pathogenesis	of	AL	could	be	advanced	markedly	by	performing	additional	analyses	
in	human	anastomotic	tissues	during	and	after	surgery73.	The	use	of	human	tissue	
will	 lead	 to	 a	 reduced	 demand	 of	 experimental	 research,	 thereby	 reducing	 the	
numbers	 of	 animals	 that	 are	 being	 used	 nowadays.	 Furthermore,	 with	 current	
technologies,	we	are	capable	of	 replacing	animals	with,	 for	example,	organoids	 to	
investigate	 the	molecular	 process	 of	 intestinal	 healing	 in	more	 detail	 or	 to	 use	 a	







from	 the	 largely	 unexplained,	 complicated	 biological	 process	 of	 anastomotic	
healing.	Anastomotic	healing	should	be	completely	elucidated	 in	order	 to	develop	
interventions	that	may	stimulate	anastomotic	healing	and	subsequently	prevent	AL.	
New	 studies	 should	 focus	 on	 identifying	 risk	 factors	 for	 AL	 before	 starting	 large	
randomized	controlled	trials	for	specific	interventions.	This	can	positively	influence	
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carcinoom	 (CRC)	 gediagnostiseerd.	 Het	 was	 daarmee	 de	 meest	 voorkomende	
oncologische	 aandoening	 in	 2015,	 bij	 zowel	 mannen	 als	 vrouwen.	 Het	 aantal	
patiënten	 met	 CRC	 zal	 toenemen	 door	 een	 stijgende	 incidentie,	 door	 de	
bevolkingsgroei,	 door	 de	 vergrijzing	 en	 door	 het	 recent	 gestarte	 bevolkings‐
onderzoek.	Jaarlijks	overlijden	4.000	mensen	aan	de	gevolgen	van	CRC.	Twee	derde	
van	 de	 patiënten	 met	 CRC	 ondergaat	 een	 operatieve	 behandeling	 waarbij	 de	
darmtumor	verwijderd	wordt.	Dit	blijft	ondanks	allerlei	nieuwe	(radio)therapieën	
de	hoeksteen	van	de	behandeling	voor	colorectaal	carcinoom.	Het	beloop	rondom	
de	 operatie	 bij	 colorectale	 chirurgie	 is	 cruciaal	 voor	 de	 klinische	 uitkomst	 met	
betrekking	 tot	 overlijden	 en	 functioneel	 herstel.	 Daarnaast	 heeft	 deze	 operatieve	
behandeling	een	grote	impact	op	de	zorgkosten.		
In	 de	 afgelopen	 decennia	 is	 de	 perioperatieve	 zorg	 verbeterd	 dankzij	
ontwikkelingen	 in	de	anesthesie,	minimaal	 invasieve	operatieve	 technieken	en	de	
introductie	van	‘fast‐track’	protocollen	welke	gericht	zijn	op	een	snel	postoperatief	
herstel	 van	 de	 patiënt.	 Er	 ontstaan	 echter	 nog	 steeds	 complicaties	 na	 colorectale	
chirurgie,	waarvan	naadlekkage	de	meest	gevreesde	is.	Naadlekkage	ontstaat	als	de	
twee	aan	elkaar	gemaakte	darmuiteinden	‐	de	darmnaad	oftewel	anastomose	‐	niet	
goed	 geneest;	 de	 darminhoud	 lekt	 dan	 in	 de	 buikholte	wat	 kan	 leiden	 tot	 onder	
andere	buikvliesontsteking	en	abcesvorming.		
Bij	 712	 van	 de	 10.426	 (6,8%)	 geregistreerde	 patiënten	 met	 een	 colorectale	
resectie	 ontstond	 in	Nederland	 in	2014	een	naadlekkage	met	 een	heroperatie	 tot	
gevolg	 (Dutch	 Surgical	 Colorectal	 Audit	 (DSCA)	 2014).	 Dit	 ging	 gepaard	met	 een	
hoge	 morbiditeit,	 verlengd	 ziekenhuisverblijf	 en	 zelfs	 mortaliteit.	 Naadlekkage	
wordt	 bovendien	 geassocieerd	 met	 verminderde	 ziekte‐specifieke	 overleving	 en	
toegenomen	kans	op	het	 terugkeren	van	colorectaal	carcinoom.	De	 incidentie	van	
naadlekkage	is	helaas	gelijk	gebleven	in	de	afgelopen	decennia,	dit	komt	met	name	
door	 het	 gebrek	 aan	 kennis	 van	 een	 normale	 naadgenezing	 (Hoofdstuk	 1).	 Het	
proces	van	wondgenezing	in	de	darm,	bijvoorbeeld	bij	het	aanleggen	van	een	naad,	
wordt	 vaak	 vergeleken	 met	 wondgenezing	 van	 de	 huid.	 De	 darmgenezing	 vindt	
inderdaad	 plaats	 in	 de	 drie	 bekende	 fasen	 van	 ontsteking,	 proliferatie	 en	
remodelling.	Er	zijn	echter	ook	substantiële	verschillen;	 zo	gaat	de	darmgenezing	
veel	 sneller	 dan	 de	 genezing	 van	 de	 huid,	 zijn	 er	 verschillende	 cellen	 en	 stoffen	







worden	 hiervoor	 proefdieren	 gebruikt,	 waarin	 een	 darmnaad	 gemaakt	 wordt.	
Omdat	het	nog	onmogelijk	is	de	darmgenezing	op	moleculair	niveau	bij	de	mens	in	
kaart	 te	 brengen	 wordt	 ook	 in	 de	 experimenten	 beschreven	 in	 dit	 proefschrift	
gebruikt	gemaakt	van	diermodellen.		
Niet	alle	modellen	worden	even	vaak	 in	de	 literatuur	gebruikt.	Teneinde	meer	
duidelijkheid	 over	 deze	 modellen	 en	 vergelijkbaarheid	 tussen	 de	 verschillende	
studies	 te	verkrijgen,	 is	het	cruciaal	dat	onderzoekers	overeenstemming	bereiken	
over	wat	belangrijk	is	bij	het	onderzoek	naar	darmnaden.	Om	die	reden	hebben	we	
een	 Delphi‐analyse	 uitgevoerd.	 Dat	 is	 een	 onderzoeksmethode	 waarbij	 de	
meningen	van	een	groot	aantal	experts	wordt	gevraagd	en	door	de	antwoorden	van	
de	 experts	 anoniem	 terug	 te	 koppelen	 aan	 eenieder	 wordt	 in	 een	 aantal	 rondes	
geprobeerd	 tot	 consensus	 te	 komen.	Een	van	de	uitkomsten	van	deze	 studie	was	
dat	de	hond	en	het	konijn	geen	gevalideerde	modellen	zijn	voor	dit	soort	onderzoek	




door	 de	 respondenten	 als	 zeer	 geschikt	 bevonden,	 hoewel	 de	 bruikbaarheid	 nog	
bewezen	dient	te	worden	in	de	praktijk.		
	
Ondanks	 de	 hoeveelheid	 studies	 die	 worden	 uitgevoerd	 naar	 het	 onderwerp	
naadlekkage,	is	het	nog	steeds	onduidelijk	hoe	zo’n	naadlekkage	eigenlijk	ontstaat.	
We	weten	niet	goed	wat	er	mis	gaat	bij	normale	naadgenezing	wat	leidt	tot	lekkage	
van	darminhoud.	Om	het	naadgenezingsproces	meer	 in	detail	 in	kaart	 te	brengen	
hebben	 we	 gebruik	 gemaakt	 van	 de	 relatieve	 nieuwe	 techniek	 ‘massa‐
spectrometrie	 imaging’	 (Hoofdstuk	 3).	 Deze	 techniek	 stelt	 ons	 in	 staat	 om	
onderscheid	 te	 maken	 tussen	 de	 verschillende	 lagen	 van	 de	 darmwand	 en	
specifieke	 stoffen	 te	 identificeren	 als	 potentiele	 aangrijpingspunten	 om	 het	







en	 experimenteel	 onderzoek	 dat	 patiënten	 die	 bepaalde	 pijnstillers	 met	
ontstekingsremmende	werking,	 zogenaamde	NSAIDs,	 kregen	 rondom	de	 operatie	




op	 naadlekkage;	 zo	 is	 aangetoond	dat	 remming	of	 depletie	 van	 het	 enzym	Cyclo‐





Verder	 zijn	 er	 aanwijzingen	 dat	 een	 normale	 samenstelling	 van	 de	 slijmlaag	
(mucus)	in	de	darm	belangrijk	is	bij	de	normale	naadgenezing.	Zo	zagen	we	dat	het	




mucuslaag	 in	de	darmen	geen	natuurlijke	habitat	 is	 voor	 verschillende	bacteriën.	
Bacteriën	 zijn	 essentieel	 om	het	 natuurlijk	 evenwicht	 in	 de	darmen	 te	 behouden.	
Een	van	de	taken	van	de	bacteriën	in	de	darm	is	vezels	uit	de	voeding	af	te	breken	
naar	kleinere	deeltjes	waar	wij	energie	uit	kunnen	halen.	Bij	deze	omzetting	komen	
korte‐keten	 vetzuren	 vrij,	 stofjes	 die	 weer	 door	 de	 darmcellen	 als	 voedingsstof	
gebruikt	kunnen	worden.	Een	van	die	korte‐keten	vetzuren	is	butyraat.	Dit	stofje	is	
al	 vaker	 onderzocht	 in	 de	 darm	 en	 er	 is	 aangetoond	 dat	 dit	 de	 naad	 versterkt	
wanneer	dit	als	klysma	wordt	gegeven	in	ratten.	In	dit	proefschrift	is	getracht	een	
betere	 methode	 dan	 klysma’s	 uit	 te	 testen	 om	 zo	 ook	 darmnaden	 in	 het	 colon	
hogerop	 (proximaal)	 te	 kunnen	 versterken,	 alsmede	 het	 butyraatklysma	 te	
verrijken	 met	 andere	 stoffen	 (Hoofdstuk	 6).	 Helaas	 leverden	 deze	 experimenten	
weinig	nieuwe	inzichten	op	en	lijkt	butyraat	suppletie	middels	klysma	toch	de	beste	
optie.	 In	 de	 kliniek	 is	 men	 echter	 terughoudend	 met	 het	 geven	 van	 klysma’s	
wanneer	 een	 darmnaad	 is	 aangelegd.	 Artsen	 zijn	 bezorgd	 dat	 het	 klysma	 door	






om	 preventie	 van	 naadlekkage	 middels	 een	 lijm	 of	 een	 patch	 te	 bereiken.	 In	
hoofdstuk	7	onderzochten	we	verschillende	commercieel	verkrijgbare	lijmen	en	het	
effect	daarvan	op	het	ontstaan	van	naadlekkage,	stenose	en	algeheel	welzijn	van	de	




















(Hoofdstuk	 8).	 Voorzichtigheid	 is	 dus	 geboden	wanneer	 het	 gaat	 om	 het	 gebruik	
van	 nieuw	 ontwikkelde	 materialen.	 Naast	 effectiviteit	 is	 veiligheid	 ook	 een	
belangrijk	 punt	 voor	 het	 testen	 in	 een	 diermodel.	 Zo	 zijn	 adhesies	 veel	








materialen	 te	 testen.	 Er	 wordt	 er	 dus	 nog	 steeds	 gebruik	 gemaakt	 van	 dier‐





Het	 proces	 van	 naadlekkage	 na	 dikke‐darm	 chirurgie	 blijft	 tot	 op	 heden	nog	 niet	
opgehelderd.	 Hierdoor	 blijken	 veelbelovende	 technieken	 ter	 preventie	 van	
naadlekkage	 in	 de	 klinische	 praktijk	 helaas	 niet	 succesvol.	 Wanneer	 de	
pathofysiologie	van	naadlekkage	beter	in	beeld	kan	worden	gebracht	kan	dit	leiden	
tot	nieuwe	aangrijpingspunten	waarmee	 in	de	 toekomst	het	 genezingsproces	 van	
de	 darmnaad	 kan	 worden	 verbeterd	 en	 daarmee	 naadlekkage	 kan	 worden	
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Valorisation	 is	often	defined	as	 the	process	of	 value	 creation	 from	knowledge,	by	
making	 it	 applicable	 and	 available	 for	 economic	 or	 societal	 utilisation,	 and	 by	
translating	it	in	the	form	of	new	business,	products,	services	or	processes1.		
	
The	 aim	 of	 this	 chapter	 is	 to	 take	 a	 brief	 look	 upon	 the	 return	 of	 investment	
society	 has	 received	 from	 the	 knowledge	 gathered	during	 this	 PhD	 trajectory.	As	
the	work	in	this	thesis	largely	focuses	on	experimental	animal	studies,	it	is	evident	
that	 not	 all	 results	 can	 directly	 be	 translated	 to	 the	 clinical	 setting.	 Here	 the	
translation	 of	 our	 academic	 findings	 regarding	 possibilities	 for	 future	
implementation	and	economic/societal	value	will	be	discussed.		
Economical	relevance		
This	 thesis	 focused	on	the	problem	of	anastomotic	 leakage,	a	severe	complication	
after	 colorectal	 surgery.	 The	 burden	 to	 society	 of	 colorectal	 cancer	 surgery	 can	
significantly	 be	 reduced	 by	 implementation	 of	 the	 knowledge	 obtained	 from	 this	
project	 for	 several	 reasons.	 In	 the	Netherlands	 approximately	 10.000	 oncological	
colorectal	operations	are	performed	each	year2.	With	an	 incidence	 in	anastomotic	
leakage	of	about	15%,	this	implies	1500	cases.	Notably,	the	incidence	of	colorectal	
carcinoma	 is	 expected	 to	 rise	 in	 the	 coming	 years	 due	 to	 national	 screening	





in	 this	 thesis	 ‐,	 preventing	 complications	 in	 approximately	 500	patients	 yearly	 in	
the	Netherlands.	With	a	mortality	of	15%,	roughly	75	deaths	can	be	prevented	each	




operating	 room,	 stoma‐related	 complications,	 re‐intervention	 for	 ostomy	 closure,	
longer	nursing	care,	materials	(e.g.	antibiotics,	ostomy	bags)3.	It	has	been	estimated	





have	 a	 scale	 of	 charges	 for	 individual	 consultations	 and	 services	 involved.	
Moreover,	the	costs	of	rehabilitation,	physiotherapy,	prolonged	absence	from	work	
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also	 has	 significant	 advantages	 for	 patients	 who	 undergo	 colorectal	 surgery;	 as	
anastomotic	leakage	is	associated	with	high	disability,	diminished	quality	of	life	and	
a	 potential	 worse	 oncological	 outcome6,7.	 In	 2008	 a	 study	 was	 published	 that	
describes	 how	 patients	 receiving	 a	 stoma	 after	 colorectal	 surgery	 had	 poorer	
quality	 of	 life,	 lower	 body	 image,	 poor	 social	 activity	 and	 also	 had	 significantly	
higher	depression	and	anxiety8.	All	 these	morbidities	can	be	explained	by	the	fact	
that	these	patients	face	problems	including	adapting	to	the	new	anatomy,	managing	
the	 stoma	 and	 continuing	 normal	 activities	 in	 their	 socio‐cultural	 environment.	
Also,	work	productivity	of	these	patients	decreases	significantly	due	to	the	level	of	
disability	related	to	multiple	abdominal	operations	or	presence	of	a	stoma.	Finally,	
anastomotic	 leakage	 itself	 has	 an	 adverse	 effect	 on	 postoperative	 health‐related	




anastomosis	 and	 identifying	 local	 molecular	 and	 biochemical	 responses	 that	
disturb	healing	is	scientifically	relevant	in	itself.	In	depth	studies	into	this	topic	are	
essential	 in	 order	 to	 develop	 effective	 strategies	 and	 agents	 to	 combat	 healing	
disturbance	 and	 to	 prevent	 leakage.	 Knowledge	 gained	 on	 disturbed	 bowel	
anastomotic	 healing	 can	 be	 tested	 on	 other	 intestinal	 anastomoses,	 such	 as	
pancreatic	and	esophageal	anastomoses,	that	are	known	to	frequently	leak.	In	this	
thesis	 relative	 new	 techniques	 such	 as	 mass	 spectrometry	 were	 used	 in	 a	 pilot	
study	 and	 this	 study	 will	 be	 able	 to	 define	 the	 value	 of	 mass	 spectrometry	 in	
identifying	biochemical	processes	in	the	gut	wall.	This	may	reveal	data	relevant	for	
other	pathophysiological	processes,	such	as	cancer	development	and	inflammatory	
bowel	 disease	 and	 diverticulitis.	 In	 addition	 to	 new	 techniques,	 relatively	 new	
animal	models	were	used	to	investigate	leakage	prevention.		
Use	of	animal	models	
The	 studies	 performed	 during	 this	 PhD	 thesis	 focused	 on	 risk	 factors	 of	
anastomotic	leakage	on	the	one	hand	and	on	potential	preventive	interventions	on	
the	other	hand.	The	latter	was	extensively	studied	in	the	European	AnastomoSEAL	
project10.	 The	 AnastomoSEAL	 Consortium	 worked	 on	 the	 development	 of	 a	 new	
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product	 to	 prevent	 anastomotic	 leakage.	 AnastomoSEAL	 was	 produced	 as	 a	
biocompatible,	 resorbable	 sealant	 patch	 that	 was	 applied	 around	 the	 site	 of	
anastomosis;	 unfortunately	 this	 project	 did	 not	 reach	 its	 final	 goal,	 since	
experimental	studies	showed	unexpected	adverse	events.	The	use	of	animal	models	







in	 this	 type	 of	 research.	 Furthermore,	 more	 standardization	 can	 be	 reached	 by	
following	 the	 ARRIVE	 guidelines11.	 Experienced	 researchers	 in	 the	 field	 are	
convinced	that	this	provides	more	transparency	and	more	comparability	between	
studies.	 In	 addition,	 experts	 on	 intestinal	 anastomotic	 leak	 have	 held	 an	
International	 Summit	 (first	 in	 2012,	 recently	 in	 2016)	where	 the	majority	 of	 the	
respondents	 consider	 that	 current	 experimental	 animal	 models	 of	 anastomotic	
leakage	are	useful	 and	 should	 continue12.	However,	 they	also	advocate	 the	use	of	
human	 anastomotic	 tissues	 for	 more	 analytical	 research	 and	 promote	 clinical	
studies	to	define	and	characterize	the	biological	variables	that	are	associated	with	
anastomotic	healing	versus	 leakage.	The	REVEAL	study	 (started	Summer	2015	 in	
Maastricht)	 aims	 to	 establish	 and	 validate	 a	 diagnostic	 algorithm	 for	 the	 pre‐
operative	 prediction	 of	 AL	using	 a	 combination	of	 inflammatory,	 immune‐related	
and	genetic	parameters13.	With	the	results	from	the	REVEAL	study,	the	recognition	
of	 patients	 who	 are	 at	 risk	 for	 AL	 is	 expected	 to	 increase;	 subsequently	
recommendations	for	patients	at	risk	can	be	made	regarding	deviating	stomas	and	
possible	 preventive	 strategies.	 Lastly,	 the	 REVEAL	 study	 aims	 to	 develop	 an	
algorithm	 for	 post‐operative	 diagnosis	 of	 AL	 at	 an	 earlier	 stage,	 which	 will	
positively	reflect	on	short‐term	survival	rates.	
Perspective	on	knowledge	utilisation	
During	 the	 work	 for	 this	 thesis,	 collaboration	 with	 several	 national	 and	
international	 scientists	 has	 been	 established.	 These	 partnerships	 are	 crucial	 to	
accelerate	research,	improve	transparency	between	research	centres	(Rotterdam	&	
Nijmegen)	and	to	direct	cross‐fertilize,	which	 leads	 to	 innovation.	Furthermore,	 it	
can	 be	 considered	 irrational	 that	 in	 a	 relative	 small	 country	 as	 the	 Netherlands	
researchers	are	investigating	the	same	topics,	unintentionally	delaying	work	–	not	
to	 mention	 wasting	 time	 and	 money	 –	 that	 may	 lead	 to	 the	 solution	 of	 AL;	 an	
important	health	problem	that	is	too	extensive	to	be	studied	by	a	single	researcher.	
Therefore,	 the	 taskforce	 anastomotic	 leakage	 was	 re‐established	 (as	 part	 of	 the	
work	 group	 Coloproctology),	 with	 the	 purpose	 to	 provide	 more	 transparency	 in	
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current	 experimental	 research,	 national	 registration	 of	 patients	 with	 AL	 and	
increase	collaboration	regarding	the	conduction	of	clinical	studies14.	This	is	in	line	
with	one	of	the	aims	of	the	Dutch	Organization	for	Scientific	Research	(NWO):	that	
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Allereerst	 natuurlijk	 mijn	 promotor	 en	 co‐promotor,	 ik	 had	 met	 geen	 ander	
team	dit	willen	meemaken….	
Prof.	 Bouvy,	 beste	Nicole,	 als	 jij	 niet	 m’n	 promotor	 was	 geweest	 had	 ik	
nooit	zo’n	leuke	tijd	gehad!	Altijd	welkom	om	even	binnen	te	lopen,	even	te	bellen,	





Ik	 hoop	 dat	 we	 in	 de	 toekomst	 nog	 veel	 zullen	 samenwerken	 en	 ben	 je	 erg	
dankbaar	voor	alle	mogelijkheden	die	je	me	hebt	gegeven	de	afgelopen	jaren!	
Dr.	 Derikx	 ofwel	 Professor	 Joep,	 ook	 al	 ben	 je	 dan	 officieel	 nog	 geen	
professor,	 aan	 je	 kennis,	 kunde	 en	 inzet	 zal	 het	 niet	 liggen.	 Jij	 bent	 de	 meest	
enthousiaste	dokter	die	ik	ken,	zowel	over	klinische	zaken	als	over	het	onderzoek.	






De	 leden	 van	 mijn	 promotiecommissie,	 allereerst	 natuurlijk	 Prof.	 Stassen,	
bedankt	voor	het	vertrouwen	 in	zowel	mijn	wetenschappelijke	werk	als	klinische	
potentie.	Prof.	van	Goor,	dank	u	wel	voor	de	samenwerking,	aan	de	ideeën	zal	het	
niet	 liggen,	 jammer	 dat	 de	 tijd	 en	 moeite	 (nog)	 niet	 heeft	 geresulteerd	 in	 de	
financiële	boost	waar	we	op	gehoopt	hadden.	Dr.	Roumen	en	Dr.	Jonkers,	helaas	
nog	 niet	 veel	 intensief	 samengewerkt,	 maar	 daardoor	 kon	 u	 wel	 in	 de	
beoordelingscommissie	 plaatsnemen:	 heel	 veel	 dank	 voor	 het	 lezen	 en	 kritisch	
beoordelen	 van	 dit	 manuscript.	 Daarnaast	 in	 het	 bijzonder	 Steven,	 we	 hebben	























hair:	 volgens	mij	 heb	 ik	 inmiddels	met	bijna	 iedereen	van	het	 lab	wel	 een	kamer	
gedeeld,	 maar	 gezien	 de	 jaloezie‐app	 –	 laten	 we	 in	 het	 midden	 houden	 wie	 nou	
wel/niet	jaloers	was	op	wie	–	en	het	feit	dat	jullie	bij	mijn	laatste	meest	stressvolle	














Dirkster,	 ben	 jou	 en	 Kostan	 nog	 steeds	 dankbaar	 dat	 jullie	 me	 in	 de	 kelder	
hebben	achtergelaten	hoewel	ik	destijds	alleen	maar	kon	huilen	dat	ik	in	mn	uppie	
met	die	knaagdieren	zat.	De	enige	manier	om	 iets	 te	 leren	 is	om	het	zelf	 te	doen,	
daar	heb	je	helemaal	gelijk	 in,	maar	een	experiment	door	 jou	te	 laten	voordoen	is	
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van	 binnen	 ;)	 Later	 tijdens	 ons	 gezamenlijk	 ANIOSsen	 werd	 dat	 meer	 dan	 eens	
duidelijk!	 Ben	 trots	 op	 je	 dat	 je	 je	 hart	 gevolgd	 hebt	 en	 als	 ik	 niet	 uit	 iets	
microscopisch	kom	ben	 jij	de	1e	die	 ik	bel!	Mo	met	de	bulderlach	–	altijd	 leuk	om	






Sander,	 verenigd	 door	 onze	 voorliefde	 voor	 mucus	 en	 lekker	 weer,	 bedankt	
voor	alle	tips	en	tricks	zowel	qua	onderzoek	als	bij	de	gezelschapsspellen.		
	










Het	 leuke	 aan	 een	 groot	 lab	 is	 dat	 je	 met	 heel	 veel	 verschillende	 mensen	
samenwerkt	 en	 dus	 ook	 veel	 verschillende	 dingen	 kan	 delen..	 in	 willekeurige	
volgorde:	Lieve	Lori	 fijn	dat	als	we	samen	eten	er	ook	echt	gekletst	en	geluisterd	
wordt,	let’s	keep	it	up,	maar	dat	gaat	helemaal	goedkomen	nu	we	herenigd	zijn	en	
de	 aankomende	 6	 jaar	 alle	 cursussen	 samen	 gaan	 volgen,	 ons	 vol	 storten	 in	 de	
opleiding	en	nog	veel	WBS’sen	onveilig	gaan	maken	met	onze	dansmoves!		
Lieve	 Briete	 &	 Yvonne,	 mn	 favo	 Uns40	 ladies,	 altijd	 fijn	 om	 even	 langs	 te	
huppelen	 bij	 jullie,	 even	 goed	 te	 kletsen	 over	 het	 leven	 en	 te	 dromen	 over	 de	
toekomst.	 Jasper	&	Tim,	 jammer	maar	misschien	 ook	 wel	 beter	 dat	 jullie	 apart	
zaten	al	die	 tijd	 ;)	Vic	 ik	ga	 je	nooit	Billy	noemen,	hoop	dat	het	goed	met	 je	blijft	
gaan	op	alle	vlakken!	Charlotte	–	altijd	het	goede	voorbeeld,	ook	nu	 in	de	kliniek	
als	mijn	mentor	;)	Altijd	mijn	go‐to‐girl	als	ik	vragen	heb	over	wat	dan	ook	en	dan	
ook	 nog	 gezellige	 eetsessies	 erbij!	 	 Givan,	 zullen	 we	 samen	 prijzen	 winnen	
voortzetten	en	vertalen	naar	goede	CASH	en	ABSITE‐scores?	 JM	 (bootypopping!),	
Liliane	 (mooi	 he,	 Afrikaanse	 billen),	Toine,	Rutger	&	RJ	 (in	 1	 adem),	Thiemo,	
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Britt,	Kirsten,	 Evelien,	Milou	 (nu	 weer	 collega’s!	),	Rianne	B,	Timme,	 Paul,	






















Lieve	 collega’s	 van	 het	 Zuyderland;	 zowel	 de	 bazen,	 assistenten	 als	
verpleging:	Ontzettend	bedankt	voor	het	warme	welkom,	de	vele	leermomenten,	de	












de	A‐KO	zijn	 jullie	mijn	medemeiden	geweest		Gek	om	zoveel	 jaren	 lief	 en	 leed	
met	elkaar	te	delen	en	dat	we	nog	steeds	zulke	goede	vriendinnen	zijn.	Ben	heel	blij	




















Liefste	 pap	 en	 mam,	 vanaf	 kleins	 af	 aan	 hebben	 jullie	 Joost	 en	 mij	 altijd	
gestimuleerd	om	het	meeste	uit	het	leven	te	halen	en	uitdagingen	niet	uit	de	weg	te	





Allerliefste	 Jules,	 ik	 had	 het	 echt	 niet	 getrokken	 zonder	 jou..	 hoe	 suf	 het	
misschien	 soms	 ook	 lijkt,	 samen	promoveren	 is	 echt	 chill..	muziekje	 aan,	 drankje	
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It	was	 during	 this	 period,	while	 simultaneously	
studying	 Pharmaceutical	 Sciences,	 that	 helped	
spark	her	interest	in	scientific	research	which	in	
turn	 motivated	 her	 to	 perform	 experiments	 in	
the	 laboratory.	 In	 2009,	 she	 received	 her	
Bachelor’s	 degree	 in	 Biomedical	 Sciences	 and	 started	 her	 research	master	 (Arts‐
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